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THE EVALUATION OF MATERNAL RH ANTIBODIES AND AN 
ASSESSMENT OF THEIR RELATION TO RH HAEMOLYTIC 
DISEASE OF THE NEWBORN 
Chapter I 
INTRODUCTION 
The association of haemolytic disease of the newborn 
with blood group differences between the mother and her 
unborn child was first recognized by Levine and Stetson 
(1939) in a patient who gave birth to a stillborn macer-
at ed fetus. They established that the mother had been 
immunized with an antigen which the infant had inherited 
from the father. It was subsequently confirmed by Land-
steiner and Wiener (1940) that the antibody described by 
Levine and Stetson was identical to the antibody they had 
obtained when rabbits were injected with Rhesus monkey 
red cells. The blood group factor associated with this 
haemolytic condition was thereafter called the Rhesus 
( Rh) f ac t or. 
It is now well established that Rh-immunization is the 
result of transplacental passage of fetal Rh-positive 
red cells into Rh-negative mothers. The effect of this 
process of immunization on the clinical condition of the 
infant starts when the maternal Rh-antibody enters the 
infant's circulation through the placenta. The an t i body 
becomes attached to the fetal Rh-positive red cells and 
shortens their life span. The degree of severity of this 
haemolytic process depends on the rate of fetal red cell 
destruction induced by the antibody and the ability of 
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the fetus to compensate by increased red cell production. 
If the rate of red cell destruction during gestation is 
greater than its production through extramedullary erythro-
poietic activity then anaemia results and may be followed 
by intrauterine death. Should the affected fetus surv ive 
the hostile in utero environment complications associa ted 
with hyperbilirubinaemia may develop which can lead to 
severe brain damage (kernicterus). 
In white American, British and South African populat-
ions haemolytic disease of the newborn due to Rhesus in-
compatibility occurs in one out of 150 full-term pregnan-
cies (Levine, Vogel and Rosenfield, 1953; Vos, 1967). 
Approximately 70 per cent of infants born with Rh haem-
olytic disease will be severely enough affected to require 
treatment (Kelsall, Vos and Kirk, 1958). Universal accept -
ance of the necessity for routine Rh-typing of all preg-
nant women, coupled with detailed antenatal serological 
investigations has now greatly simplified the problem of 
anticipating Rh haemolytic disease. However, for the 
obstetrician and paediatrician there remains the issue of 
individual prognosis and case management and it is with 
this respect that a multitude of intriguing and often un-
answerable questions can be provided by experienced immuno-
haematologists. 
During the past decade significant advances have been 
made towards the prevention of Rh haemolytic disease. 
Based on the fundamental concept that passive immunity 
can prevent active immunity (Smith, 1909), investigators 
in England and the United States were able to show that 
the simple injection of Rh antibodies into Rh-negative 
mothers can also suppress Rh immunization (Finn, Clark~, 
Conohoe, McConnell, Sheppard, Lehane and Kulke, 1961; 
Freda, Gorman and Pollack, 1963). The efficacy of this 
2 
approach has now been firmly established (Clarke, 1967; 
Pollack, Gorman, Hager, Freda and Tripodi, 1968). 
In spite of these advances in the prevention of Rh 
immunization, the risk of Rh-negative mothers becoming 
immunized to the Rhesus antigen is still high. Condition:> 
influencing the continuous occurrence of Rh immunization 
are related to several factors among which the failure of 
the mother to receive passive therapy during and after 
pregnancy IS probably the main cause. There is al so a 
good deal of evidence to suggest that the suppression of 
Rh immunization produced by anti-Rh is antigen-specific 
(Mollison, 1972). This means that the administration of 
specific anti-D prevents the formation of anti-D but not 
the formation of other types of antibodies which are 
likely to cause haemolytic disease of the newborn, e.g. 
anti-C, anti-E, anti-Kell and Fya and anti-Jka . Therefore, 
haemolytic disease of the newborn remains a significant 
c 1 in i c a I pro b I em. 
In the antenatal diagnosis of Rh haemolytic disease it 
is important that the presence of placenta-permeable anti .. 
bodies is first recognized in the maternal serum. From 
then on it can generally be expected that the severity of 
the disease process in utero will be related to the inten.o 
sity of antibody formation in the mother. Under this 
stimulus destruction of the unborn ~hild's Rh-positive 
red cells leads to the formation of various end products 
including the toxic unconjugated bilirubin which has an 
affinity for certain nerve cells in the brain. 
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Quantitative tests for the determination of unconjug-
ated bilirubin in liquor amnii will therefore directly 
reflect the intensity of fetal red cell destruction tak-
ing place in utero. The ability to predict the severity 
of Rh haemolytic disease by examining the amniotic fluid 
has been confirmed by Bevis (1956), Mackay (1961), Liley, 
(1961) and Freda, (1964). 
Although prognosis by amniotic fluid studies appears 
to be simple , a considerable number of complications can 
occur following the practise of inserting a needle into 
the uterus (amniocentesis). The most common hazards are: 
(1) damage to fetal blood vessels on the surface of the 
placenta, which has been reported to occur in nearly 15 
per cent of patients (Zilliacus and Ericksson, 1958); 
this complication has induced early separation of the 
placenta causing fetal death in a number of instances 
(Mayer, 1963); (2) if the placenta is traversed at the 
puncture, fetal Rh-incompatible cells invariably enter 
the maternal circulation to intensify Rh-antibody product-
ion. Walker and Jennison (1962) reported a post-amnio-
centesis antibody rise in 41 per cent of mothers. Thus 
in those cases where fetal blood has been aspirated by 
amniocentesis the chances of increasing Rh-immunization 
and intens~fying the haemolytic process in utero are 
considerably greater. It has therefore been accepted 
that amniocentesis should be carried out only when the 
maternal antibody value is raised above a certain crit-
ical level (Queenan, 1966 ; Kubli, 1966; Vos, 1969). 
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A major problem in the application of Rh antibody 
determinations is the selection of suitable serological 
methods. In a study concerning the in vitro reactivities 
of Rh antibodies Hill and Soules (1957) showed that three 
orders of antibodies are clearly recognizable by differ-
ent testing procedures: (1) the "agglutinin"; this is an 
Rh antibody best demonstrated by its ability to agglutin-
ate cells in a medium of physiological saline; (2) the 
"agglutinoid", which can be demonstrated by the blocking 
test and ind i rect anti-human globulin test but not by any 
enzyme test, and (3) the " cryptagglutinoid", which is 
detectable by the indirect anti-human globulin test, 
albumin and other colloids and by enzyme-treated cells. 
A fourth order of Rh antibody, the "papain type" which 
was described by Dodd and Eeles (1961) is detectable 
solely by enzyme techniques. 
The relat i onship between the various orders of Rh anti-
bodies to the general immunization process has established 
that Rh antibodies measured by the indirect anti-human 
globulin test are of far greater prognostic significance 
than those determined by the albumin or enzyme tests 
(Vos, 1958; Tovey and Valaes, 1959; Zeitlin and Boorman, 
1963 ; Jacobs, 1962; Hubinot, 1961). 
A disturbing complication of the indirect anti-human 
globulin test is that considerable variation in results 
may be obtained when the same method is used by other 
workers in different laboratories (Goldsmith, Mourant 
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and Bangham, 1967). Thus it is difficult to compare the res -
ul ts obtained by one laboratory wi th those of another. 
Although this lack of agreement may reflect variations In 
individual standards of measuring Rh antibody activity, 
several other causes also cannot be ignored. For ins tanc e, 
it has now become clear that Rh antigens may occupy a 
greater, or lesser, area of the red cell membrane, de-
pending upon the zygosity of the Rh antigen and its quan-
titative distribution in family members (Rochine and 
Hughes-Jones, 1965; Masouredis, Dupuy and Elliott, 1967). 
In view of the difficulties in assessing the clinical 
conditions of this disease by serological means, extens-
ive investigations were carried out to examine the relat-
ionship of several methods of Rh antibody determination. 
(1) the standardized indirect anti-human globulin titrat-
ion test (Vos and Kirk, 1958); (2) the partial absorption 
test (Vos, 1 958) and (3) the Rh antibody inhibition test 
(Vos, 1969). It was hoped that these studies would pro-
vide valuab l e information for the evaluation of differ-
ent methods in the diagnosis of the severity of Rh haem-
olytic disease of the newborn. The development of satis-
factory testing procedures was of fundamental importance 
to the progress of the entire study. 
A notable achievement resulting from these investigat-
ions has been the acknowledgement that the partial absorpt-
ion test, described in Chapter VII, has been recommended 
as a testing procedure by the Council on Immunohaematology 




THE INDIRECT ANTIGLOBULIN TITRE 
Chapter II 
A CRITICAL EVALUATION OF TI-IE DIRECT AND INDIRECT ANTI-
HUMAN GLOBULIN TITRATION TESTS 
1. INTRODUCT ION 
Since the discovery of Rh haemolytic disease of the 
newborn by Levine and Stetson (1939) and Landsteiner and 
Wiener (1940), investigators have encountered many diff-
iculties in predicting the severity of the disease before 
birth. To evaluate the condition of the infant by clin-
ical signs only can be most misleading and clinicians are 
obliged to look to the laboratory for information to clar-
ify an otherwise obscure clinical picture. 
After much trial and error we adopted the antiglobulin 
test of Coombs, Mourant and Race (1945) as a routine pro-
c edure for the determination of the severity of Rh haem-
olytic disease. Both the direct and indirect methods 
were employed and standardized in every detail (Vos and 
Kirk, 1958). In Coombs et aI's description of the use 
of rabbit anti-human globulin serum for detecting the 
sensitization of red blood cells by Rh antibodies, they 
emphasized the necessity for several washings of the sen-
sitized cells prior to adding the antiglobulin reagent. 
In many laboratories investigators wash the sensitized 
cells by adding an excess (10 to 20 vol.) of 0.85 per 
cent saline solution, inverting the tube to resuspend 
the cells, centrifuging and removing the supernatant sal. 
ine solution and then repeating the procedure until three 
washings have been completed. 
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Serologists are aware that simple resuspension of cells 
a large volume of physiological saline solution IS in-
adequ~te for reproducible end points in titrations with 
antiglobulin reagents. We found that other laboratories 
using the same test serum and the same antiglobulin serum 
often obtained titration values that were less than our 
own; in some instances the discrepancies were startling. 
A technique was therefore devised to eliminate these diff-
erences and to make titration values obtained in various 
laboratories more comparable. This is particularly im-
portant when maternal Rh antibody titres are used as a 
guide for the induction of labour and the treatment of the 
newborn infant (Kelsall and Vos, 1955; Kelsall, Vos, Kirk 
and Shield, 1957). 
Initially our improved washing procedure consisted of 
using a Pasteur pipette to withdraw a suspension of sensit-
ized cells out of the test tube and then vigorously expell-
ing the cells back into the tube . This was repeated 10 to 
15 times to ensure thorough washing. Although this proced-
ure yielded consistent end-points in all of the titrations 
it was tedious and time-consuming. A simple machine was 
therefore designed to provide a means of shaking a rack 
of tubes at a constant speed. The results obtained show 
that sensitized cells that are washed by means of mechan-
ical agitation yield consistently higher titration values 
than do cells that are washed by means of simple resuspen-
sion In a large volume of physiological saline. 
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2. THE CELL-WASHING MACHINE 
A rack-ho l der is mounted on a rocker arm that is rigid-
ly coupled through an eccentric to a 1/20-h.p. electric 
motor than can run at 1 000 rpm. The reciprocal motion 
moves the rack-holder horizontally with a maximal displace-
ment of 1.3cm. The light aluminium rack carries 20 tubes 
(0.5 by 5,0 cm). The tubes are closed with small rubber 
stoppers and are seated on sponge-rubber cushions; they 
are held rigidly in position by a hinged plate that folds 
forward against the rubber stoppers when the rack is mount-
ed on the rack-holder. In order to facilitate rapid place-
ment and removal the rack is held on the rack-holder by 
means of a keyed slide. When removed it may be fitted 
into a stand on the operator's bench. Fig.1 IS an illus-
tration of the cell-washing machine with a rack mounted on 
the rack-holder. 
3. TECHNIQUE OF ANTIGLOBULIN TITRATION 
Indirect antiglobulin titration - The specifically react-
ive test cells are washed mechanically three times in 10 
vol of 0.85 per cent saline solution and then resuspended 
in a sufficient amount of physiological saline solution 
t o yield a 10 per cent suspension of cells. 0.4 ml of the 
undiluted se r um to be tested is pipetted into the first 
and second serial test tubes. To the second and to each 
succeeding tube, 0.4 ml of 0.85 per cent saline is added. 
Serial doubling dilutions are then prepared In the usual 
manner. To each of the tubes 0.4 ml of the 10 per cent 
suspension is added and the tubes incubated at 37° C for 
1 hr. (We have adopted the convention of calling the dil-
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Figure 1: Photograph of cell-washing 
"machine, with the rack for tubes 
mounted on the rack holder. 
1 1 
ution in the first tube 1:2). 
After incubation the sensitized cells are washed three 
times by mechanical shaking for 30 sec. each time with 20 
vol. of 0.85 per cent physiological saline. After removal 
of the supernatant fluid from the final washing two drops 
of anti-human globulin reagent (known to yield optimal re-
actions with Rh-sensitized cells) are added to the washed 
sensitized cells in the test tube. This suspension is 
then pipetted onto a glass slide so that a pool of cells 
approximately one inch in diameter is formed. The slide 
is then placed in a moist chamber at room temperature. 
After being left undisturbed for 10 minutes the slide is 
gently tilted forward and the agglutination read against 
a well-illuminated ground-glass screen using a 5 x magnif-
ication head fitting eyepiece. As a control, unsensitized 
group 0, Rh-positive cells are tested in parallel with the 
sensitized cells. 
Direct antiglobulin titration ~ Adult or infant cells 
sensitized in vivo are washed mechanically three times in 
20 vol. of O. 85 per cen t sa 1 ine sol uti on. Af ter remov ing 
the supernatant saline from the final washing, two drops 
of anti-human globulin reagent are added to the washed 
cells in the test tube. This suspension is then pipet ted 
onto a glass slide. The results are read as described 
for the indirect antiglobulin ti tration test . Group 0, 
Rh-positive nonsensitized red blood cells are used as con-
t rol s. 
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4. COMPARISON OF THE EFFECTIVENESS OF TWO CELL WASHING 
PROCEDURES 
Indirect ant i globulin titrations - Seven Rh antisera 
were titrated by the indirect antiglobulin technique and 
two procedures were used for washing the sensitized cells. 
In the first series the cells were washed three times by 
adding 10 vol. of 0.85 per cent saline solution and then 
inverting the tube in order to resuspend the cells. In 
the other series the cells were washed three times by mech-
anical agitation on the cell-washing machine for 30 sec. 
The results in Table 1 indicate that in all instances the 
end point of the titration was higher for the mechanically 
washed cells . In cases 2, 3, 5 and 6 the prozone observed 
in the lower dilutions of the manually washed cells was 
not present when the cells were washed mechanically. 
Direct antiglobulin titrations - A similar set of results 
for the direc t antiglobulin test was obtained using the 
same two methods of washing cells (Table 2) . Cases 1 to 
4 were red cells obtained from the umbilical cords of in-
fants born to Rh-immunized mothers. Cases 5 and 6 were 
adult cells that were sensitized with known Rh antisera. 
In case 5 the Rh antiserum had an indirect antiglobulin 
titre of 1:128; case 6 a titre of 1:4096. The mechanically 
washed cells yielded higher end points in four out of six 
cases. In five cases a conspicuous prozone was observed 
in the lower dilutions for the manually washed cells; this 
was absent wh en the cells were washed mechanically. 
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TABLE 1 
Compari son of indirect antiglobulin titrations using two methods of washing sensitized cells 
Case Specificity Method DILUTION OF TEST SERUM 
Num- of an t ibody of 
ber Washing 1:2 1: 4 1:8 1:16 1:32 1: 64 1: 128 1:256 1: 512 1:1024 
1 an t i-D A +++ +++ +++ ++ ++ + + W 0 0 
B ++++ ++++ ++++ +++ +++ +++ ++ + W Tr 
2 an t i-C A + ++ +++ + W Tr 0 0 0 0 
B ++++ +++ +++ +++ +++ ++ + W 0 0 
3 anti-D A ++ +++ +++ ++ + + W Tr 0 0 
B ++++ +++ +++ +++ +++ ++ + W Tr 0 
4 an t i-D A + + W Tr 0 0 0 0 0 0 
B +++ +++ ++ ++ + Vi Tr 0 0 0 
5 anti-C + A 0 W ++ +++ +++ ++ + W Tr 0 
an t i-D 
B ++++ ++++ ++++ ++++ +++ +++ +++ ++ + W 
6 an t i-D A ++ +++ ++++ +++ ++ ++ + W Tr 0 
B ++++ ++++ ++++ +++ +++ +++ ++ + W Tr 
7 an t i-D A +++ ++ + W Tr Tr 0 0 0 0 
B ++++ +++ +++ ++ + W Tr 0 0 0 
* Sensitized cells were washed 3 times in 20 vol. of 0.85 per cent sa line solution 
A - cells resuspended in physiological sa line solution by manually inverting the tube 
B - cells shaken in physiological sa line solution for 30 sec. each wash on the cell-
washing machine. 




Comparison of direct an t i glob u 1 in titration using two methods of washing sensitized cells 
Case Method DILUTION OF ANTIGLOBULIN SERUM 
Number Of 
Washing 1: 2 1: 4 1: 8 1: 16 1:32 1: 64 1: 128 1:256 1:512 1:1024 1:2048 1: 4096 1:8192 
1 A +++ +++ ++ + Tr Tr Tr ?Tr 0 0 0 0 0 
B ++++ ++++ ++++ +++ +++ ++ + W Tr 0 0 0 0 
2 A ++ +++ +++ + W Tr Tr 0 0 0 0 0 0 
B ++++ ++++ ++++ +++ +++ ++ + W Tr 0 0 0 0 
3 A ++ +++ ++++ +++ +++ ++ + + W Tr Tr ?Tr 0 
B ++++ ++++ ++++ ++++ ++++ +++ +++ ++ + + W Tr 0 
4 A + +++ ++++ ++++ +++ ++ + W W Tr Tr ?Tr 0 
B ++++ ++++ ++++ ++++ ++++ ++++ ++++ +++ +++ ++ + W Tr 
5 A +++ ++++ +++ + Tr Tr Tr 0 0 0 0 0 0 
B ++++ ++++ ++++ ++++ +++ ++ + W Tr 0 0 0 0 
6 A () 0 + +++ ++++ ++++ +++ ++ + W Tr Tr Tr 
B ++++ ++++ ++++ ++++ ++++ ++++ ++++ ++++ +++ +++ +++ + W 
~< Sensitized cells were washed 3 times in 20 vol. of 0.85 per cent physiologic sa 1 i ne sol ut ion: 
A - cells resuspended in physiologic sed ine solution by means of manually inverting the tube; 
B - cells shaken in physiologic saline solution for 30 sec. each wash on the cell-washing 
machine . 
W = weak; Tr = trace. 
..... 
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5. HAEMOLYSIS AND ELUTION OF ANTIBODIES BY MECHANICAL 
WASHING 
The amoun t of cellular damage caused by the mechanical 
washing procedure was studied by measuring the percentage 
of red cell haemolysis. Adult and cord-blood cells that 
were stored as heparinized blood at 4 0 C and then washed 
mechanically for 60 sec. with 0.85 per cent saline solut-
ion showed no measurable haemolysis when used within 24 
hours of collection. The amount of haemolysis was O. 1 
per cent for cells stored between 24 to 48 hours and it 
increased to 1.0 per cent for cells that were stored at 
4 0 C for more than 72 hours . 
The possibility that antibodies may be released from 
sensitized cells during the washing procedure was also 
studied. Adult cells that were sensitized with various 
Rh antisera were washed mechanically three times and the 
supernatant f luid from the washings was pooled. The wash 
liquor was then dialysed against gum acacia and the con-
tents of the bag reconstituted to the original volume of 
serum by add i tion of AlB serum. No unabsorbed antibody 
was detected in the wash-liquor when the ratio of cells 
to serum (10% suspension of cells) removed all the Rh 
antibodies from the original serum. When an excess of 
antibody was present in the original serum it was invar-
iably noted that similar excesses could also be found in 
the wash-liquor, although at a lower concentration than 
in the original serum. It is in such instances that a 
prozone is frequently obse r ved in direct or indirect anti-
globulin titrations when the cells are washed manually. 
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It is important to note however that even though antibod-
ies are detectable in the wash-liquor from these cells when 
they are mechanically washed, the end point in the titrat-
ion when using the anti-human globulin test was always 
considerably higher than by the manual method. 
6. DISCUSSION 
Although investigators have emphasized the importance 
of cell washing to free Rh-sensitized cells from contamin-
ation with human serum prior to adding the anti-human 
globulin reagent, little direction has been given as to 
the precise method to be used. Our studies have revealed 
that great differences in end-point can occur in the dir-
ect and indirect antiglobulin test when two different 
methods are used for washing the sensitized cells. The 
mechanical procedure for washing red blood cells for the 
anti-human globulin test has the advantage of (1) yielding 
higher titration values and (2) enabling persons to obtain 
constant and reliable results, even when they are using 
the technique for the first time. If the directions for 
performing anti-human globulin titrations are followed as 
outlined, wor kers in various laboratories should obtain 
identical values. This is particularly important if the 
anti-human g l obulin test for the quantitation of Rh anti-
bodies in the maternal serum is to be used as a prognostic 
aid in the management of such patients. 
An observation of special interest with regard to anti-
human globulin titrations is that the prozone phenomenon 
which can be observed when using manual procedures is 
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absent when the sensitized cells have been vigorously 
washed mechanically. A prozone is obtained with Rh anti-
bodies only when the sensitized cells do not absorb all 
of the antibody from the serum. If the ratio of cells to 
serum is changed in such a manner that no excess antibody 
remains, a prozone is not formed when the antiglobulin 
reagent is added. 
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The results of experiments in which the wash-liquor 
from mechanically washed, sensitized cells was reconstit-
uted to the original volume of serum, by means of dialysis, 
demonstrated that in instances where excess antibody was 
present in the original serum, antibody was also rem0ved 
from the cells by the washing procedure. This suggests 
that additional antibody is coated 100sely around the cells 
in these instances; this loosely bound antibody, if not re-
moved by vigorous washing, interferes with the antiglobulin 
reaction. The interference occurs (1) when this loosely 
bound Rh-antibody is present in excess, as in the lower 
dilutions of the indirect antiglobulin reaction, or (2) 
when the antiglobulin antibody is in excess, as in the 
lower dilutions of the direct titration with antiglobulin. 
The fact that the end point of the anti-human globulin 
titre is higher when the cells are washed mechaniGally 
than when they are washed manually (even in instances 
where free Rh-antibody is detected in the wash liquor), 
indicates that loosely bound antibody may enhance a pro-
zone phenomenon. The warning given by Coombs and his co-
workevs (1945) against too much washing because of the theor-
etical possibility that antibodies may be washed from the 
cells does not appear to apply when dealing with Rh-antibodies. 
Chapter III 
AN EVALUATION OF THE FREQUENCY OF INCREASED RH-ANTIBODY 
STIMULATION DURING PREGNANCY BY THE INDIRECT ANTIGLOBULIN 
TEST. 
1. INTRODUCT I ON 
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Since the discovery that Rh-negative mothers can be 
protected against Rh immunization by the passive adminis-
tration of anti-D gammaglobulin (Finn, Clarke, Donohoe, 
McConnell, Sheppard, Lehane and Kulke, 1961; Freda, Gorman 
and Pollack, 1964), considerable attention has been focused 
on the incidence and effect of feto-maternal bleeds occurr-
ing at delivery. Evidence that fetal red cells can find 
their way into the maternal circulation during pregnancy 
indicates that antigenic stimuli for Rh-antibody formation 
can be expected before, as well as after, the delivery of 
an Rh-positive infant (Taylor and Kullman, 1961; Robinson, 
'Villiams, Jakobowicz, Moore and Silberman, 1966). 
Even though investigators employ different methods for 
the antenatal detection of fetal red cells there is close 
agreement that the frequency of positive findings increases 
during the final months of pregnancy. While not every 
feto-maternal bleed necessarily constitutes an active pro-
cess of iso-immunization (because individual differences 
in the mechanism of antibody formation can be expected), 
it nevertheless raises the problem that antenatal haemorr-
hage from the fetus to the mother can initiate or intensify 
antibody stimulation. Antenatal variations in antibody 
specificity, nature of immunoglobulin involved, or simple 
antibody titre differences can therefore be considered as 
evidence that renewed fetal bleeds have taken place . 
Results of this investigation show that Rh-antibody 
follow-up studies performed throughout pregnancy can often 
clearly reveal the frequency of transplacental haemorrhage 
and its effect on fetal wastage. Although past observat-
ions have indicated that the initial development of Rh 
immunization occurs as a result of the trauma of parturit-
ion, we have found that it can also occur as a consequence 
of fetal bleeds during pregnancy. 
2. MATERIALS AND METHODS 
Rh-immunized mothers in this analysis were examined 
from the first trimester of pregnancy. In no ins tance 
were mothers included in whom the production of Rh anti-
bodies might have been the result of previous Rh-incompat-
ible blood transfusions and only Rh-incompatible mother-
infant combinations were examined . 
For the evaluation of Rh-antibody titres the standard-
ized method of indirect antiglobulin titration was used 
(Chapter 11) . Since the frequency of antenatal episodes 
of Rh immunization is known to differ in Rh-negative 
mothers who become immunized by fetal Rh-positive red 
cells, the question of when and how often these mothers 
do show increased episodes of antibody production was im-
portant . To determine ~hese variations the investigator 
must first resolve the accuracy of his indirect antiglob-
ul in t i tra t ion procedure. Tab Ie 3 shows tha t wi thin the 
range of one dilution tube nearly 20% of inaccurate res-
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TABLE 3 
Accuracy in evaluation of Rh-antibody titres by standardized indirect 
antiglobulin method when determined by 2 investigators (blind test) 
134 Samples of Rh Antibodies Examined 
Ti tre First Second Average Accuracy in predicting 
differences invest- invest- variat- increased ep i sodes of Rh 
igator igator ion immunization when variat-
% error % error % error ions exceed 
3 d i 1 ut ion 0.0 0.0 0.0 100% 
tubes 
2 d i 1 ut i on 6. 7 5. 9 6.3 93. "70/0 
tubes 




ults can be recorded for the same samples of blood when 
tested by two investigators. For a 2-dilution-tube diff-
erence the percentage of error is narrowed to 5%. The 
absence of titration inaccuracies exceeding three dilution 
tubes is significant in that an observed increase of this 
magnitude can confidently be regarded as a renewed episode 
of immunization. Assuming that titre difference's (!If three 
dilution tubes or more can also imply that transplacental 
passage of Rh-incompatible fetal red cells has taken place, 
then it should also be possible to assess how often such 
occurrences generally take place during pregnaney. 
3. RESULTS AND DISCUSSION 
Table 4 records an analysis of 818 Rh-negative mothers 
who were either already immunized before the present preg-
nancy or became immunized at some stage during the present 
pregnancy. The findings for different gestation periods 
clearly show that a significantly greater frequency of ep-
isodes of increased Rh-antibody production occurs after 
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32 weeks gestation. Considering that this indicates in-
creased fetal red cell leakage across the placental barrier, 
the results appear to be in agreement with the findings of 
Betke (1966) who also found a greater percentage of fetal 
red cells in t he maternal circulation towards the end of 
pregnancy. 
Table 5 records a similar investigation of the 818 Rh-
immunized mothers, comparing those who were immunized be-
fore the present pregnancy with those who were not. Of 
importance here was the observation that the frequency of 
TABLE 4 
Analysis of frequency of antenatal episodes of Rh-immunization 
observed among 818 Rh-immunized mothers examined at various 
stages of pregnancy 
Gestation range Total number Epi sodes of Rh immunization of mothers observed >!' 
examined No. % 
25 weeks or less 818 0 0.0% 
26-28 weeks 818 53 6.4 
29-31 weeks 805 106 13. 1 
32-34 weeks 773 166 21. 4 
35-37 weeks 713 254 35.6 
38-40 weeks 289 167 57. 7 





Comparative analysis of frequency of antenatal episodes of Rh immunization observed 
among mothers not immunized and those already immunized before present pregnancy 
Gestation range 






Mothers not immunized 


















Average for all gest-199 54 27. 1 
at ions 
Mothers already immunized 












Ep is odes _" 




63 10. 5 
104 18.4 
167 32. 5 




X2 (1)16.449 P = 0.001 
X2 ( 1) 9.454 P = 0.01 
X2(1) 6.771 P = 0.01 
X2(1) 3. 160 n. s. 
X2(1) 2.178n.s. 
X2 11. 838 P = 0.001 
>:< Represents Rh-antibody titre increase of 3 dilution tubes or more. 
N 
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raised episodes of immunization was significantly greater 
among mothers in whom Rh antibodies were detected for the 
first time. This increase appears to be closely associated 
with the duration of pregnancy. Mothers not immunized be-
fore the present pregnancy recorded a significantly greater 
frequency of episodes of immunization before 35 weeks of 
pregnancy than the Rh-negative mothers who were already 
immunized. 
It would be unrealistic to assume that such differences 
are directly influenced by significant variations in the 
incidence of transplacental bleeds occurring between moth-
ers immunized and not immunized before the present preg-
nancy, and the most likely explanation for the decreased 
occurrence of episodes of immunization is that the mother 
who is already immunized has a remarkable ability to con-
ceal the recognition of the fetal Rh-positive antigen as a 
potential stimulus. Such a hypothesis seems quite accept-
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able when we consider that these mothers can only be the 
recipients of fetal Rh-positive red cells which were al-
ready sensitized in utero by placenta-permeable antibodies, 
whereas mothers who were not immunized before the present · 
pregnancy were more often exposed to fetal red cells poss-
essing the full expression of the Rh antigen. As such, the 
mechanism of Rh-antibody stimulation is comparable with the 
studies of Stern, Goodman and Berger (1961). They showed 
that sensitized Rh-positive red cells are far less antig-
enic than unsensitized red cells and these findings led to 
the evaluation of the prevention of Rh immunization by the 
injection of anti-D immunoglobulin. 
If the indication of apparent suppression of increased 
antibody production is an accurate deduction of the exper-
i mental findings of Stern et al. (1961) it can be seen that 
this protection is not constant throughout pregnancy_ In 
fac t, it appears to decrease among the pre-immunized moth-
ers as pregnancy progresses towards term. Since only small 
transplacental bleeds are expected before 30 weeks of preg-
nancy, with more profuse bleeds generally occurring after 
this time (Betke, 1966), it is possible that a breakdown 
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in protection is induced by the introduction of signific-
ant variations in the amount of Rh-positive red cells cross-
ing the placental barrier after 30 weeks' gestation. This 
situation bears a striking resemblance to the inability of 
anti-D gammaglobulin to secure complete protection against 
rhesus immunization when massive feto-maternal bleeds take 
plac e (Dudok de Wit and Borst-Eilers, 1968; Woodrow, Bow-
ley, Gilliver and Strong, 1968). 
These deve l opments suggest that there are at least two 
way s in which the intensity of increased Rh- antibody pro-
duction can be stimulated during pregnancy. One is the re-
suI t of imperfectly understood defects of the placenta, 
which allow greater quantities of fetal red cells into the 
maternal circulation, while the other is undoubtedly close-
I y assoc ia ted wi th external vers ion, (Vos, 1967; Rob inson, 
Williams, Jakobowicz, Moore and Silberman, 1966), the re-
peated application of abdominal amniocentesis, (Zipursky, 
Pollock, Chown and Israels, 1963), or certain modes of 
obstetric management during the third stage of labour 
(Morrison, 1967). 
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The results so far presented show that fetal red cells 
often cross the placental barrier to stimulate increased 
Rh-antibody pr,oduction in the mother. Not yet firmly 
established, however, is the effect of these episodes of 
immunization on the clinical manifestation of Rh-haemolytic 
disease. Table 6 details an analysis of 208 mothers' who 
for the first time showed Rh antibodies during ap Rh-incom-
patible pregnancy. It is interesting to note that fetal 
wastage {combined stillb~rths and neonatal deaths} can be 
anticipated in the first immunizing pregnancy. Thus, the 
tendency to consider all primary immunization cases as 
mildly affected infants, who generally do not require 
further treatment, will involve a certain amount of risk 
unless constant follow-up studies are carried out to meas-
ure the intensity of the haemolytic process in utero. 
Compared with the values of fetal wastage observed 
among the already immunized series of mothers {Table 7}, 
it is significant that fetal losses among the primary 
immunization ca'ses consistently took place after 35 weeks 
of pregnancy when Rh-antibody stimulation appeared to be 
most intense. This type of pattern suggests that the time 
during which an Rh-positive fetus is exposed to Rh-antibod-
ies is of some importance in determining the severity of 
the h~emolytic process in utero. 
The findings presented in Tables 6 and 7 show that a 
significant percentage of fetal wastage can be attributed 
to the occurrence of renewed episodes of Rh-antibody stim .. 
ula t ion. This implies that the protective factor against 
increased Rh-antibody formation in the already immunized 
mother can be reversed through the reactivities of pro-
gressively large fetal bleeds, which in turn intensify 
the haemolytic process. 
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TABLE 6 
Evaluation of incidence of fetal wastage (stillbirths and neonatal deaths) in relation 
to antenatal episodes of increased Rh-antibody production observed for 208 mothers who 
were not immunized before present pregnancy 
Total No. 
Gestation range of mothers 
observed 
ANTENATAL EPI SODES OF IMMUNIZATION 
Observed* Not observed 
Fetal wastage Fetal wastage 
No. % No. % No. 0/0 No. % 
25 weeks or less 208 0 0 0 0 208 100.0 0 0 
26-28 weeks 208 27 12. 9 0 0 181 87. 1 0 0 
29-31 weeks 208 43 20.6 0 0 165 73.4 0 0 
32-34 weeks 208 62 29. 8 0 0 146 70.2 0 0 
35-37 weeks 200 87 43.5 2 2.3 113 56.5 0 0 
38-40 weeks 167 109 65.2 5 4.6 58 34.8 1 1.7 




Evaluation of incidence of fetal wastage (stillbirths and neonatal deaths) in relation 
to antenatal episodes of increased Rh-antibody production observed for 610 mothers who 
were already immunized before present pregnancy 
Total No. ANTENATAL EPISODES OF IMMUNIZATION 
of mothers 
Gestation range observed Ob served ':' Not ob served 
Fetal wastage Fetal wastage 
No. % No. % No. % No. "0 
25 weeks or less 610 0 0 0 0 610 100.0 0 0 
26-28 weeks 610 26 4. 2 10 38.4 584 95.8 3 O. 5 
29-31 weeks 597 63 10. 5 27 42.7 534 89.5 5 1. 0 
32. 34 weeks 565 104 18.4 26 25.0 461 81. 6 8 1.7 
35-37 weeks 513 167 32. 5 49 29. 3 346 67.5 21 6. 0 
38-40 weeks 122 58 47.5 8 13. 7 64 52. 5 3 4.6 




THE EFFECT OF EXTERNAL VERSION ON INCREASED RH-ANTIBODY 
STIMULATION DURING PREGNANCY 
External version is known to be associated with in-
creased transplacental haemorrhage (Robinson et al. 1966). 
It was therefore important to investigate the potential 
hazards of this procedure in Rh haemolytic disease. 
To determine the frequency and intensity of antenatal 
Rh-immunization as a result of external manipulation we 
examined two separate hospital recording systems. They 
comprised laboratory estimations and clinical follow-up 
reports which when combined revealed those patients who 
were subjected to external version and those who were not. 
The fact that this information was not routinely requested 
by the investigator before this study commenced, or during 
the time that the Rh-negative mothers were examined for Rh 
antibodies, shows that bias was avoided in evaluating the 
effect of external version on antenatal immunization. 
Only Rh-negative mothers examined from the first tri-
mester of pregnancy were included so that the frequency of 
the first occurrence of Rh antibodies or subsequent in-
creases in Rh antibody production could be measured. 
Of the 227 cases selected 119 formed the external ver-
sion series and 108 the control series. Only Rh-incompat-
ible mother-child combinations were used. The indirect 
antiglobulin titre values of maternal Rh antibodie's were 
divided into three groups: (i) those with values of 1:64 
31 
3 2 
or less; (ii) 1:128,1:256 and 1:512 and (iii) 1:1024 or 
more. The evaluation of Rh antibody titre differences re-
corded in the first trimester of pregnancy and before del-
ivery would then indicate the intensity of Rh-immunization 
for that pregnancy. 
Table 8 details the occurrence of episodes of Rh-immun-
ization among the external version and control series of 
mothers. It shows a higher percentage of cases with init-
ial production of Rh antibodies in the external version 
series (43.7% compared with 26.8%). Although the number 
of cases is small the difference is significant (X2 (1) = 
7.046; p = <.0.01). 
When the overall frequency of antenatal Rh-immunization 
is examined i t is evident that the version cases not only 
show more frequent involvement in the secondary production 
of Rh-antibodies (among those already immunizeq) but also 
appear to produce higher titres than the control series 
(X2 (1) = 17.025; P = <: 0.001). 
To assess whether the results in Table 8 may have been 
obtained by chance selection it was necessary to evaluate 
the frequency of primary evidence of episodes of Rh-immun-
ization in a random series of hospital clinic admissions. 
The phrase 'primary evidence of Rh-immunization' refers to 
the observation that Rh-antibodies were detected for the 
first time at some stage during the second half of preg-
nancy among mothers who were confirmed not to have had Rh 
antibodies during the first half of the present pregnancy. 
Table 9 details this analysis. Of an unselected series of 
TABLE 8 
Comparison of the frequency of antenatal episodes of Rh immunization in Rh negative mothers 
on whom external version was carried out after 32 weeks gestation, and Rh negative mothers 
on whom such manipulations were not done 
Maternal Rh antibody value External version Con t rol series 
during: series: 108 mothers 
First trimester At delivery 119 mothers 
of pregnancy Positive episodes No epi sodes of Positive epis- No episodes 
of immunization immunization odes of immuniz- of immuniz-
ation ation 
No. Total % No. Total % No. Total % No. Total % 
Negative 1: 64 or less 20 16 
1:128-1:512 13 52 43.7 8 29 26.8 
1:1024 or more19 5 
1:64 or less 1:64 or less 7 13 
1:128-1:512 8 18 15. 1 7 5. 8 10 14 12. 9 13 12.0 
1:1024 or more10 4 
1:128-1:512 1:128-1:512 17 14. 3 16 16 13.4 7 6.4 29 
1:1024 or more17 7 29 26.8 
1: 1024 or more 1:1024 or more 9 9 7.5 16 16 14.8 

















version performed 492 
(9. 5% ) 
No external 
version performed4768 
External version 113 
Number and per-
centage of Rh 
negative mothers 







No external 1007 
version performed 
Rate of Rh immuniz-
ation in total num-
ber of pregnancies 
1 in 151 pregnancies 
w 
~ 
6 380 consecutive admissions, 5 260 mothers were classi-
fied as Rh positive (82.5%) and 1 120 as Rh negative 
(17.5%). The frequency of external version carried out 
after 32 weeks gestation did not differ significantly be-
tween Rh positive (9.5%) and Rh-negative (10.0%) mothers. 
Of the 1 120 Rh-negative mothers tested routinely on an 
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average of 2.8 occasions during the first half of pregnancy 
and on an average of 4.3 occasions during the second half 
of pregnancy, 42 (3.7%) produced Rh antibodies before the 
birth of their infants. This represents a rate of one case 
of Rh immunization out of every 151 random pregnancies. It 
was found that 7.9% of the external version series produced 
Rh antibodies compared with only 3.2% of the controls. For 
the total number of Rh-negative mothers examined the diff-
2 
erence is significant (X (1) = 6.186; P = .::: 0.02). This 
observation indicates that the results presented in Table 
8 are not due to chance selection and that the higher freq-
uency of antibody production in patients subjected to ex-
ternal version is real. 
The antibody-producing response in Rh negative volunteers 
deliberately transfused with Rh positive blood is known to 
vary significantly (Wiener, 1949; Waller 1949). Mollison 
(1956) suggests that 'some volunteers are readily sensit-
ized, others are difficult to sensitize and some, perhaps, 
cannot be sensitized at all'. We have found further evid-
ence to indicate that this situation also exists with res-
pect to antenatal Rh immunization. Thus, whilst it has 
been shown that Rh antibody production is increased among 
those mothers who received external manipulation, a far 
greater percentage (92.2%) (Table 9) of the Rh-negative 
female population at risk consistently fail to become 
immunized. 
That Rh immunization cannot always be induced even 
among 'high risk' cases as a result of the delivery of an 
Rh-positive infant was also established by Woodrow et al. 
(1965). Even among their selected Rh-negative mothers 
who consistently had Rh incompatible fetal red cells in 
36 
the maternal circulation, a larger percentage always failed 
to become immunized. It therefore seems evident that Rh 
immunization involves more than the single event of receiv-
ing Rh-incompatible blood, either by deliberate transfus-
ions or by disruption of the placental circulation. The 
distinction between those who can be readily immunized and 
those who can not is a matter for future study. The sus-
ceptible class of Rh-negative mothers who have the ability 
to develop Rh-antibodies could be considered as a separate 
group capable of ready sensitization to primary exposure 
and also to subsequent episodes of immunization. This 
appears evident from the results we have obtained. In 
these mothers the intensity of Rh antiQody production was 
significantly increased by the possible disruption of th~ 
placental circulation as a direct result of external vers-
ion. A similar effect was also reported by Wood~ow et al. 
(1965) with respect to transplacental haemorrhage as a 
result of delivery. In their studies a significantly 
greater percentage of mothers produced Rh antibodies dur-
ing the post-natal period when transplacental haemorrhage 
had been evident. 
While there may be differences of opinion with regard 
to the risk of increasing antenatal immunization by exter-
nal version the possibility of intensifying the haemolytic 
process in the child as a consequence of this procedure 
cannot be ignored. Therefore, the policy of limiting all 
antenatal manipulations which might disrupt the placental 
circulation should be strictly maintained. 
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Chap ter V 
THE INFLUENCE OF ABO BLOOD GROUP INCOMPAT IB ILITY ON RH 
I MMUNI ZAT ION 
1. INTRODUCTION 
Since Levine (1943) first observed the influence of 
the ABO blood group system and its relationship to Rh 
immunization during pregnancy, other investigators have 
confirmed that Rh-immunization in pregnancy is signific-
antly less in ABO incompatible matings than in ABO com-
patible matings. This deficiency had been interpreted 
as being due to ABO compatible pregnancies providing a 
more favourable condition for the survival of Rh positive 
fetal red cells in the Rh negative mother (Levine, 1958). 
In ABO incompatible conceptions it is assumed that the 
presence of anti-A and anti-B in the maternal serum has 
an inhibiting effect on the production of Rh antibodies 
by the transplacental passage of fetal Rh positive red 
cells of blood groups A or B. 
Because the prognosis of Rh-haemolytic disease is 
closely related to the maternal Rh antibody titre during 
pregnancy, the frequency of ABO incompatibility in relat-
ion to the maternal Rh antibody titre was examined using 
a standardized indirect antiglobulin technique, as des-
cribed in Chapter II. 
2. MATERIALS AND METHODS 
The obstetric records of 836 Rh-immunized mothers were 
available for examination. Of these, 25 were rejected 
where previous transfusion of Rh-positive blood might 
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have caused Rh-sensitization. Another 80 Rh-immunized 
mothers were rejected since the paternal blood groups and 
Rhesus genotype were unknown. 85 unaffected Rh-negative 
infants compa t ible with their mother's Rh type were ex-
cluded. Forty-three Rh-immunized mothers found during 
the postnatal period were also rejected for two important 
reasons: (1) t he maternal Rh-antibody titre could differ 
considerably f rom the antenatal value due to episodes of 
immunization i nduced by the trauma of parturition, and 
(2) the postnatal cases were initially diagnosed by the 
clinical manifestation of Rh-haemolytic disease and not 
by routine an t enatal testing. This would increase the 
number of moderately and severely affected Rh cases in 
the random sample, while mildly affected Rh-positive 
infants without clinical signs of Rh haemolytic disease 
are not referred to the laboratory. A total of 603 mother, 
father, and infant combinations among Rh-immunized famil-
ies remained as suitable for study. 
In some in s tances when blood from stillborn infants 
could not be examined for their ABO and Rh status by 
the convention al method of testing, the ability of the 
red cell stroma to inhibit the appropriate antiserum was 
used to establish these factors. 
For the evaluation of ABO compatible and incompatible 
matings in the control series 214 families with histor-
ies of normal deliveries were examined. Mothers with 
obstetric histories of spontaneous abortion were not 
included. As these cases were drawn from the same hospital 
they represented a population similar to that under study. 
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The second group of control cases used for the evaluat-
ion of ABO incompatible combinations was composed of Rh-
negative mothers and their Rh-positive infants in whom 
the absence of Rh-sensitization was confirmed during ante-
natal testing and by the direct Coombs test on the infant's 
red cells at birth . . 548 mother-infant combinations were 
examined in this category. The mean number of pregnancies 
experienced by these mothers was not sign.ificantly diff-
erent from that in the mothers producing Rh antibodies 
(3.2 pregnancies per mother compared with 3.8 pregnancies 
per mother in the Rh-immunized series). 
3. RESULTS 
Table 10 compares the frequency of ABO compatible and 
incompatible combinations in Rh-immunized father-mother 
and mother-child combinations with a similar combination 
of non-immunized cases. As expected, the overall occurr-
ence of ABO incompatible matings in the Rh-immunized fam-
ilies was lower than the values observed in the control 
series. 
The distribution of ABO incompatible combinations in 
the control series (31.6%) compared with the value (32.8%) 
reported by Reepmaker, Nijenhuis and van Loghem (1962) who 
examined 1 210 Rh-negative non-immunized mothers and their 
husbands. The 24.0 per cent incidence of ABO incompatible 
mating s recorded in the current series of 603 Rh-immunized 
families also compares favourably with the reported incid-
ence of 24.7 per cent by Levine (1943). However, it 
differs from the value of 18.5 per cent reported by Reep-
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TABLE 10 
Rh inununized Fami I ies wi th Rh immunized Rh nega t ive 
families normal deliv- mother and Rh non-inununized 
father-mother eries positive child and Rh 'pas it ive 
comb ina t ions father-mother combinations child combinat-
comb ina t ions ions 
Combinations No. % No. % No. % No. % 
ABO cornEa t ible 
o x 0 153 25.3 40 18.6 199 33.0 180 32.8 
o x A 117 19.4 54 25.2 67 11. 2 48 8. 8 
o x B 34 6. 1 8 3. 7 24 3.9 20 3.7 
o x AB 12 1.9 3 1.4 
A x A 118 19. 5 33 15.4 180 29.9 154 28. 1 
A x AB 13 2. 1 2 o. 9 15 2.4 6 1.1 
B x B 8 1.3 3 1.4 27 4.4 23 4.2 
B x AB 2 O. 3 2 O. 9 8 1.4 4 O. 7 
AB x AB 1 O. 1 2 O. 9 5 0.8 4 O. 7 
458 76.0 147 68.4 525 87.0 439 80. 1 
ABO incomEa t ib Ie 
A x 0 86 14.4 32 15.0 50 8.3 64 11. 8 
B x 0 17 2.8 12 5. 8 9 1.5 12 2. 2 
AB x 0 2 0.3 2 0.9 
AB x A 5 0.8 1 0.4 7 1.2 8 1.4 
AB x B 1 O. 1 1 0.4 4 0.7 8 1.4 
AxB 17 2. 8 10 4.8 5 0.8 11 2.0 
B x A 17 2.8 9 4.3 3 0.5 6 1. 1 
145 24.0 67 31.6 78 13.0 109 19. 9 
Totals: 603 214 603 548 
~ ..... 
maker, Nijenhuis and van Loghem (1962) on 1 742 families 
immunized by the Rh factor. 
The differences in the distribution of ABO incompat-
ible combinations between mother and infant among the Rh-
immunized series are smaller than the corresponding values 
observed for mother-infant combinations in the non-immun-
ized Rh-negative mothers. The 13.0 per cent frequency of 
mother-child ABO incompatibility noted in the present Rh-
immunized series is practically the same as the value of 
12.6 per cent reported by Levine in 1958 but it differs 
considerably from the 7.3 'per cent frequency reported by 
Reepmaker (1955) on 1 608 Rh-immunized mothers. 
Table 11 tabulates the distribution of the 603 Rh-
immunized families, classified according to the highest 
observed Rh-antibody titre, into three groups: (1) those 
with titres of 1:64 or less; (2) those with titres of 
1:128, 1:256 and 1:512 and (3) those with titres of 1:1024 
or more. The percentage of ABO compatible and incompat-
ible matings is recorded for each Rh-antibody titre group 
together with the outcome of the last pregnancy. 
The significant relationship between the maternal Rh-
antibody titre value and the severity of Rh-haemolytic 
disease is compatible with the observations reported by 
Kelsall et al. (1957) and Kelsall, Vos and Kirk (1958). 
Although the overall percentage of ABO incompatible 
matings in the 603 families with Rh-immunization is 24.0 
per cent, it IS interesting that this percentage varies 
from as high as 34.7 per cent in mothers producing Rh 
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TABLE 11 
Distribution of ABO compatible and incompatible combinations in Rh negative 
mothers with various titres of Rh antibodies 
Maternal Rh Classification ABO compa t ib Ie ABO incompatible 
an t i body tit re of infant** matings matings 
at term>:' No. 0/0 No. % Total 
GrouE 1 Livebirths 63 64.8 34 35. 2 97 
1:64 or less Died Nil Nil Ni I Stillbirths 1 Nil 1 
All cases 64 65.3 34 34.7 98 
GrouE 2 Livebirths 199 73.7 71 26.3 270 
1:128-1:512 Died 7 70.0 3 30.3 
10 
Stillbirths 12 80.0 3 20.0 15 
All cases 218 73.9 77 26. 1 295 
GrouE 3 Livebirths 92 84.4 17 15.6 109 
1:1024 or more Died 27 84.4 5 15. 6 32 
Stillbirths 57 82.6 12 17.4 69 
All cases 176 83.8 34 16. 2 210 
All cases com- Livebirths 354 74.3 122 25.7 476 
bined Died 34 80.9 8 19. 1 42 
Stillbirths 70 82.3 15 17.7 85 
All cases 458 75.9 145 24. 1 603 
* Tested by the standardized 
1958). 
indirect antiglobulin technique (Vos and Kirk 
** Last born infants. 
~ 
w 
antibodies with titres of 1:64 or less, down to 16.2 per 
cent in those producing Rh-antibodies with titres of 
1:1024 or more. 
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When the distribution of ABO compatible and incompat-
ible matings among Rh-immunized mothers with low Rh-anti-
body titres (1:64 or less) was compared with those pro-
ducing higher titres (1:1024 or more) it was confirmed 
that the distribution of ABO incompatibility in these 
two groups differed significantly (X2 = 12.24; P = 0.001). 
Table 12 compares the same three groups of Rh-antibody 
titre values with the frequency of ABO incompatible com-
binations of the last born Rh-positive child. For ease 
of comparison this table also shows the ABO incompatibil-
ity of father-mother combinations as recorded in Table 11. 
The results of these two sets of combinations detail the 
mangitude of selection in Rh-antibody titre values, and, 
whilst ABO incompatibility between fathers and mothers 
appears twice as great (34.7% as opposed to 16.2%) in the 
lower Rh-antibody titre group (1:64 or less) when compared 
with the results observed In the higher titre group (1:1024 
or more), this difference is at least five times greater 
(26.5% as opposed to 3.7%) when the actual ABO incompatib-
ility status of the mother and child is taken into account. 
The 26.5 per cent value of mother-child ABO incompatible 
combination observed in the lower titre group of Rh-immun-
ized mothers is also greater than the values recorded for 
the control series of non-immunized mother-child combinat-
ions, which was 19.9 per cent. 
TABLE 12 
The relationship of maternal Rh antibody titre values to ABO incompatible combinat-
ions, zygosity of the father's Rh genotype and mean number of pregnancies 
Freq uency of 
Maternal Rh fa ther-mothe r 
ant ibody titre ABO incompat-
i b I e comb ina t-at term and 
ions total number of 
mothers examined No. % 
GrouE 1 
1:64 or less 34 34. 7 
(98 mothers) 
GrouE 2 
1 : 128-1 : 512 77 26 . 1 
(295 mothers) 
Groul?..-.l. 
1: 1 024 or more 34 16. 2 
( 2 10 mothers) 






i b I e comb ina t -
ions 
No. % 
26 26 . 5 
42 14. 2 
10 4.7 
78 13.0 
Father's D antigen zygosity in Total and 
relation to ABO compatible and mean no. 
incomEatible matings of pregs. 
. . by Rh im..'llun-
ABO cornEa t ib Ie ABO IncomEatlble. d th 
DID DId DID DId lze mo er 
No. % No. % No. % No. % No. Mean 
value 
31 46.9 35 53. 1 15 46.8 17 53. 2 352 3.6 
117 53.6 101 46.4 44 57. 1 33 42 . 9 1121 3. 8 
112 64.3 62 35.7 28 77. 7 8 22.3 882 4. 2 
260 56.7 198 43.3 87 60.0 58 40.0 2355 3.8 
~ 
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When the distribution of mother-child ABO incompatibil-
ity was compared between mothers with low Rh antib~dy 
titre values (1:64 or less) and those with higher titre 
values (1:1024 or more) it was confirmed that mother-child 
ABO incompatibility differed significantly in the two cat-
(X
2 
1 ) egories of Rh-immunized mothers = 20.31; P = 0.00 . 
The same table also compares the relationShip of mater-
nal Rh-antibody titre values with the father's D antigen 
zygosity status. These results' were obtained by the con-
ventional use of specific D,C,E,c and e antisera, while 
the genotypes were assigned on the basis of reactions 
against these sera, using the table of most frequent 
occurrence (Race and Sanger, 1962). The zygosity distrib-
ution among ABO compatible and incompatible matings does 
not appear to differ in mothers with Rh antibody titres 
of 1:64 or less (ABO compatible 46.9% DID and 53.1% Did; 
ABO incompatible 46.8% DID and 53.2% Did), but marked 
variations were seen in ' those with Rh antibody titres of 
1:1024 or more (ABO compatible 64.3% DID and 35.7% Did, 
ABO incompatible 77.7% DID and 22.3% Did) to implicate 
homozygosity (DID) alone as a most suitable condition for 
the production of high titre Rh antibodies even among ABO 
incompatible matings. 
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The overall distribution of homozygous DID fathers also 
differed significantly in the low titre group of Rh-immun-
ized mothers (1:64 or less) when compared with the frequency 
of their occurrence in the high-titred group of mothers 
2 
(1: 1024 or mor e) (X = 10.06; P = 0.001). 
When the influence of the mean number of pregnancies on 
the variations in Rh-antibody titre was studied (Table 12) 
it was noted that there was a slight increase in pregnan-
cies where the maternal Rh- antibody titre was 1:1024 or 
more. These higher values are most probably associated 
with the mother's increased desire to give birth to a 
live-born ch i ld, particularly in a category where the 
fetal wastage due to stillbirth and neonatal death are 
significantly greater than among the lower titre group 
of mothers (Table 11). The distribution of parity does 
not otherwise appear to be associated with the intensity 
of Rh-antibody titre values in the mother. 
When the total number of pregnancies among the low 
titre group of Rh-immunized mothers was compared with 
the numbers of pregnancies observed in the high t~tre 
group of mothers, no sign i ficant deviations were observed 
(X2 = 2.77; P = 0 . 09). 
Rh-immunized mothers with previous histories of spon-
taneous abortion were also investigated in relation to 
their maternal Rh-antibody titre value (Table 13). Of 
the 603 mothers in this series, a total of 60 (9.9%) had 
a history of early abortion. It was interesting to find 
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that the greater percentage of mothers with previous hist-
ory of abortion (22 . 4%) fell into the lowest Rh-antibody 
titre group (1:64 or less) . This was different from the 
Rh-immunized mothers with antibody titre values of 1:1024 
or more, where only 6.1% of mothers had experienced one 
or more abortion. 
A differential study of the frequency of abortion in 
relation to ABO compatible and incompatible matings among 
TABLE 13 
Incidence of Rh immunized mothers with history of abortion in relation to ABO compat-
ible and incompatible matings 
ABO compatible matings 
Maternal 


























12 18. 1 
20 9. 2 
12 6. 9 
44 9.6 
ABO incompatible matings 
Families 
wi thout 







Mo the r s wit h 




5 6. 5 
1 3.0 
16 11. 1 
All cases combined 
Number 
of 












13 6. 1 
60 9. 9 
combined: _________________________________ _____________________________________________________________________ _ 
~ 
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Rh-immunized mothers showed that the occurrence of abort-
ion appeared to be the same in both combinations. 
The less frequent occurrence of abortions in the higher 
Rh-antibody titre category of mothers primarily suggests 
that the intense production of Rh-antibodies may have a 
suppressing effect on the synthesis of antibodies assoc-
iated with the aetiology of abortion. 
For ABO compatible father-mother combinations the fre-
quency of spontaneous aborters among the low titre group 
of Rh-immunized mothers differed significantly from the 
high titre group (X2 = 6 . 16; P = 0.013). This difference 
was also significant for the ABO incompatible matings 
(X2 = 6.94: P = 0.009), However, in the overall occurr-
ence of aborters between ABO compatible and incompatible 
combinations, the difference was not signjficant (X2 = 
0.18;P=0.7). 
Table 14 shows the distribution of mother-father and 
mother-child ABO incompatible combinations in relation 
to their maternal Rh-antibody titre value. These results 
are tabulated to show that the frequencies of ABO incom-
patibility in the two series do not differ significantly 
from each other. The random frequency of ABO incompatible 
mother-child combinations observed among non-immunized 
mothers is included in the same table to show the degree 
of variation existing for the two series examined in the 
same populat ion. 
The rathe r remarkable differences observed in the dis-
tribution of ABO incompatible mother-child combinations 
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TABLE 14 












1:64 or less 43 = 39.0% 34 = 34.7% 
GrouE 2 
1: 128-1: 512 59 = 24.0% 77 = 26.1% 
GrouE 3 
1:1024 or 24 = 14.2% 34 = 16.2% 
more 







32 = 29.0% 26 = 26.5% 
35 = 14.2% 42 = 14.20/0 
14 = 8.4% 10 = 4.7% 
81 = 15. 5% 78 = 13.0% 
Non-immunizedCcon-











between the group (i) series of Rh-immunized mothers 
(29%) and the group (iii) series (8.4%) demonstrates 
clearly the effect on maternal Rh antibody production 
when immunization is induced by both ABO and Rh-incompat -
ible fetal red cells. 
Table 15 evaluates the number and percentage of ABO 
compatible and ABO incompatible mother-child combinations 
among Rh incompatible conceptions followed throughout the 
antenatal period for the behaviour pattern of Rh immunizat-
ion. In 195 cases the first evidence for the production 
of Rh antibodies was observed during the second or third 
trimester of pregnancy in pat i ents known not to be sensit-
ized in the first trimeste r. A total of 30, or 15.3 per 
cent of the pregnancies resu l ted in the delivery of ABO 
incompatible infants. 
These findings confirm t hat ABO incompatibility does 
not prevent Rhesus negative mothers from producing Rh 
antibodies. Considering that the random frequency of ABO 
incompatibility in non-immunized mothers observed in the 
same population area is on l y 19.9 per cent (Table 14), the 
much higher percentage recorded among Rh-immunized mothers 
with Rh antibody titre values of 1:64 or less , either dur-
ing the initial stage of Rh antibody production (26.5%) 
or in mothers who were already immunized prior to the 
present pregnancy (32.6%) suggests that combined ABO and 
Rh incompatibility may in f act enhance the mother's potent-
ial i ty to become immunized . If th i s is so, then the pre-
sent explanation for the much lower frequency of ABO in-
compatibility observed among the high titred (1:1024 or 
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TABLE 15 
Maternal Rh antibody titre values during the first and third trimesters of pregnancy 
in relation to the frequency of mother-child ABO compatible and incompatible com-
Maternal Rh antibody values 
during: 
First trimester Third trimester 
of of 
pregnancy pregnancy 
Negative 1:64 or less 
1:128-1:512 
1:1024 or more 
1:64 or less 1:64 or less 
1:128-1:512 
1:1024 or more 
1:128-1:512 1:128-1:512 
1:1024 or more 
1:1024 or more 1:1024 or more 
Totals 
binations 
Mother-child ABO blood group combination 
ABO compa t ib Ie ABO incompa t ib Ie Total 
47 = 73.5% 17 = 26.5% 64 
78 = 88.7% 10 = 11. 3% 88 195 
40 = 93.0% 3 = 7.0% 43 
31 = 67.4% 15 = 32.6% 46 
47 = 85.5% 8 = 14.5% 55 125 
24 = 100.0% 0=0.0% 24 
85 = 83.4% 17 = 16.6% 102 150 
43 = 89.6% 5 = 10.4% 48 
44 = 88.0% 6 = 12.0% 50 50 
439 = 84.5% 81 = 15.50/0 520 
11l 
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more) Rh-immunized mothers cannot be accepted as the re-
sult of direct interaction of maternal anti-A or anti-B 
antibodies on ABO and Rh-incompatible fetal red cells. 
One possible explanation is that when the maternal 
antibody-forming mechanism is called on to produce two 
different types of antibodies (anti-A or anti-B which 
are generally associated with haemolysin production and 
anti-Rh which is not), it may do so but with reduced 
ability to form high titred Rh-antibodies. 
The possibility that Rh-immunized mothers producing 
high titred Rh-antibodies possess the ability to select 
at the cervical level conceptions which are ABO compat-
ible rather than ABO incompatible, as postulated among 
classical infertility conditions by Behrnman, Buettner-
Janusch, Heglar, Gershowitz and Tew (1960) and Vas (1965), 
must remain in doubt until the incidence of immune anti-A 
or anti-B haemolysins can be assessed among Rh-immunized 
mothers. 
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Levine's hypothesis (1943) that ABO incompatible Rh-
positive fetal red cells are more likely to be eliminated 
from the maternal circulation before mothers can respond 
to the production of Rh-antibodies is not compatible with 
the findings in this analysis . However, our observations 
are in agreement with others (Nevahlinna and Vainio (1956), 
Murray, Knox and Walker (1965) that fetal ABO incompatib-
ility among Rh-immunized mothers affords a significant 
degree of protection against the occurrence of severe 
manifestations of Rh-haemolytic disease in the newborn. 
This protection appears to be based upon the mother's 
inability to produce higher titres of Rh-antibodies in 
approximately 80 per cent of the ABO incompatible combin-
ations examined. 
4. DISCUSSION 
This investigation has shown that differences in the 
distribution of ABO incompatible matings not only occur 
between Rh-immunized families and the control series, 
but also can be expected when the maternal response to 
the production of Rh antibodies is taken into account . 
These differences range from the normal random distribut-
ion of ABO incompatible matings where the maternal Rh-
antibody titre value is 1:64 or less (26.5%) down to val-
ues frequently reported by others when the Rh antibody 
titre is 1:1024 or more (12 . 0%), 
ABO incompatibility among Rh immunized families has 
been reported to range between 24.7% (Levine, 1953) and 
13.0% (Stern, Davidsohn and Masaitis, 1956), There has 
been no information to indicate that such wide variations 
may in some instances be influenced by the inclusion of 
a greater proportion of severe cases of Rh incompatibility 
with mothers possessing higher Rh-antibody titre's than 
would normally be expected in a random selection of Rh-
immunized mothers . This situation can occur when the Rh-
immunized families used for this type of investigation 
are composed of a large number of Rh cases which are 
brought to the attention of the investigator because of 
the obvious clinical manifestation of Rh-haemolytic dis-
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ease, while mild forms of Rh-disease in infants not re-
quiring treatment are not included. The use of Rh-
immunized families detected by routine antenatal testing 
alone would therefore appear to be the only approach 
that would ensure that the normal distribution of mild 
and severe forms of Rh-haemolytic conditions are included 
In an analysis of this nature. By observing this rule 
of selection we found that the frequency of father-mother 
and mother-child ABO incompatible combinations did not 
differ significantly in mothers producing low-titred Rh-
antibodies (1:64 or less) when compared with the distrib-
ution of these combinations in non-immunized mothers. 
Where the Rh-immunized mothers produced high titred 
(1:1024 or more) Rh antibodies the frequency of mother-
child ABO incompatibility differed significantly from 
the random results (4.7% as opposed to 19.9%). The wide 
variations of mother-child ABO incompatible combinations 
reported by Levine (1958) of 12.6% and Lucia and Hunt 
(1950) of 4.4% can most likely be attributed to the marked 
differences in the maternal Rh antibody titres of the 
mothers investigated in the two series. 
The influence of the father's D antigen zygosity on 
maternal Rh antibody titres showed the expected higher 
frequency of DID matings in mothers with Rh antibody 
titres of 1:1024 or more, particularly among the ABO in-
compatible matings (ABO compatible: DID, 64.3% and Did, 
35.7%; ABO incompatible: DID, 77.7% and Did, 22.3%), 
suggesting that group A or B homozygous DID fathers among 
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the incompatible combinations possess a greater potential-
ity to induce the formation of high titre Rh-antibodies 
than heterozygous DId fathers of the same blood groups. 
The effect of parity on the maternal Rh-antibody titre 
response does not appear to be significant and confirms 
the general observation that mothers with only two pre-
vious pregnancies can sometimes possess extremely high Rh 
antibody titres while those with at least six pregnancies 
may possess lower Rh-antibody values. 
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The belief that ABO incompatible matings in Rh-haem-
olytic disease are a sound protection against Rh-immuniz-
ation was only confirmed in mothers with high titre Rh-anti-
bodies. The normal frequency of ABO incompatible matings 
found in either father-mother or mother-child combinations 
among those producing lower values (1:64 or less) of Rh-
antibodies provided evidence to suggest that the trans-
placental passage of fetal ABO incompatible Rh-positive 
red cells may not necessarily prevent the mother from 
being immunized. The protective mechanism assumed by ABO 
incompatibility does not appear to be of any significance 
in this category of Rh-immunized mothers. 
Chapter VI 
THE EVALUATION OF THE INDIRECT ANTI-HUMAN GLOBULIN TITRE 
AS A PROGNOSTIC INDEX 
1. RH ANTIBODY LEVELS IN THE MATERNAL SERUM 
A most important factor observed from comparing Rh 
antibody titres with the clinical severity of the disease 
has been the wide variations of results that different 
investigators obtain. This is probably caused from 
lack of standardization in technique and methods adopted. 
Of the several methods known to determine the presence of 
Rh antibodies (saline test, enzyme test, albumin replace-
ment test and anti-human globulin test), we have found 
the indirect antiglobulin test to be the most dependable 
(Vos,1969). 
Using the standardized indirect anti-human globulin 
test (described in Chapter II), the relationship between 
the Rh antibody titre of the mother at delivery and fetal 
wastage was examined. 429 infants ' were studied where Rh 
antibodies were detected in the mother1s serum. All cases 
were included in which an antiglobulin titration of the 
mother's serum was carried out either on the day of birth, 
or within two or three days prior to birth, and where the 
pregnancy continued for at least 20 weeks. 56 (13.0%) of 
the 429 infants were Rh-negative. Of the remaining 373 
Rh-incompatible infants, 65 (17.4%) were stillborn and 
308 (82.6%) were liveborn. Thirty-four of the liveborn 
infants (9.1% of the incompatible infants) subsequently 
died, 20 of them despite prompt and adequate exchange-
t ransfus ion. The other 14 were untreated, having died 
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before exchange-transfusion could be started. Four of 
these untreated infants were of 30 weeks or less gestat-
ion. Table 16 shows the distribution of these cases by 
the indirect antiglobul i n ti t re of the mother's serum at 
term. The fetal wastage from all causes rises from 1.7 
per cent where the maternal titre is 1:64 or less to 63.4 
per cent where the titre i s 1:2048 or more. Infants born 
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to mothers with titres of 1:64 or less, with the exception 
of four cases,received no treatment. 
Almost all of the fe t al wastage in this series occurred 
in cases where the maternal antiglobulin titre at term 
was 1:512 or more. The remaining cases, although indicat-
ing that stillbirth or neonatal death may occur where the 
maternal titre is lower than 1:512, have to be considered 
in the light of the actual causes of death. Of the four 
stillbirths in the lower-tit r e categories, two at least 
were not due primarily to Rh-incomp~tibility, one being a 
mongol and the other an anencephalic monster. There were 
six neonatal deaths in the same titre categories. One of 
these was of only 29 weeks' gestation, was untreated, and 
died primarily of prema t u ri ty; another died at the age of 
four days with an obstruct ion of the duodenum, whilst one 
died at home aged three weeks , the cause of death being 
septicaemia. Thus of the 10 cases where a stillbirth or 
a neonatal death resulted if the mother had an antiglobulin 
titre at term of less than 1:512, only five were due prim~ 
arily to Rh-incompatibility. This means that in this series 
95 per cent of the fetal wastage due to Rh-incompatibility 
occurred in mothers with an indirect antiglobulin titre at 
TABLE 16 
Distribution of 373 cases of incompatible infants born to Rh-immunized 
mothers by maternal indirect antiglobulin titre at term 
Maternal No. of Li veborn Rh+ infants Stillbirths % Foetal 
titre at cases Survived Died wastage term 
1:64 or less 60 59 0 1 ':' 1.7 
1: 128 30 28 1 1*':' 6.7 
1:256 60 53 5 2 11. 7 
1:512 70 62 4 4 11.4 
1: 1024 82 46 9 27 43.9 
1:2048 or more 71 26 15 30 63.4 
All titres: 373 274 34 (9.1%) 65 ( 17. 4%) 
(73. 5%) 
>!' Mongol ** Anencephalic monster 
\J1 
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term of 1:512 or more. 
Although there is a close relationship between the 
maternal indirect antiglobulin titre at term and the 
chance of having a successful outcome of pregnancy, this 
by itself does not mean that early induction of labour 
should be carried out if the maternal titre at 36 weeks 
is 1:512, because it could remain at this level during 
the next four weeks . The relationship between maternal 
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indirect antiglobulin titre at delivery and outcome, as 
shown in Table 16, indica t es the chance of successful 
outcome in such cases to be greater than 90 per cent. 
However, the picture obtained from considering the relat-
ionship of a single maternal indirect antiglobulin titrat-
ion at term and the chance of survival can be most mislead-
ing. It does not indicate whether the titre determined 
at the time of delivery has just arrived at that level, 
perhaps quite suddenly from a low or zero value, or 
whether the fetus has been exposed to the same quantity 
of antibody for a cons i derably longer length of time. 
In 222 Rh-immunized mothers with Rh-incompatible preg-
nancies, antibody titrations were carried out weekly or 
fortnightly during the last 10 weeks of pregnancy. This 
made possible the calculation of a 'titre index' to give 
some measure of the effect of the titre level and the 
duration of the response on the severity of the disease 
in the affected child. The titre index is calculated by 
mUltiplying the titre code number by the number of weeks 
and summing for the total 10- weeks period. The code num-
bers used range from 1 , f or a titre of 1:16 or less, 2, 
f 1 32 3 f 1 64 e tc to 9, for a titre of 1 : 4096 or : , , or : , . , 
or more. Thus a mother who has maintained a titre of 
1:1024 over the whole 10-weeks period will have a titre 
index of 7xl0 = 70. On the other hand, a mother who has 
a titre of 1:1024 at term but started the 10-weeks period 
with a titre of 1:64 and rose progressively each two weeks 
up to this titre will have an index of 2x3 + 2x4 + 2x5 + 
2x6 + 2x7 = 50. 
The distribution of the 222 cases in four categories 
of titre index where this information is available IS 
given in Table 17. Where the titre index is 40 or less, 
as it was in 87 of the cases (39%), the chance of death 
is only 3.4 per cent. The one stillbirth was the mongol 
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referred to previously. If the titre index is between 41 
and 60 the chance of death is 23.9 per cent and from 61-70 
it is 59 per cent. If the titre index is above 70, as it 
was in 25 of the cases, the chance of death is 80 per cent. 
On the basis of these results it is possible to estim-
ate the increase in severity which will occur if a preg-
nancy is allowed to continue for any particular length of 
time. For example, if a mother has reached 36 weeks and 
has a titre of 1:1024 and during the previous six weeks 
her titre score has reached 40, then even if her titre 
remains unchanged she will accumulate 4x7 = 28 points to 
give a final titre index of 68 if the pregnancy continues 
to full term. This means that there is almost a 50 per 
cent chance that the infant will be stillborn, or, if 
liveborn, will be very seriously affected, with a 30 per 
TABLE 17 
Relationship between maternal indirect antiglobulin index and outcome of 
pregnancies of Rh-sensitized mothers 
See text for method of calculating the index 
Indirect No. of Liveborn Rh+ infants Stillbirths 
antiglobulin cases Survived Died index 
40 or less 87 84 2 1 ;'< 
41-60 71 54 8 9 
61-70 39 16 3 20 
71 and over 25 5 4 16 
All indexes 222 159 17 46 
>!< Mongol 









cent chance of death. In some of the liveborn cases 
death will occur before exchange-transfusion can be 
started. It is clear, therefore, that accurate knowledge 
of the maternal antibody level and its behaviour from the 
26th week of pregnancy onward enables one to predict be-
fore birth the degree of severity of the disease in the 
affected child with a high degree of accuracy. 
2. THE RELATIONSHIP OF MATERNAL INDIRECT ANTIGLOBULIN 
TITRE, CORD-BLOOD HAEMOGLOBIN AND RETICULOCYTE PERCE~­
AGE IN THE PROGNOSIS OF RH HAEMOLYTIC DISEASE 
This series comprises 218 consecutive pregnant women 
In whom anti-Rh antibodies were detected by the indirect 
antiglobulin technique. 24 women gave birth to Rh-negative 
infant s. In 35 cases the pregnancy ended in a stillbirth 
and in the remaining 159 cases an Rh-positive infant was 
born al ive. The cells of these infants when examined 
immediately after birth gave a direct Coombs positive 
result in each case. 
Values for cord-blood haemoglobin were determined using 
an MRC grey wedge photometer. Statistical analysis re-
vealed no significant difference between different observ-
ers determining haemoglobin by this method. Reticulocyte 
percentages were determined according to the technique of 
Steensma (1955). Of the total of 159 Rh-positive infants 
of immunized mothers born alive in the present series, 
estimations of cord-blood haemoglobin were made in 147 
and reticulocyte percentage in 145. 
In an attempt to increase the prognostic value of the 
indirect antiglobulin titre, this titre was correlated 
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with the value for cord-blood haemoglobin of liveborn Rh-
positive infants. The results for the 147 cases for 
which both sets of information were available and for the 
various treatment categories are shown in Figure 2. When 
the value for cord-blood haemogl~in results are plotted 
against the logarithm of the indirect antiglobulin titre 
a significant correlation is evident (r = -0.612). 
Figure 2 shows that all but three of the 19 deaths 
occurred among babies born to mothers whose indirect 
antiglobulin titre was 1:1024 or higher. These 16 deaths 
represent 30.5 per cent of all the cases in this category. 
Similar observations were also made for babies born with 
cord-blood haemoglobin values of 10 gm/100 ml or less. 
There were 17 deaths in this category, representing 40.5 
per cent of the cases. It is clear, then, that although 
the maternal indirect antiglobulin titre at delivery is 
highly correlated with values for cord-blood haemoglobin, 
it is not an ideal indicator for forecasting the severity 
of the disease. However, because the antiglobulin titre 
of the maternal serum is determined before birth it is a 
valuable guide for the management of the case. Under 
these circumstances a slight loss in efficiency may be 
more than compensated by the practical value of inducing 
labour at the earliest time consistent with safety factors 
involved in premature birth if the mother's titre is ris-
ing toward the level of 1:1024. 
Pickles (1949) considers that the number of immature 
cell types present during the first day of life is of 
considerable prognostic significance in cases of haemoly-
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Figure 2: The distribution of 147 cases of 'incompatible' infants 
born alive to immunized mothers, by values for cord-blood haemo-
globin and the maternal antiglobulin titre at term. 
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tic disease of the newborn. Figure 3 reveals, as expected, 
an inverse correlation which is highly significant between 
haemoglobin values and reticulocyte percentage in the cord 
bloods of 145 Rh-positive infants born alive to Rh-immun-
ized mothers. The data in Figure 3 is best fitted by a 
non-linear curve, the equation for which is Hb = 16.429 -
0.299 X + 0.002X2 where X is the reticulocyte percentage. 
In this series, 17 of the 19 deaths had values for 
cord-blood haemoglobin of 10 gm/100 ml or less. But of 
these deaths 15 occurred among the 25 cases with a retic-
ulocyte percentage of 28 or higher. It is clear that re-
ticulocyte counts can be used in conjunction with values 
for cord-blood haemoglobin to give a good index of the 
chance of survival. Used alone, however, the reticulocyte 
percentage is not quite such a good prognostic index as 
cord blood haemoglobin. If a discrimination is based on 
a reticulocyte percentage of 20 or higher, which includes 
16 of the 19 deaths in the series, and is therefore com-
parable with a discrimination based on an indirect anti-
globulin titre of 1:1024 or higher, the number of deaths 
represents 37 per cent of the cases in the category. How-
ever, reticulocyte percentages, like values for cord-blood 
haemoglobin, suffer from the disadvantage that their use 
for prognostic purposes must wait upon the birth of the 
ch i ld. 
Mollison and Cutbush (1951) correlated values for cord-
blood haemoglobin in their series with concentration of 
bilirubin. They concluded that predictions based on val-
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rubin combined are not significantly better than those 
based on haemoglobin values alone. Our data confirmed 
this conclusion and this particular analysis was not 
carr i ed fur ther. 
It is clear that considered separately the indirect 
antiglobulin titre of the maternal serum at term is not 
quite so good a prognostic tool as the values for cord-
blood haemoglobin or the reticulocyte percentage. How-
ever, it does possess the real advantage of giving an 
antenatal prognosis of severity and can therefore be used 
as a guide for timing the induction of labour. Once the 
child is born prognosis can be based on a combination of 
antibody titre, cord-blood haemoglobin and reticulocyte 
percentage. The distribution of cases in Figure 2 shows 
that a high maternal antibody titre with a low value for 
cord-blood haemoglobin is far more serious than a similar 
titre with a haemoglobin value above 10 gm/100 ml. It is 
also obvious from the distribution of cases in Figure 3 
that the prognosis is serious if the child is born with a 
reticulocyte percentage above 20. 
Table 16 shows that 93 per cent of infants survive when 
the indirect antiglobulin titre of t~e maternal serum is 
less than 1:128. As the titre increases so also does the 
number of stillbirths and neonatal deaths in the treated 




THE PARTIAL ABSORPTION TEST 
Chap ter VI I 
THE PARTIAL ABSORPTION (PA) TEST FOR TITRATING RH 
ANTIBODIES 
1. INTRODUCTION 
The main reason for carrying out serological tests on 
the Rh-immunized mother during pregnancy is to provide 
the obstetrician with a reliable indication of the sever. 
ity of the haemolytic process in the fetus. Ideally he 
would like to know before the infant is born whethe+ it 
w·ill be mildly or severely affected; whether if the preg-
nancy is allowed to continue to its natural term the fetus 
will be liveborn or stillborn, and whether, if the father 
has been shown to be a heterozygote the fetus is Rh-posit-
ive or Rh-negative. 
Previous studies (Part I, Chapte~ VI), have shown that 
the titre of Rh-antibodies in the maternal serum, when 
de t ermined by the ind i rec t anti g 1 obul in method, is high 1 Y 
correlated with the severity of the haemolytic process in 
the child. An indirect antiglobulin titre at term of 1;64 
or less is of no pathological significance and in such 
cases almost all infants survive without treatment. 
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As the indirect antiglobulin titre increases, so does 
the severity of the disease, and even though the infant 
may be born alive and exchange-transfused, the chance of 
survival is less. The majority of stillbirths due to Rh 
incompatibility are associated with maternal indirect anti-
globulin titres of 1:1024 or more. The indir,ect antiglob-
ulin titre has therefore been found to be a valuaple guide 
for determining whether early induction of labour is nec-
essary. However, the indirect antiglobulin titre alone 
can sometimes give rise to misleading predictions. In 
some cases an antiglobulin titre of 1: 1024 may be assoc-
iated with cord haemoglobin values well within the normal 
range in the newborn infant. At the other extreme, the 
same titre may be associated with a moribund infant having 
a haemoglobin of 4 grammes/100 millilitres and a retic-
ulocyte count of 50%; or, even more misleading, a mother 
may have an indirect antiglobulin titre of 1:1024 through-
out pregnancy, only to be induced and delivered of an Rh-
negative infant. A similar serological picture in another 
case may result in a macerated stillborn fetus at 35 weeks. 
Detailed studies carried out to investigate these discrep-
ancies revealed that if the newborn infant has no, or 
little free Rh antibody in circulation, the case is always 
mild; whereas the most severe cases are associated with 
high indirect antiglobulin titres of free Rh antibody in 
the infant's serum. Attention was focussed, therefore,on 
the absorbing capacity of adult non-sensitized Rh-positive 
cells toward maternal sera from mild and severe cases. It 
was found that when one volume of maternal serum, obtained 
on the day of delivery , was incubated with one volume of 
adult Rh-positive c ells, the amount of free antibody lef t 
behind in the serum was almost always identical with the 
amount found in one volume of the cord-serum of the infant. 
Further observations showed that it was not necessary to 
use intact Rh-pos i tive cells for carrying out this test, 
as identical resu lts were obt a i ned if one volume of a sus-
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pension of haemolysed adult Rh- positive cells was substit-
uted "for the intact cells. 
On the basis of these findings we developed a new anti-
body test which, when used in conjunction with the indir-
ect antiglobulin test, enables a much more accurate prog-
nosis of the outcome of pregnancy to be made. The test 
is referred to as the part i al absorption (PA) test. The 
relationship of this test to other tests of Rh antibody 
determinations currently in use, and its behaviour during 
pregnancy was investigated. 
2. MATERIALS AND METHODS 
Antibody titrations - Indirect antiglobulin titrations 
were carried out as described in Chapter II. The blocking 
and conglutination tests were performed using the method 
of Wiener and Hurst (1947) and Wiener, Hurst and Sonn 
(1947). Albumin titrations followed the procedure of 
Diamond and Denton (1945). 
Preparation of standard haemolysed cell suspensions 
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Heparinized or oxalated blood was collected from the arm 
veins of healthy Group 0, CDe/CDe (RIR1) or Group 0, CDe/ 
cDE (RIR2) donors . The cells were packed and washed three 
times in large volumes of physiological saline, the samples 
pooled and the cells finally packed by centrifuging at 
3 000 rpm for 30 minutes. An accurate 25 per cent saline 
suspension of the packed cells was made and this was di-
vided into two-millilitre samples in screw-cap McCartney 
bottles ready for daily use. This standard suspension of 
cells was haemolysed by freezing to -20 0 C for 48 hours. 
These haemolysed cell suspensions may be stored for at 
least twelve months at this temperature without detectable 
loss of absorbing capacity. 
Procedure for the partial absorption (PA) test - The 
standard haemolysed cell suspension was thawed to room 
temperature and shaken thoroughly before use. 0.4 milli-
litre of this suspension was added to 0.4 millilitre of a 
1:4 saline dilution of the maternal serum in a small test 
tube. The two solutions were mixed by shaking and left 
at room temperature for 15 minutes. The free Rh antibody 
remaining in the mixture was titrated in doubling dilut-
ions using the indirect antiglobulin technique. The first 
tube in this titration was read as 1: 16, SInce this is the 
dilution at this stage of the original maternal serum. 
Partial absorption titres lower than 1:16 have been found 
to be of no significance and were scored as negative. 
3. RESULTS 
The partial absorption titre of the maternal serum and 
the free Rh antibody in the infant's serum. 
In Table 18 the PA titre of the maternal serum at the 
time of delivery is compared with the titre of free anti-
body in the infant's cord blood as determined by the in-
direct antiglobulin method. A total of 187 cases was 
available where the infant was liveborn, Rh-positive, and 
in which both titrations had been carried out. In all 
these cases the infant's cells gave a positive direct re-
sponse to the Coombs test at the time of birth. 
of the cases (89%) the PA titre of the maternal 
In 166 
serum was 
either identical with, or within one tube dilution of the 
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TABLE 18 
Comparison of maternal partial absorption titre at 
the time of birth with titre of free antibody in the 
Tube dilutions 
of maternal titre 
compared wi th 1 































1 "0" = maternal PA titre identical with indirect 
antiglobulin titre of cord serum. 
-1,-2,-3 = maternal PA titre one, two or three tube 
dilutions below indirect antiglobulin titre 
of cord serum. 
+1,+2,+3,+4 = maternal PA titre one, two, three or 
four tube dilutions above indirect antiglob-
ulin titre of cord serum. 
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titre of free Rh antibody in the cord serum. In a further 
10 cases the two titration values did not differ by more 
than two dilution tubes. 
Of the 11 cases in Table 18 where the maternal PA titre 
differs from the free antibody titre in the cord-serum by 
more than two dilution tubes, one mother was grossly oed-
ematous, and five infants were oedematous at birth; simple 
dilution may account for part at least of the differences . 
In the five cases in which oedema was not present in the 
infant no satisfactory explanation can be offered for the 
discrepant results. 
Despite the wide range of clinical conditions in the 
infants in this series, the PA titre of the maternal serUI>1 
at the time of delivery in 90 per cent of the cases was 
within the limits of one tube dilution, the same as the 
free antibody titre of the infant's cord sercum. This fact 
suggests that in the majority of cases the PA titre may be 
used during the course of pregnancy as a reliable indicator 
of the amount of free antibody in the fetal circulation. 
Comparison of the partial absorption test with conglutin-
ation, albumin, blocking and indirect antiglobulin tests 
Cases were chosen to compare the PA titre with the 
blocking, conglutination, albumin and indirect antiglob-
ulin titres as determined by standard techniques. The 
results of ten cases are given in Table 19. No correlat-
ion was observed between the PA titre and the plasma con-
glutination or albumin titres. There is a correlation, 














Comparative tests on maternal Rh sera 
Partial Blocking Indirect Plasma 
Absorpt- titre antiglob- c ongl-
ion titre ul in utinat-
titre ion 
titre 
1:2048 1:64 1: 4096 1: 16 tr 
1:1024 1: 64 1: 4096 1 : 64 tr 
1: 512 1: 64 1:2048 1:256tr 
1:256 1: 4 1: 4096 1: 1024 
1:256 1: 8 1:2048 1: 128 
1:256 1:4 1:1024 1: 512 
Negative Negative 1: 512 1 : 1024 
Negative Negative 1: 512 1:256 
Negative Negative 1:256 1:64 















or the indirect antiglobul i n titre. These relationships 
were then examined more thoroughly on a larger series of 
cases. Table 20 shows the results for 42 samples of mat-
ernal sera examined . The r e is a significant positive cor-
relation between both FA titre and blocking titre, and FA 
titre and indirect antiglobulin titre, but the correlation 
coefficient (r = 0 . 90) fo r the former is slightly higher 
than for the latter (r = 0 . 83) . 
Another interesting observation was that although the 
FA titre was correlated with the blocking titre, the 
method was more sensitive than the blocking test. In some 
cases indirect FA titres as high as 1:256 were recorded 
even though the results of the blocking tests were still 
negative. In this series of cases the highest blocking 
titre observed was 1:128. 
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Studies carried out to compare the FA titre with methods 
of determining Rh-antibody by various enzyme tests (ficin , 
papain and bromelin), failed to show a positive correlation 
between these two procedures. 
Behaviour of the partial absorption titre during pregnancy 
Examination of detailed case histories in which the 
maternal FA titre was determined at regular intervals 
throughout pregnancy revealed certain basic patterns in 
the FA titre response associated with clinical outcome , 
ranging from mildly affected infants to grossly hydropic 
stillborn infants. Since the pattern of response is some-
times more informative than a single titration value ob-
tained near term, typical examples are described. 
TABLE 20 
Partial absorption titre, blocking titre and indirect antiglobulin titre for 
various maternal sera 

























































































































































































(a) Stillbirths - In nearly all ca~es of stillbirth due 
to Rh-incompatibility the indirect antiglobulin titre at 
the time of delivery was 1:1024 or more and was maintained 
at a high level for at least 10 weeks before delivery 
(Part I, Chapter VI). The PA titre in these cases can re-
main at a relatively low level throughout the greater part 
of pregnancy but may then rise rapidly. If death occurs 
In utero the PA t itre may start to fall again, though the 
indirect antiglobulin titre generally remains steady (vide 
infra). A high indirect antiglobulin titre maintained 
throughout pregnancy does not necessarily mean that the 
fetus will be seriously affected. But if a high indirect 
antiglobulin titre is associated with a high PA titre 
throughout pregnancy and the fetus is Rh-positive, the 
outcome is invariably fatal. 
(b) Severely affected liveborn infants - These are nearly 
always associated with a maternal indirect antiglobulin 
titre of 1:1024 or higher, but the PA titre is often low 
early in pregnancy and shows a sudden rise, often to a 
high level shortly before birth. 
(c) Moderately affected infants - One of the puzzling 
features of previous work on the relationship between mat-
ernal antibody levels and severity of the disease in the 
infant has been the occurrence of relatively high antibody 
levels in the maternal serum throughout pregnancies which 
have terminated with the birth of a moderately affected 
infant. In typical cases the indirect antiglobulin titre 
of the maternal serum may persist at a moderately high 
level of 1:512 throughout the greater part of pregnancy, 
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but the FA titre remains low, at 1:16 or less, and does 
not rise appreciably near term. Another category of mod-
erately affected infants can be distinguished in those 
cases in which the indi r ect antiglobulin titre is low or 
zero at the commencement of pregnancy, but rises to a 
high value during the third trimester. The FA titre may 
show a parallel rise . In these cases, however, the rise 
in antibody level occurs too late to seriously affect the 
infant before birth. 
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(d) Rh-negative infants - In families In which the father 
is heterozygous Did it is important to be able to distin-
guish an Rh-negative fetus from an Rh-positive fetus if 
a correct prognosis is to be made before birth. At pre-
sent there is no certain way by which this may be done. 
The behaviour of the FA titre during pregnancy, however, 
is a somewhat better guide than the behaviour of the in-
direct antiglobulin titre alone . If the indirect antiglob-
ulin titre remains high through the last four months of 
pregnancy, as a result of antibodies from a previous preg-
nancy, but the FA titre remains negative or very low, it 
is an indication that no fresh immunization has taken 
place. In general the FA titre responds more rapidly 
than the indirect antiglobulin titre to a new episode of 
immunization and it tends to fall again to low levels be-
fore the next pregnancy commences. Fersis'tently low FA 
titres throughout pregnancy are therefore more frequent 
when the fetus is Rh-negative and is failing to stimulate 
the production of more Rh- antibody. 
(e) The effect of death in utero and maternal oedema on 
the FA t i tre - In some cases a fall in the FA titre 
may occur as pregnancy progresses. This may be due to 
three causes : (a) an Rh-negative fetus, (b) death in 
utero and (c) maternal oedema. Both (b) and (c) indicate 
the remarkable sensitivity of the FA titre as an index of 
what is occurring in the mother and the fetus. Somet imes, 
in severe cases of Rh-immunization, the fetal heart stops 
several weeks before parturition. If the FA titre is 
high when death occurs it shows a fall in about one-half 
of the cases . In a series of 20 stillbirths in which the 
FA titre was determined at regular intervals through the 
last ten weeks of pregnancy, eight cases showed a marked 
decline of two or more dilution tubes in the FA titre 
before the end of pregnancy. In each of these cases a 
badly macerated fetus was born. In six of the remaining 
12 cases the fetus was again macerated but there was no 
detectable fall in the FA titre before delivery. It IS 
important to note that although the FA titre fell in 
nearly half of the 20 stillbirth cases, in no si n gle case 
did we observe the indirect antiglobulin titre to show a 
similar fall. 
4. DISCUSSION 
A number of attempts have been made to analyse the 
complexity of the maternal antibody response to Rh anti-
gens by both physico-chemical and serological means (Cann 
et al. 1952; Krieger and Williams, 1955; Wiener and Gordon 
1953; Greenwalt and Wagner, 1955). So far no one has 
found a relatively simple test which, when applied to 
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, 
the maternal serum antenatally, can predict with high 
probability the severity of the haemolytic process in the 
child and its chances of being stillborn, or, if born 
alive, of living with or without exchange-transfusions. 
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It has been reported (Davidsohn and Stern, 1948; Wiener 
eta 1. 1 952 ) t ha t bloc king an t i bod i e s are ass oc i at ed wit h 
more severe manifestations of erythroblastosis in the baby, 
and de Kromme and Vervaat (1953) attempted to show that 
variations in conglutination-positive and conglutination-
negative reactions can be used to explain differences in 
the severity of the disease. 
Titration values obtained by the FA test have there-
fore been of importance in the understanding of the com-
plexity of Rh-antibody production in response to the stim-
ulus of an Rh-incompatible pregnancy. Diamond (1947) 
noted that severe cases of erythroblastosis were assoc-
iated with the presence of free-Rh antibody In the cord 
serum of an affected infant. Our results show that if 
one volume of packed adult cells or the equivalent volume 
of haemolysed cells is used to absorb one volume of mat-
ernal serum the antibody left free in the serum, as meas-
ured by the indirect antiglobulin technique, can vary 
over a wide range of values. For instance, in cases 
where the indirect antiglobulin titre is 1:1024 the anti-
body left free in the serum can vary from zero up to, but 
never exceeding 1: 1024. The titre of free ant ibody is the 
FA titre, and our results confirm and extend the observat-
ions of Diamond. The first conclusion to be drawn from 
these results is that in vivo the absorbing power of 
the fetal red cells is roughly the same as that of adult 
red cells. Secondly, since all infants in whom the FA 
titre is zero are mildly affected, it would suggest that 
the haemolytic process in the fetus does not commence 
until all the antigenic sites on the red cells have been 
saturated with antibody, or blocked from accepting more . 
Work in progress indicates that at least two kinds of 
antigen-antibody reaction are involved in the process of 
absorbing Rh-antibodies on Rh-positive cells. In the 
first of these the antibody is bound firmly to the cell 
and can be released only by extracting with ether which 
completely alters the structure of the Rh antigen on the 
cell surface. In the second the antibody bound to the 
Rh antigen can be released simply by freezing and thawing 
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the cell. In this way the cell is haemolysed but the anti-
genic sites are relatively undamaged. When cells are sen-
sitized with an Rh serum with a zero FA titre and then 
thoroughly washed, no Rh-antibody is released after haem-
olysis caused by freezing and thawing. If, however, the 
cells are sensitized with an Rh serum which has a positive 
FA titre, the antibodies released from the cells after 
freezing and thawing are found to be identical with the FA 
titre of the original serum. 
These results indicate that under conditions where the 
sensitizing serum has a positive FA titre, a portion of 
the Rh antibodies is in equilibrium with its corresponding 
antigen. A tentative hypothesis suggests that it is only 
when sensitized cells carry antibody in this manner that 
they are readily haemolysed in the fetal circulation. If 
this interpretation is correct, then the amount of free 
antibody in the cord serum, as estimated by the PA tech-
nique, would be related directly to the rate of cell de-
struction in vivo. The persistence of such a process. at 
a high rate over several weeks is almost certain to result 
in severe or fatal manifestations of erythroblastosis in 
the inf an t. 
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Chapter VIII 
THE EVALUATION OF THE PARTIAL ABSORPTION TEST IN 
THE PROGNOSIS OF RH HAEMOLYTIC DISEASE 
1. INTRODUCTION 
It was shown in Chapter VI that the prognostic value of 
the maternal antiglobulin titre is considerably improved 
if titrations are carried out regularly during the last 
ten weeks of pregnancy. The titration values are given a 
code number from 1 to 9 and these are summed for each 
week to give a titre index. This is a measure not only 
of the height of the titre, but of the length of time that 
the titre has been operating. Although the titre index 
is a much better guide to the likely outcome of any part-
icular pregnancy than is a single titre value for antibod-
ies in the maternal serum at term, there is still a small 
number of cases which do not fit into the general pattern. 
It is believed that the explanation for some, at least, of 
these exceptional cases is to be found in the differing 
amounts of antibody which are left in the infant's serum. 
In Chapter VII a simple partial absorption (PA) test was 
described which enables an estimate of the amount of anti-
body in the fetal serum to be made from titrations carried 
out on the maternal serum. The present chapter provides a 
more rigorous evaluation of this test. 
2. MATERIALS AND WETHODS 
Venous blood samples were collected from Rh-negative 
women as part of the routine antenatal tests. When Rh 
antibodies were present in the maternal serum every effort 
was made to obtain samples at regular intervals. During 
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the last three months of pregnancy samples were taken at 
fortnightly, or even weekly intervals, whenever possible. 
Samples of infant blood were obtained from the fetal end 
of the umb i I ical cord at birth. The indirect antiglobulin 
procedure used was described in Chapter II. The me thod of 
carrying out the partial absorption test on the maternal 
serum was described in Chapter VII. 
The determination of cord-blood haemoglobin values and 
reticulocyte percentages, and the methods of carrying out 
exchange-transfusion have been described in detail by 
Kelsall, Vos, Kirk and Shield (1957). 
3. RESULTS 
290 Rh~immunized mothers were examined for whom the in-
direct antiglobulin titre and the PA titre of the maternal 
serum were available at the time of delivery. There were 
41 liveborn Rh-negative infants. Of the remaining 249 Rh-
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incompatible pregnancies, 36 resulted in stillborn infants: 
of the 213 liveborn Rh - positive infants 21 subsequently 
died despite prompt and adequate exchange-transfusion. 
Maternal PA titre at delivery and survival of Rh-incompat -
ible infants The single death among the 57 cases in 
which the PA titre at the time of delivery was zero was an 
anencephalic monster (see Table 21). There were no pathol-
ogical signs that death in this case was In any way due to 
Rh incompatibility. In addition, one of the neonatal 
deaths, where the mother had a PA titre of 1:16, was due 
primarily to obstruction of the duodenum. Of the other 
deaths in the low-titre categories of 1'. 16 d 1 32 an : , shown 
TABLE 21 
Distribution and outcome of cases of Rh-incompatible infants born to 
immunized mothers by partial absorption titre of the maternal serum 
at term 
PA Liveborn infants St i llborn Total No. Percentage 
titre Survived Died infants infants mortality 
0 56 0 1 57 1. 75 
1: 16 40 3 1 44 9.09 
1:32 17 2 1 20 15. 00 
1: 64 25 2 3 30 16.67 
1: 128 10 2 3 15 33.33 
1:256 25 3 7 34 26.47 
1:512 12 5 8 25 52. 00 
1 : 1024 7 4 10 21 66.67 
1:2048 0 1 2 3 100.00 
or more 




in Table 21, at least one of the neonatal deaths and both 
of the stillbirths were to mothers who were suffering from 
toxaemia of pregnancy with marked oedema. In many cases 
oedema associated with a stillbirth results in a fall in 
the PA titre before birth (Vos, 1958) and this may well 
have happened in the other case where the infant died very 
soon after birth. The fall in the PA titre reduces its 
usefulness as a prognostic guide in such cases, particul-
arly if the only titration carried out is near the end of 
pregnancy. 
It can therefore be concluded that the risk of still-
birth due primarily to Rh-incompatibility (when the mater-
nal PA titre at birth is lower than 1:64), In the absence 
8 8 
of marked oedema in the mother, is no greater than in normal 
pregnanc ies . For PA titres of 1:64 or more the risk of 
neonatal death or stillbi r th is greater. In two- th i rds of 
the cases with a maternal PA titre at birth of 1:1024 the 
infants were either stillborn or died soon after birth, 
whilst no infant has survived yet when the maternal PA 
titre was 1:2048. 
Correlation of maternal FA titre with cord-blood 
haemoglobin values It was shown in Chapter VI that 
the maternal indirect antiglobulin titre at term is highly 
correlated with the cord-blood haemoglobin values (r = 
-0.62). For 178 of the l i veborn Rh-incompatible infants 
in the present series both cord-blood haemoglobin values 
and the PA titre of the maternal serum at term are avail-
able. The distribution of these values, together with 
the method of treatment and outcome is shown in Figure 4. 
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Figure 4: The dis t rib uti on of 179 live-born 
Rh-incompatible infants by cord-blood haem-
oglob in value and maternal P. A. titre at the 
time of birth. 
When this distribution is compared with the evaluation of 
maternal indirect antiglobulin titre at term and cord-
blood haemoglobin value, as shown in Chapter VI, it is 
clear that the PA titre of the maternal titre gives a 
much better indication of the severity of the haemolytic 
process in the child than does the maternal indirect anti-
globulin titre. This is in fact borne out by the statis-
tical analysis which gives a correlation coefficient be-
tween the PA titre and cord-blood haemoglobin value of 
- O. 72. 
For infants compatible with their mothers for the Rh 
factor, the range of cord-blood haemoglobin values is from 
11.0 to over 20.0 g/100ml, with a mean value of 16.24 and 
a standard deviation of 1.7. It might be expected there-
fore that for any particular level of the maternal PA 
titre there would be a corresponding spread of cord-blood 
haemoglobin values. Figure 4 shows this to be true. 
Relationship between maternal indirect antiglobulin titre 
and partial absorption titre - If all cases are consid-
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ered in which the maternal indirect antiglobulin titre at 
the time of birth is 1:1024, the cord-blood haemoglobin 
values can range from 3.0 to 17.0 g/100m1 with approximately 
half of the cases possessing haemoglobin values above 10.0 
g/100ml. (Figure 2, Chapter VI). It has been found that 
infants with haemoglobin values above 10.0 g/100ml. are 
not bad risks for exchange-transfusion. However, in cases 
in which the maternal indirect antiglobulin titre at birth 
is 1:1024 but the cord-blood haemoglobin value is below 
10.0 g/100ml. the infants have a much poorer prognosis for 
survival even when exchange-transfused. 
For any given maternal indirect antiglobulin titre the 
PA titres of the maternal serum can vary over a wide range 
in different cases. In Table 22 the distribution of cord-
blood haemoglobin values for 95 Rh-positive liveborn in-
fants born to mothers with a maternal indirect antiglob-
ulin titre at term of 1:512 to 1:4096 is given in relat-
ion to the difference between the indirect antiglobulin 
titre and the PA titre of the maternal serum. The differ-
ence in titre is expressed in dilution tube numbers. This 
means that for a particular indirect antiglobulin titre 
(1:1024 for example), the corresponding PA titre can range 
from the same value (difference = 0) down to 1:16 (differ-
ence = 6 dilution tubes). 
From the distribution of cases In Table 22 it is clear 
that there is a high correlation between the difference 
in titre and the cord-blood haemoglobin value (r = 0.61). 
This means that the PA titre enables us to improve consid-
erably on the prognosis based on the maternal indirect 
antiglobulin titre at term. Of the 95 liveborn infants 
recorded in Table 22, 15 subsequently died. None of these 
deaths occurred, however, among the 24 infants in whom the 
PA titre was more than three dilution tubes lower than the 
maternal indirect antiglobulin titre at term. Thus, a 
high indirect antiglobulin titre In the mother need not be 
considered a serious sign if the PA titre at the same time 
is low. 
Stillbirths - There were 36 stillbirths among the 249 
incompatible infants. One of these was an anencephalic 
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TABLE 22 
Relationship between cord-blood haemoglobin values in Ii veb orn Rh-
inc ompa t i b Ie infants and the difference between the maternal indir-
ec t antiglobulin titre and FA titre at term 
Difference in tube numbers between All 
Cord-b lood maternal indirect ant i-globul in titre 
haemoglobin value titre and FA titre at term differences 
(grammes per 100 6 5 4 3 2 1 0 mi 11 i Ii t res) 
18. 0 or more 
16. 0 to 17.9 1 1 
14.0 to 15.9 1 6 4 6 3 20 
12.0 to 13.9 2 3 3 4 4 3 19 
10. 0 to 11.9 4 4 10 4 22 
8.0 to 9.9 3 7 4 1 15 
6.0 to 7.9 1 5 2 0 8 
4. 0 to 5.9 1 3 4 1 9 
2.0 to 3.9 1 0 1 
All values 4 9 11 19 32 16 2 95 
...0 
N 
monster: the maternal indirect antiglobulin titre was only 
1:128 and the PA titre was zero at term, so that it seems 
reasonable to consider that Rh incompatibility was not of 
aetiological significance. Of the remaining 35, 27 were 
associated with peak PA titres of 1:256 or more (see Table 
21). It is necessary to use the peak PA titre in these 
cases since in many cases of stillbirth the PA titre drops 
rapidly after death has occurred in utero. A terminal 
value of the PA titre in such cases therefore does not 
represent the true value to which the living fetus has 
been exposed. 
The rapid drop in the maternal PA titre which often 
occurs after the fetus has died means that prognosis 
based on a single titration value obtained near term is 
likely to be misleading. This probably explains why eight 
of the stillbirths in Table 21 were associated with PA 
titres of 1:128 or less. In a number of these it was 
possible to obtain blood samples from the mother only 
near term. If these cases had been titrated at regular 
intervals over at least the last ten weeks of pregnancy 
the peak values obtained would almost certainly have been 
significantly higher. 
For 73 of the incompatible pregnancies in the present 
series antibody titrations have been carried out on the 
maternal serum before the end of the second trimester. 
Table 23 shows that in these cases, when the PA titre was 
already 1:64 or higher at the twenty-fourth week of gest-
ation, only one out of 17 infants survived; 12 were still-
born and four died after birth. Indeed, of the children 
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TABLE 23 
Outcome of cases in which the maternal FA titre was determined before 
Outcome 
the end of the second trimester 
Maternal FA titre at or before 24 weeks 
gestation 
o 1:16 1 : 32 1:64 1:128 1:256 1:5121 : 1024 1:2048iAll titres 
Liveborn-survivedl28 7 6 1 o o o o o 42 
Li veb orn-d i ed 2 1 2 3 1 o o o o 9 
St i llborn 2 3 5 1 2 5 1 2 1 22 
....0 
~ 
of mothers who had a FA titre at all at the end of the 
second trimester, only 14 out of 43 incompatible infants 
survived. Clearly, the occurrence of a FA titre in the 
maternal serum at any level early during pregnancy is an 
unfavourable sign. If it is 1:64 or more the fetus almost 
always dies. 
The Rh-negative infant - There were 41 Rh-negative infants 
born to mothers who had been immunized by a previous preg-
nancy. In the majority of these cases the indirect anti-
globulin titre was of little value in helping to predict 
before birth whether the infant would be Rh-positive or 
Rh. negative. In fact, 34 of these Rh-negative infants 
were born to mothers with an indirect antiglobulin titre 
of 1:128 or more - that is, in the range which would make 
an exchange-transfusion necessary if the infant was Rh-
positive (Table 24). Actually 25 of the pregnancies were 
terminated artifically, since a correct determination of 
the infant's genotype could not be made before birth. 
The FA titres of the same cases show an entirely diff. 
erent distribution; 18 of the mothers had a zero FA titre 
at the time of birth and a further 13 had a FA titre only 
in the lowest dilution. In these latter cases the FA 
titre value of 1:16 had been maintained unchanged during 
the greater part of pregnancy. The constant antibody 
level was true also of all but two of the 10 cases with 
a maternal FA titre higher than 1:16. In one of the ex-
ceptional cases the FA titre fell from an early value of 
1:512 to 1:128 at term. In the other case the FA titre 




Distribution of Rh-negative infants born to immunized 
mothers by indirect antiglobulin titre and PA titre of 
the maternal serum at birth 
Ti tre 
Dis t rib uti on of infants 
PA titre Indirect anti-
globul in titre 
Zero 18 
1: 16 13 3 
1:32 4 2 
1:64 3 2 
1: 128 3 1 1 
1:256 9 
1: 512 1 1 
1: 1024 3 
Total 41 41 
and represents the only example in which an Rh-negative 
infant waS born to a mothe r who had a rise in either in-
direct antiglobulin or FA titre during the course of preg-
nancy. 
The distribution of cases In Table 24 shows that the 
FA titre is of greater value than the maternal indirect 
antiglobulin titre in deciding whether a pregnancy should 
be allowed to terminate spontaneously. If the father is 
known to be heterozygous Did, then a zero or constantly 
low FA titre maintained throughout pregnancy is a reason-
able indication that the infant is Rh-negative. In such 
cases, even i f the indirect antiglobulin titre is high, 
the pregnancy can be allowed to continue. It must be 
emphasized, however, that if this course is adopted,weekly 
checks of the FA titre are essential during the last two 
months. In some cases In which an incompatible infant is 
involved the FA titre may remain at a low level until the 
last few weeks, only to rise rapidly with serious conseq-
uences for the infant if labour is not induced immediately. 
4. DISCUSSION 
A technique for estimating indirectly the amount of Rh 
antibody free in the infant's serum by a partial absorpt-
ion test on the maternal serum gave early indications that 
it would improve the reliability of prognosis based on the 
maternal indirect antiglobulin titre alone. The present 
evaluation of this test, based on a series of 290 cases 
has confirmed this. 
The correlation between cord~blood haemoglobin value 
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and maternal FA titre is higher than between cord-blood 
haemoglobin value and the ordinary indirect antiglobulin 
titre. Indeed, the variability in cord-blood haemoglobin 
value for any particular maternal indirect antiglobulin 
titre is due almost entirely to the variability in the FA 
titre. 
severe 
The value of the discrimination between mild and 
cases which the use of the FA test makes possible 
is indicated by the fact that no deaths have occurred 
among cases with a maternal indirect antiglobulin titre 
of 1:512 or more where the maternal FA titre was more 
than three dilution tubes lower (Table 22). 
The use of the FA test enables also a much safer pre-
diction of an Rh-negative infant in cases in which the 
father is known to be heterozygous Did. This is an im-
98 
portant use of the test if it means that some pregnancies 
which would otherwise merit early induction will be allowed 
to continue to full term when the FA titre is zero or 
steady at 1:16. However, the FA test is not so valuable 
in predicting stillbirths unless the titrations have been 
carried out at regular intervals during pregnancy. This 
appears to be due mainly to the very marked drop in the 
FA titre which may take place when death occurs in utero. 
Terminal titration values obtained shortly before birth 
therefore mislead, since they may suggest a milder degree 
of involvement than is true when the pregnancy terminates 
with the birth of a grossly hydropic fetus. However, the 
records show that if the maternal FA titre at the end of 




THE RH ANTIBODY INHIBITION TEST 
Chapter IX 
THE SIGNIFICANCE OF THE RH ANTIBODY INHIBITION TEST 
IN DETERMINING THE SEVERITY OF RH HAEMOLYTIC 
DISEASE OF THE NEWBORN 
1. INTRODUCTION 
Evidence was presented in Chapter III to show that 
increased Rh-antibody stimulation can be expected more 
often towards the last few weeks of pregnancy than in 
early pregnancy. Since only Rh-incompatible fetal red 
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cells entering the maternal circulation can be responsible 
for this increase, it is likely that stronger fetal move-
ments during the latter part of pregnancy may also be the 
cause of some placental bleeds which lead to increased 
Rh-antibody stimulation. While it is accepted that epis-
odes of immunization are associated with renewed antigenic 
stimuli, it is also known that the over-all effect of such 
stimuli often leads to increased fetal wastage in the form 
of stillbirth or neonatal death. This was confirmed by 
investigating a large series of Rh-immunized mothers who, 
during pregnancy, showed Rh-antibody titre increases of 3 
dilution tubes or more, but since an analysis of this nat-
ure only showed the general effect of antibody behaviour 
over a large series of cases, it does not necessari ly 
imply that the severity of Rh-haemolytic disease can be 
accurately predicted in each individual case by this pro-
cedure. This is obvious when it is considered that a 3-
fold increase in Rh-antibody titre from a value of 1~8 to 
1:64 is of a smaller magnitude than an increase which be-
gins at 1:256 and rises to 1:4096. Also, it has been 
established that Rh-antibody titrations alone do not 
clearly prognosticate the severity of Rh-haemolytic dis-
ease in all instances. 
These findings led to the introduction of a 'titre 
index' system and a partial absorption test. With the 
former procedure some quantification can be obtained by 
computing the product of the maternal titre and the time 
during which the Rh-ant {bodies were present, while with 
the latter procedure partial antibody quantification is 
obtained by recording the amount of Rh-antibody not re-
moved after one absorption by Rh-positive red cells. 
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A procedure of Rh-antibody quantification is now intro-
duced which considers both the time factor and the amount 
of antibody to which the infant has been exposed during 
pregnancy. With this method it is not necessary to meas-
ure the amount of antibody by the conventionai titration 
method, which, as shown previously, was found to lack re-
producibility (Chapter II). The striking variations found 
by Race and Sanger (1954) in their attempts to remove Rh 
antibodies by repeated absorption with packed Rh-positive 
red cells were taken into consideration. The effective-
ness of Rh-antibody absorption values was compared with 
conventional titration procedures with the aim of estimat-
ing the extent of accuracy for predicting the severity of 
Rh-haemolytic disease in individual cases. 
2. MATERIALS AND METHODS 
Rh-immunized mothers were examined from the first tri-
mester of pregnancy onwards . Mothers were excluded where 
the production of Rh-antibodies may have been the result 
of previous Rh-incompatible blood transfusions, and only 
Rh-incompatible mother-infant combinations were used. For 
the evaluation of Rh-antibody titres the standardized In-
direct antiglobulin titration method was used. 
Rh antibody inhibition test 
Preparation of standard haemolysed Rh-positive cell 
suspensions Blood collected in ACD solution from a 
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pooled source (2 or 3 donors) of group 0, R1 r (CDe/cde) 
donors was washed three times in large volumes of physiol-
ogical saline and finally packed by centrifugation at 
3 000 rpm for 30 minutes. An accurate 50% saline suspens-
ion of the packed cells was made and divided into 10 mI. 
aliquots for daily use. This standard suspension of 
cells was haemolysed by freezing at -20 0 C for 48 hours. 
It may be stored for many months at this temperature with-
out detectable loss of capacity to inhibit Rh-antibodies. 
Since significant differences in the inhibition of Rh-
antibody can be expected when CDe/cde or cDE/cde red cells 
are used it is important that only CDe/cde donors are 
selected for the preparation of standard haemolysed test 
cells. The heterozygous genotype is always preferred . 
because it not only resembles more directly the phenotype 
of all Rh-immunized infants' red cells but also ensures 
that consistent inhibition results are obtained. DU_ pos-
itive red cells should not be included in the donor pool 
as the antibody inhibition capacity of these red cells is 
quite different from that of D+ DU bloods. 
Method of testing - The standardized suspension of haem-
olysed Rh-positive cells was thawed at room temperature 
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and shaken thoroughly before use. A constant volume 
(0.4 mI.) of haemolysed cells was placed into six test 
tubes, numbered 1 to 6. To tube 1 was added one volume 
(0 4 I) of a 1.·2 saline dilution of Rh antiserum (1 part • m. 
undiluted serum and 1 part saline in this instance was re-
cognized as a 1:2 dilution of serum and not 1: 1); to tube 
2, 1 volume (0.4 ml.) of a 1:4 saline dilution of Rh anti-
serum and to tubes 3,4,5 and 6 similarly increased dilut-
ions of Rh antiserum were added (1:8, 1:16, 1:32 and 1:64). 
The diluted serum and haemolysed cells in each test tube 
were mixed and left undisturbed at room temperature for 
10-15 minutes. The free Rh-antibody not inhibited by the 
haemolysed suspension of Rh-positive red cells was meas-
ured by adding one volume (0.4 ml.) of unhaemolysed Rh-
positive red cells and left for a further 20 minutes at 
room temperature. The presence or absence of free Rh-
antibodies in each test tube was then determined by the 
indirect antiglobulin test. The need to use avid broad-
spectrum anti-human gammaglobulin serum must be emphasized 
because antiglobulin reagents of lesser quality cannot al -
ways detect free antibody on the red cells by this proced -
ure. 
Interpretation of results - Since an increasing amount 
of Rh antigen (in the form of haemolysed Rh-positive red 
cells) is actually combined with the Rh antiserum, a meas-
urement can be made of the amount of Rh antigen that is 
required to inhibit the Rh antibody. From tubes 1 to 6 
the ratio of serum to Rh antigen varies from 1·.1 t 1 2 o : , 
1 : 4, 1: 8 , 1: 16 and 1: 32. The absence of Rh-antibodies in 
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the first tube, which represents 50% packed haemolysed 
cells and a 1:2 dilution of serum (1:1 ratio), indicates 
that 1 unit of Rh-positive red cells was required to in-
hibit the Rh-antibody. Should a positive indirect anti-
g I obul in re suI t be rec orded f or tube 4 and not 5, it in-
dicates that the anti-Rh serum required 8 units of packed 
Rh-positive red cells to remove the antibody. The results 
are summarized in Table 25 . 
To obtain a quantitative evaluation of the amount of 
Rh-antibody to which the infant has been exposed over a 
given period of pregnancy the observed Rh-antibody inhib-
ition unit is multiplied by the duration of pregnancy to 
record an 'inhibition index' . For example, an Rh-immunized 
mother who at 32 weeks' gestation was able to maintain a 
constant 'inhibition value' of 36 units will have an 'inhib-
ition index' of 32 x 36 = 1152. In other circumstances 
the Rh-antibody inhibition test can reveal marked changes 
during pregnancy as a result of increased antibody stimul-
ation. When this occurs the 'inhibition index' may be ob-
tained by the procedure set out in Table 26. At least 
one examination must be performed before 24 weeks of preg-
nancy in order to obtain a baseline value. Sub sequent 
tests may then be carried out at two-weekly or monthly 
intervals depending on the results obtained. 
3. RESULTS AND DISCUSSION 
Table 27 shows how closely the fetal wastage rate is 
related to the maternal Rh-antibody titre recorded at del-
i very. It is impor tan t to emphas i ze, however, t ha t such 
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TABLE 25 
Results of Rh-antibody inhibition test 
Test Volume of 
Rh anti-tube haemolysed 
body No. red cells Ant i-Rh serum 
used ( 50% inhibition 
packed CDe/ Vol ume Dilution units 
cde cells) 
1 0.4 ml 0.4 ml 1: 2 1 
2 0.4 ml 0.4 ml 1: 4 2 
3 0.4 ml 0.4 ml 1: 8 4 
4 0.4 ml 0.4 ml 1: 16 8 
5 0.4 ml 0.4 ml 1:32 16 
6 0.4 ml 0.4 ml 1:64 32 
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TABLE 26 
Calculating inhibition index 
Patient examined Observed Progressive calcul-
at: Rh ant i- at ion of the inhib-
(duration of preg- body inhib- ition index during 
nancy) . ition uni t pregnancy 
15 weeks 4 15x4 = 60 
23 weeks 4 23x4 = 92 
28 weeks 16 27x4 +1 x 16 = 124 
30 weeks 16 124+2 x 16 = 156 
32 weeks 32 156+16 + 1x32 = 204 
36 weeks 32 204+ 4 x 32 = 332 
TABLE 27 
Relationship between maternal indirect antiglobulin titre and outcome of pregnancy 
Maternal Rh ant i body Rh nega t i ve Rh positive infants Overa 11 fetal 
titre at delivery mothers wastage 
No. Survived Died S t i llb orn No. % 
1 : 64 or less 176 176 0 0 0 0.0 
1:128-1 : 512 326 310 10 6 16 4.9 
1 : 1024 or more 316 164 53 99 152 48. 1 





a correlation can be seen only in a combined analysis of 
many cases and that misleading information can easily be 
deduced from it if it is assumed that all Rh-immunized 
mothers with antibody titres of 1:1024 or more will have 
severely affected Rh-positive infants. The findings do, 
however, confirm that no fetal wastage due to Rh-immuniz-
ation need be expected if a mother has an antibody titre 
of 1:64 or less. For practical purposes a number of inves -
tigators (Crawford, Cameron and Walker, 1966; Farre ll and 
Davis, 1967) have therefore accepted that amniocentesis 
need not be performed on Rh-immunized mothers with low 
Rh-antibody titres. 
It has often been reported that Rh-antibody tit rations 
cannot be regarded as a reliable criterion for the pre-
diction of the severity of Rh-haemolytic disease in indiv-
idual cases. We also found this to be so by correla ting 
the range of cord-blood haemoglobin values against the 
maternal Rh-antibody titres observed at birth. Since the 
greatest percentage of false predictions can be expected 
among mothers with titres of 1:1024 or more a selective 
analysis was carried out (Table 28) . At least 40 per cent 
of the mothers had Rh-positive infants with cord-blood 
haemoglobin values greater than 10 GI100 mI. These evid-
ently tolerated the intensity of a 1:1024 titre much better 
than those with cord-blood haemoglobins less than 10 GI100 
mI. The last-mentioned group also experienced a high per-
centage of neonatal deaths. 
The variations observed between the apparent clinical 
significance of low Rh-antibody titres (1:64 or less) a nd 
TABLE 28 
Distribution of Rh positive infants born alive to immunized 
mothers with indirect antiglobulin titres of 1:1024 or more 
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Rh positive infants 
Survived Died 
No. No. % 
46 0 O. 0 
42 0 O. 0 
71 27 27. 5 
5 26 83.8 




lack of such correlation when the Rh-antibody titres are 
high (1:1024 or more) draws a tt ention to the fact that 
the conventional procedure of antibody titration does not 
adequately measure the true quantity of Rh-antibody, par-
ticularly in the higher dilutions . 
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In an attempt to discover other recognizable variations 
between low and high-titred Rh-antibodies it was found that 
significant differences often existed in the capacity of 
Rh-positive red cells to absorb Rh-antibodies. By modify-
ing the procedure in order to obtain a greater degree of 
standardization and reproducibility the Rh-antibody inhib-
ition test was compared with the antibody titration pro-
cedure. It was found (Table 29) that serum samples with 
Rh-antibody titres of 1:64 or less are not generally diff-
icult to inhibjt by one unit of haemolysed Rh-positive 
red cells, although a few cases may require four units of 
haemolysed cells. By comparison, Rh-antibody titres of 
1:1024 or more showed a significantly greater range of 
inhibition results, some requiring 2-4 units of haemolysed 
red cells while others required 16 units or more. Although 
some Rh-antibodies possessed titres of 1:1024 or more they 
appeared to have the same inhibition value as those with 
titre values of 1:64 or less. This presupposes that the 
haemolytic effect of some 1:1024 Rh-antibody titres is 
the same as some observed within the 1:64 category. 
With such marked variations observed in the ability to 
inhibit Rh-antibodies it was important to determine the 
value of this test In prognosticating the severity of Rh-
haemolytic disease before birth. Table 30 details an 
TABLE 29 
Comparative analysis between relationship of Rh antibody 
titres and inhibition test 
Maternal indir- No. of 
Units of haemolyzed cells 
ec t anti g I obul in mothers required for the 
i nh i bit i on of 
titre value examined Rh antibodies 124 8 16 32 64 
1:64 or less 56 37 13 6 
1: 128 ) 
1:256 ) 74 17 21 15 10 7 4 
1: 512 ) 
1: 1024 or more 39 2 6 13 8 6 4 
.-.-.-
TABLE 30 




80 uni t s or less 
80 - 500 units 









































analysis of 169 Rh-immunized mothers examined throughou t 
pregnancy. The inhibition test is expressed as a measure 
of 'inhibition index' which estimates the period that a n 
Rh-incompatible infant has been exposed to maternal Rh-
antibodies. By such calculations a wide range of inhib -
ition index values were recorded which, for the purpose 
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of this analysis, have been divided into three categories . 
The first category represents Rh-immunized mothers who 
throughout pregnancy have accumulated an Rh-antibody in-
hibition index of only 80 units or less . Not one of the 
Rh-incompatible pregnancies resulted in a stillbirth or 
neonatal death and more than 90 per cent of the liveb orn 
infants did not require exchange-transfusion. From this 
information it is apparent that a good correlation exists 
between a low Rh-antibody inhibition index and a less 
severe haemolytic manifestation of the disease neonatall y. 
For those mothers who had higher inhibition index value s 
during pregnancy the effec t of in utero haemolysis was 
most obvious when judged by the increased frequency of 
fetal death and the significantly raised incidence of 
infants who required exchange-transfusions. 
The findings in Table 30 show the close correlat i on 
between the Rh-antibody inhibition index and the final 
outcome of pregnancy. It was not intended to show the 
antenatal behaviour pattern of the inhibition test, nor 
the manner in which the findings should be interpreted 
to make an accurate prediction of the haemoly~ic process 
in each individual case. This will be more fully detail ed 
in the next chapter. However, the observations do emphas -
ize that an inhibition index of 500 units or more is un-
questionably associated with an intense process of immune 
Rh-antibody producti on wh ich, as shown in Table 31, can 
be responsible for the introduction of other complicating 
immunological responses o 
The presence of other antibodie s apart from anti-Rh is 
not unusual and their occurrence would seem to follow the 
same course as documented by Nilsson (1965) with regard 
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to the influence of multiple Rh- antibodies. When multiple 
Rh-antibodies are present the severity of the disease is 
usually greater; t his is probably because the total amount 
of Rh-antibodies bound to the infant's red cells is, for 
example, greater in CDe/cde infants born to mothers with 
anti-C plus anti-D, than if the same mothers had produced 
only anti-D. It is quite possible that there is a connect-
ion between increased antibody loading on the red cells 
and the severity of t he disease . However, the primary 
cause of the developmen t of mUltiple antibodies appears 
to be directly associ ated with the intensity of the stim-
ulation of the antibodies as a result of repeated episodes 
of placental haemorrhage. 
It has been shown that antibodies other than anti-Rh 
are produced in response to frequent episodes of re-immun-
ization. This complication is most often found among 
mothers with significantly raised Rh-antibody values 
(Table 31), who as a rule have more severely affected 
infants (Table 30), and possibly a greater incidence of 
placental haemorrhage. Future studies directed towards 
the prevention of plac en t al haemorrhage must therefore 
lead to an even grea t e r reduction in fetal wastage. 
TABLE 31 
Frequency of other immune red cell antibodies among mothers who were 
initially sensitized by the Rh factor 
Maternal 






8 a un its 0 r Ie s s 
80 - 500 units 




















* Rh immunization found in association with immune anti-A, B, Kell, Fya 




THE VALUE OF THE RH-ANTIBODY INHIBITION TEST 
IN RELATION TO LIQUOR AMNII STUDIES 
1. INTRODUCTION 
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Considerable progress was made in the management of 
pregnancies complicated by Rh-immunization with the intro-
duction of amniotic fluid studies (Bevis, 1950, 1952). 
Investigators have now confirmed the relationship of bile 
pigment concentration in the amniotic fluid with the 
intensity of Rh-haemolytic disease in utero. However, 
the spectrophotometric (Walker, 1957), chemical (Mackay 
and Watson, 1962) and pigment-protein ratio procedures 
(Morris, Murray and Ruthven, 1967) cannot always be 
accepted as being infallible, their shortcomings being 
too seldom emphasized while their advantages are simply 
taken for granted (Vos, 1969). 
Some investigators (Pirofsky, 1965; Robertson, 1961) 
believe that with the introduction of liquor amnii stud-
ies nothing useful can be gained by the inclusion of mat-
ernal Rh-antibody investigations. Others (Liley, 1963; 
Hyslop and Whiley, 1960; Walker, 1967) emphasize that 
the prediction of the severity of Rh-haemolytic disease 
by amniotic fluid analysis can at times be most mislead-
ing. Fully endorsed cautions about relying on the pre-
dictions obtained from amniotic fluid studies alone have 
led investigators to believe that bile pigment levels 
should be used only in conjunction with maternal Rh-anti-
body estimations (Nilsson, 1965; Crawford, Cameron and 
Walker, 1966). 
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Since repeated abdominal paracentesis on every Rh-
immunized mother can result in errors in the antenatal 
prediction of the severity of the disease (Zipursky, 
Pollock, Chown and Israels, 1963; Misenhimer, 1966), 
selective amniocentesis has become an accepted practice. 
The recording of low maternal Rh-antibody values is 
really not indicative of severe haemolytic manifestat-
ions of the disease. 
We found that by using Rh-antibody inhibition studies 
we could predict far more reliably the severity of Rh-
haemolytic disease, particularly when the significance 
of liquor amnii values appears to be in some doubt. 
Routine maternal antibody studies form an effective 
supplement to the results obtained by spectrophotometric 
analysis. Rh-antibody studies, can, in fact, be regarded 
as a test to show whether a clinically favourable fore-
cast of severity obtained by liquor examinations at 26-30 
weeks gestation continues to be the same at 34 weeks' 
gestation, especially when it is taken into account that 
more frequent episodes of re-immunization may be expected 
after 30 weeks of pregnancy (see Chapter III). 
2. MATERIALS AND METHODS 
Rh-immunized mothers were examined from the first 
trimester of pregnancy onwards . Those who might have 
produced Rh-antibodies as a result of previous Rh-incom-
patible blood transfusions were excluded and only Rh-
incompatible mother-child combinations were studied. 
To evaluate the Rh-antibody inhibition index, the 
procedure described in Chapter IX was used. Rh-ant ibody 
titre values were determined by the standardized method 
of indirect antiglobulin titration (Chapter II). 
Amniotic fluid studies - Amniotic fluid obtained by 
abdominal paracentesis was centrifuged immediately after 
collection at 4 000 rpm for 30 minutes to remove cellular 
elements and was then placed in a light-proof container 
if an immediate analysis was not carried out. Bile pig-
ment concentration in the specimen was analysed using 
the spectrophotometric procedure of Fleming and Woolf 
(1965) and total protein value by the biuret reaction 
de-scribed by Morris, Murray and Ruthven (1967). Pigment 
protein ratio was calculated as recommended by the same 
authors. Serum bilirubin estimations on the infants' 
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cord bloods were determined by the method of Powell (1954). 
3. RESULTS AND DISCUSSION 
In order to compare objectively the efficacy of amnio-
tic fluid measurements with that of Rh-antibody inhibition 
studies, an investigation was carried out on 66 Rh-immun-
ized mothers who had given birth to Rh-incompatible infants. 
In the assessment of how closely these two procedures can 
forecast the severity of fetal red cell destruction in 
utero it is important to remember that the Rh-antibody 
inhibition test determines the measured intensity of anti-
body effect up to the time of delivery. 
The amniotic fluid studies (particularly when performed 
before 30 weeks of pregnancy) can only measure the inten-
sity of fetal red cell haemolysis present at the time 
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the sample was obtained by amniocentesis. 
To reduce such variations to a minimum, only the high-
est projected spectrophotometric measurement obtained 
from a series of amniotic studies on the same patient 
was used. An average of 2 . 4 amniocentesis samples were 
tested from the 66 mothers examined. Their time of coll-
ection ranged from 28 to 33 weeks of gestation and in no 
instance were single amniocentesis studies included if 
they were performed after the 33rd week of pregnancy. A 
detailed analysis of the serological, biochemical and 
haematological findings of the 66 Rh-immunized mothers 
and their infants is shown in the Appendix of this chapter. 
To determine how closely the Rh-antibody 'inhibition 
index' and bilirubin protein values are related to the 
severity of the infant's anaemia at birth, a biserial 
correlation coefficient analysis was carried out for the 
two testing procedures against (a) the haemoglobin con-
centration of the infant's cord blood at birth; (b) total 
serum bilirubin value at birth, and (c) the severity of 
Rh-haemolytic disease as determined by the infant's 
clinical condition. Table 32 shows the results of this , 
analysis and it can be seen that both procedures (amnio-
tic fluid values and antibody inhibition studies) accur-
ately predicted that an infant's cord blood haemoglobin 
level will be low when the bilirubin/protein ratio or 
Rh-antibody inhibition index values are high. A corres-
ponding correlation is also confirmed for the ability of 
these two procedures to measure the overall severity of 
the disease. However, no real correlation was established 
TABLE 32 
A statistical evaluation of the accuracy in predicting the severity of Rh haemolytic 
disease before birth of Rh-incompatible infants by the Rh antibody inhibition test 
and amniotic fluid studies 
Comparative analysis between 
Maternal Rh ant ibody 
inhibition i ndex value 
a t delivery 
Highest bilirubin/ 
protein ratio values 
obtained between 28 
and 32 weeks gestat-
ion 
Infant cord-blood haemoglobin value 
I nfant cor d-blood b ili rubin value 
Severity of Rh haemolytic disease 
Infant cord-blood haemoglobin value 
Infant cord-blood bilirubin value 
Severity of Rh haemolytic disease 
*** denotes significance at .001 level. 
r Correlation and 
sign if ic ance 
- . 764 
>!<>.'<* (1) 
• 581 












between the bilirubin/protein ratio and the cord-blood 
bilirubin values, whereas a significant association be-
tween Rh-antibody inhibition results and cord-blood bili-
rubin values is evident. 
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Such variations lend support to the argument that the 
bilirubin/protein ratio test (done at least four weeks 
before the birth of the infant) IS able to determine only 
the intensity of in utero haemolysis noted at the time of 
collection and does not necessarily indicate the true 
intensity of red cell haemolysis to be expected at birth. 
As more frequent episodes of antibody stimulation can 
be expected as pregnancy progresses towards term, the 
lack of positive correlation between bilirubin/protein 
ratio values and cord-blood bilirubin may be influenced 
by the increased rate of red cell destruction seen after 
the amniocentesis samples were taken. The possibility 
that raised Rh-antibody production (induced by the dis-
ruption of fetal-placental circulation at amniocentesis), 
is a contributing factor cannot be ignored, and like the 
practice of external version (Vos, 1967) can be considered 
as furthering the intensity of the disease (Zipursky, Poll-
ock, Chown and Israels, 1963). 
A real measure of confidence in the prognosis of Rh-
haemolytic disease can be attained when two different 
testing procedures are employed. However, it was found 
that even if a statistical correlation between the test-
ing procedures and the severity of the disease is evident 
in a combined analysis of many cases, the same may not 
necessarily be true for some individual cases. Marked 
differences can occasionally be observed due to the con-
dition of an infant being influenced by factors other 
than Rh-immunization (Mollison , 197 2) . 
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With the knowledge that such variations can be expected 
in individual cases it appeared that the prognosis of the 
disease should ultimately be based on the assessment of a 
combination of parameters (previous history, father's Rh-
genotype, Rh-antibody value and amniotic fluid results) 
concurrent with any additional experienc e gained from 
other statistical studies . For this r eason a number of 
individual cases are included to show how the Rh-antibody 
inhibition test can be of particular significance in pro-
viding extra information about the haemolytic condition 
In utero. 
Table 33 details the study of an Rh-immunized mother 
with a previous history of two normal pregnancies which 
were not complicated by Rh- immunization. During her third 
pregnancy Rh-immunization was confirmed at 12 weeks' ges-
tation, the preliminary observations strongly suggesting 
that this was the direct result of postnatal immunization. 
A high Rh-antibody value scored at 12 weeks' gestation 
also served as an indication that the present pregnancy 
could result in a very severely affe~ted infant. This 
prediction was reached by noting that the Rh-antibody 
inhibition index value at 26 weeks would have attained a 
level of at least 832 units which, as shown in Chapter IX, 
is dangerously high. Subsequent amniotic fluid studies 
clearly confirmed that the infant was indeed likely to be 















Mrs H.L.: Age 25. 
Previous obstetric history: Two infants alive and well. No stillbirths or 
spontaneous abortions. 
Father's Rh genotype: CDe/CDe 
Rh antibody studies by: 
Indirect Inhibition 
ant i glob u lin 
titre Value Index 
1: 1024 32 384 
1: 1024 32 768 
1:1024 32 832 
1:1024 32 864 
1: 1024 32 928 
1: 1024 32 960 
1: 1024 32 1024 
Opt ical 
dens i ty 
at 
. 450 mu 
O. 170 
O. 140 
Liguor amnii studies 


















fusion may have saved the infant from being stillborn at 
32 weeks. 
The case presented in Table 34 is very similar to the 
one described in Table 33, the only d:ifference being that 
the comparative intensity of in utero haemolysis, as 
judged by the amniocentesis value, appeared to be more 
pronounced. The bilirubin/protein ratio values between 
this and the previous case were at least three times 
greater, whereas the relative Rh-antibody index value 
scored at delivery differed only slightly. 
124 
These variations do not necessarily imply that the two 
testing procedures differed in their prognostic reliabil-
ity, but it does show that individual variations can be 
expected within certain limits. There would be reason 
for real concern, of course, if the two values had been 
significantly different. Table 35 describes a case where 
it was very difficult for the clinicians to decide whether 
intra-uterine transfusion or veTY early induction of lab-
our was the better mode of treatment. This mother had a 
moderately low Rh-antibody inhibition index value when 
examined at 30 weeks' gestation and at this stage a very 
severely affected infant would not have been suspected. 
On the other hand, liquor amnii studies clearly showed 
that the infant was severely affected, the bilirubin/ 
protein ratio values obtained being greater than the re-
sults recorded for the stillborn infant in Table 33. 
Since no other immune antibodies were detected in the 
maternal serum to aggravate the haemolytic process in 




Mrs P.K.: Age 32 
Previous obstetric history: First infant died 12 days after birth. Second 
infant alive and well. Third infant stillborn at 33 weeks. Fourth infant 
Rh-affected) delivered by Caesarean section; exchange-transfused, alive 
and well. 
Rh antibody studies by: Liguor amni i studies 
Indirect Inhibition Opt ical Bilirubin Protein Ra t i 0 b i I i-gestation 







titre Value Index at ).lgm/ mgm of 
450 mu protein 
1: 512 16 352 
1: 512 16 416 
1: 1024 32 512 1. 001 10. 7 6.7 1.5 
1:2048 32 576 O. 710 10. 2 5 . 3 1.9 
1:4096 32 608 
1: 4096 32 640 
Outcome: Spontaneous labour at 35 weeks. Macerated stillborn fetus: 














Mrs C.M.: Age 30. 
Previous obstetric history: Three infants alive and well. No stillbirths 
or spontaneous abortions. 
Father's genotype: CDe/cDE 
Rh antibody studies by: Liguor amnii stud ies 
Indirect Inhibition Optical Bilirubin Protein Ratio bili-
ant ig I obul in Value Index dens i ty flgm/ml mgm/ml rubin 
titre at pgm/ mgm of 
.450 mu protein 
Not examined 
1:64 4 112 
1:64 4 120 o. 190 3.3 5. 0 0.66 
1:64 4 128 
1: 256 8 140 O. 162 3.02 3. 5 0.86 
1:256 8 156 O. 141 2.30 3.4 0.68 
1: 512 16 180 O. 135 2.27 2.9 0.80 
Outcome: Induced labour at 38/52 Infant's condition satisfactory at birth. Not 
oedematous; Rh positive, direct Coombs positive ++++; cord haemoglobin 10.3 gm%, 
reticulocytes 12%, bilirubin total 3.9 mg%, conjugated 0.3 mg%. 





urely. Follow-up studies gradually showed raised Rh-anti-
body formation while the amniocentesis values continued 
to indicate an apparently intense haemolysis in utero . At 
birth the clinical condit i on and haematological findings 
were in c'omplete accord wi th the serological findings but 
disagreed with the amniocentesis values scored since 30 
weeks of pregnancy. 
Whilst it can be accepted that a high percentage of 
predictions scored by amniocentesis investigations are 
r~liable indicators of the intensity of in utero haemoly-
sis, the recognition of some shortcomings may help future 
reasoning regarding the mechanism of bilirubin entry into 
the amniotic sac. 
Table 36 describes a case where it is again evident 
that the initial process of Rh-immunization occurred as 
a possible consequence of the trauma of parturition. In 
this instance Rh-antibody production was not very intense 
during the early stages of her second pregnancy ; however, 
from 32 weeks gestation onwards a marked increase in Rh-
antibody titre was noted, whilst the inhibition index 
value remained low. Amniocentesis values confirmed that 
the intensity of in utero haemolysis was not of clinical 
concern and that the postnatal course of the disease would 
be commensurate with such findings. It is important to 
remember however that should this mother conceive another 
Rh-positive infant soon after the present pregnancy the 
clinical outcome would most likely follow a course very 
similar to the case described in Table 34 where an already 




Mrs D.B.: Age 23. 
Previous obstetric history: One infant alive and well. No stillbirths or 
spontaneous abortions. 
Father's genotype: CDe/cde. 
Rh ant ibody studies by: Liguor amni i studies 
Indirect Inhibition Opt ica I Bi I i rub i n Protein Ra t i 0 b i I i-gestation 
antiglobulin density Fgm/ml mgm/ml rubin 
titre Value Index at ).lgm/ mgm of 
• 450 mu protein 
20/52 1:64 0 0 
25/52 1:64 0 0 
28/52 1:64 0 0 
31/52 1:64 0 0 0.012 O. 3 1. 9 O. 15 
32.52 1: 512 4 4 
34/52 1:1024 4 12 0.018 O. 7 2. 5 0.28 
35/52 1: 1024 16 28 
36/52 1: 1024 16 44 
Outcome: Induced labour at 36 weeks. Infant in excellent condition at birth. Rh positive, 
direct Coombs positive ++++, cord haemoglobin 15.6 gm%, reticulocytes 2%, bilirubin 




body values which resulted in stillbirth. 
In an effort to help women in these circumstances to 
avoid pregnancies with a high risk of stillbirth, pre-
natal counselling and examination is advocated until the 
mother can be assured that the Rh-antibody value indic-
ates that there is a good possibility of her delivering 
a live born child. 
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Finally, it must also be acknowledged that the use of 
liquor examinations is of real practical value in deter-
mining the presence of Rh-negative infants. Table 37 de-
tails a case where it was obvious from a combination of 
maternal Rh-antibody and liquor amnii values that the 
baby was Rh-negative. The prediction by amniocentesis of 
a mildly affected infant did not agree with the forecast 
of a very severely affected infant by Rh-antibody inhibit-
ion values. If we accept that Rh-antibodies destroy fetal 
red cells then the lack of haemolysis by amniocentesis 
studies almost certainly indicated that the infant's Rh-
type had to be compatible with the mother's. 
TABlE 37 
Mrs R.K.: Age 27 
Previous obstetric history: First infant alive and well; second infant affected 
by Rh-imrnunization, exchange-transfused, alive and well; third infant stillborn. 
Father's Rh genotype: cDe/cde. 
Period Rh antibody studies by: Liguor amnii studies 
of 
Indirect Inhib i t ion Opt ical Bi I i rub in Protein Ratio bili- -gestation 
antiglobulin density ugm/ml mgm/ml rubin 
titre Value Index at ugm/mgm of 
.450 mu protein 
10/52 1:2048 16 160 
25/52 1:2048 16 400 
30/52 1:2048 16 480 0.029 1.2 3. 5 0.34 
32/52 1:2048 16 512 0.021 0.9 4. 1 O. 21 
35/52 1:2048 16 560 
36/52 1:2048 16 576 






SEROLOGY, BIOCHEMISTRY AND HAEMATOLOGY OF 66 RH-IMMUNIZED MOTHERS WHO DELIVERED RH-POSITIVE INFANTS 
Liquor amnii studies 
Maternal Cord-blood estimations 
Case Rh-antibody Ratio Time of delivery , Clinical evaluation 
No. inhibition Bilirubin Protein bilirubin Haemoglobin Bilirubin treatment, and of the diseaset 
index at ",g. /ml. mg./ml. p.g. /mg. of G/IOO mi. total mg./IOO mi. outcome· 
delivery protein 
1 450 2 · 5 6·4 0·39 11 · 8 5 ·4 35/52, Ex. Tr. A & W 2 
2 560 3·2 3·6 0·89 Stillborn 28/52 4 
3 640 12·4 6 ·8 1·82 Stillborn 30/52 4 
4 204 1·4 5· 2 0·26 16·2 2·2 36/52, A & W 1 
5 620 10·7 6·7 1· 56 Stillborn 35/52 4 
6 570 1·9 6·3 0·31 6·4 8 ·6 36/52, Ex. Tr. A & W 3 
7 312 2·3 5 · 7 0 ·40 11 ·6 3·7 35/52, Ex. Tr. A & W 3 
8 36 1·1 5·4 0·20 12 · 3 3·3 36/52, A & W I 
9 144 1·2 3 ·8 0·31 12 ·0 3·0 36/52, Ex. Tr. A & W 2 
10 896 6·2 4·9 1·26 Stillborn 31 /52 4 
11 206 2 ·9 7·1 0 ·40 10 ·8 4 ·8 35/52, Ex. Tr. A & W 2 
12 428 1·4 3·4 0 ·44 9 ·4 3 ' 1 36/52, Ex. Tr. A & W 3 
13 68 1·2 5·8 0 ·20 13'6 3·4 36/52, Ex. Tr. A & W I 
14 560 1·9 3 · 1 0 · 61 10·2 2 ' 5 35/52, Ex. Tr. A & W 2 
15 488 2·4 3·8 0·63 6·8 5·2 35/52, Ex. Tr. A & W 3 
16 1,120 3·9 6·2 0·63 8 ·0 5 ' 7 35/52, Ex. Tr. A & W 3 
17 10 1'1 3·8 0·28 17 ·8 2 ' 1 40/52, A & W I 
18 72 0·8 2·8 0 ·28 13 ·3 3 · 1 38/52, A & W I 
19 24 0·6 2·9 0 ·20 15·0 3·3 40/52, A & W I 
20 180 3·3 5·0 0·66 10 ·3 3 ·9 38/52, Ex. Tr. A & W 2 
21 280 1·0 2·7 0 · 37 9 · 3 2·6 36/52, Ex. Tr. A & W 3 
22 320 2 ·0 2·8 0 · 71 10 · 7 3 ·8 35/52, Ex. Tr. A & W 2 
23 700 12 ·0 7·0 1·70 Stillborn 31 /52 4 
24 220 1·6 5'4 0·29 15 · 1 2·4 37/52, Ex. Tr. A & W I 
25 800 2·0 5·8 0·34 5 ' 1 7'2 36/52. Ex. Tr. A & W 3 
26 350 2 ·6 6·1 0·42 10 ·8 2·9 36/52, Ex. Tr. A & W 3 
27 54 1·3 6·3 0·20 13 ·8 2 ' 7 36/52, A & W I 
28 400 2·2 5·8 0·37 \1 ·0 5·0 36/52, Ex. Tr. A & W 2 
29 600 3·0 3·4 0 · 88 Stillborn 30/52 4 
30 820 8·4 7·3 1· 15 Stillborn 29/52 4 
31 840 9·7 7·2 1·34 Stillborn 34/52 4 
32 150 1·5 4·8 0·31 13 ·4 2 ·6 37/52, Ex. Tr. A & W 2 
33 230 2 ·4 5 ·4 0·44 11 · 7 4·3 36/52, Ex. Tr. A & W 2 
34 454 1·6 3 ·8 0 ·42 9 ' 1 3·7 36/52, Ex. Tr. A & W 3 
35 80 0·9 4·2 0·21 14·0 2 ' 7 37/52, Ex. Tr. A & W I 
36 540 2·0 3 · 1 0 ·64 \1 ·9 2'9 36/52, Ex. Tr. A & W 3 
37 522 2·8 4·2 0·66 7 ·0 5 ·6 35/52, Ex. Tr. A & W 3 
38 980 4 ·2 5 ·8 0 ' 72 6 ' 7 5·0 35/52, Ex. Tr. A & W 3 
39 26 1·7 7·3 0·23 15·4 2 ' 1 38/52, A & W 1 
40 92 0·5 2 ·4 0·20 14 ·3 2 ·4 39/52, A & W 1 
41 78 0 ·9 4 ·3 0·21 13 ·9 3 ·1 40/52, A & W I 
42 200 4 · 1 6 ·8 0·60 12·0 4·8 37/52, Ex. Tr. A & W 2 
43 310 1·5 4·4 0·34 10'1 3· 7 36/52, Ex. Tr. A & W 2 44 420 1·9 2'4 0 ' 79 9 ' 4 3 ' 9 35/52, Ex. Tr. A & W 3 45 640 3'4 3 ·8 0·89 Stillborn, 29/52 4 46 500 2'8 6 ' 6 0 ' 42 12'0 6'1 36/52, Ex. Tr. A & W 2 47 180 1·2 5·8 0·20 14·3 2 ' 7 36/52, Ex. Tr. A & W I 48 620 2 ·3 5·2 0·44 8·7 4'8 35/52, Ex. Tr. A & W 3 49 300 1·8 4·1 0·43 12·1 3·9 36/52, Ex. Tr. A & W 2 50 68 1·4 6·1 0·26 14 ·2 2'4 36/52, A & W I 51 96 1·0 3 · 3 0·30 15 · 1 2 · 7 37/52, A & W 1 52 190 2·0 5·2 0·38 \1·7 3'9 36/52, Ex. Tr. A & W 2 53 720 11·4 6'5 1· 75 Stillborn, 30/52 4 54 400 1·3 4 · 1 0 · 31 10 · 7 4'2 36/52, Ex. Tr. A & W 3 55 72 0 ·8 3·8 0 ·21 13'7 2 ' 1 38/52, A & W 1 56 510 1·8 3 ·0 0·60 12 · 1 3·8 36/52, Ex. Tr. A & W 2 57 480 2·3 4 ·3 0·53 9·7 4 ' 9 36/52, Ex. Tr. A & W 3 58 846 4 · 7 7·4 0·63 8·4 5'5 35/52, Ex. Tr. A & W 3 59 42 2'1 9 ' 4 0·22 16·3 2·0 39/52, A & W 1 60 960 5·2 4·8 1·08 Stillborn, 33/52 4 61 864 9·1 6'4 1' 57 Stillborn, 30/52 4 62 78 1'3 5 ·4 0·24 14 · 7 2 ·4 39/52, A & W 1 63 88 0·7 3'1 0·22 16·4 2'0 40/52, A & W 1 64 210 3·9 6·3 0·61 11·8 3 ' 9 38/52, Ex. Tr. A & W 2 65 248 1' 9 4·6 0 ' 41 12·6 3'7 37/52, Ex. Tr. A & W 2 66 310 1·7 3·2 0 ·53 10 · 7 4'3 36/52, Ex. Tr. A & W 3 
• Ex. Tr. = exchange transfusion; A & W = alive and well 
t I = mild; 2 = moderate; 3 = severe; 4 = very severe. . 
. For comparative statistical analysis of the Rh·antibody inhibition index allainst other values scored results were divided by a factor of I 000 ' ~ I I 
Index of 450 ~ 0 ·45. '.• or examp e. case 
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SUMMARY 
Using a standardized antiglobulin test for the deter-
mination of Rh-antibodies it was found that Rh- immunizat-
i on occurs in one or more episodes during pregnancy and 
that the resulting antibody titre can either be high or 
low. The frequency of increased antibody stimulation, as 
determined by a three-fold rise in the indirect antiglob-
ulin titre, appears to be directly related to a large per-
centage of fetal wastage. The findings also show that a 
significantly greater number of episodes of increased Rh-
antibody production occur after 32 weeks gestation, indic-
ating more frequent fetal red cell leakage across the 
placental barrier. The practice of external manipulation 
for breech presentation or transverse lie, which is known 
to cause fetal-maternal haemorrhage, should therefore be 
avoided among Rh-immunized mothers. The results presented 
confirm that these procedures can disrupt the placental 
circulation and the ultimate risk involved in intensifying 
the haemolytic process in utero cannot be ignored. 
Antenatal follow-up studies also established that the 
incidence and intensity of Rh-immunization can differ as 
a consequence of fetal-maternal ABO blood group variations. 
In mothers who produced lower values of Rh-antibody titres 
(1 : 64 or less) the incidence of mother-child ABO blood 
group incompatible combinations was generally within the 
normal range (20%), whilst the reverse (4.7%) was true 
for mothers producing high-titre Rh-antibodies (1:1024 or 
more). This disparity between the production of high and 
low Rh-antibody titres by ABO and Rh-incompatible fetal 
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cells suggests that significant suppression of Rh-antibody 
formation can result from 'double incompatibilities'. 
The antibody titre of the maternal serum at term, as 
measured by the indirect antiglobulin technique, is not 
quite such a good prognostic index for forecasting the 
chance of survival of individual Rh-positive infants as 
are the values for cord-blood haemoglobin or reticulocyte 
percentage. However, titration values of the maternal 
serum have the distinct advantage of being determined be-
fore birth and can indicate the best management of the 
case. 
Another aspect of this investigation was the assess-
ment of a partial absorption (FA) test which enables the 
quantity of Rh-antibodies free in the fetal serum to be 
estimated by titrations carried out on the maternal serum. 
With this test a more accurate prognosis can be made of 
the outcome for the infant than if the indirect antiglob-
ulin titre IS used alone. In a study of 290 cases of in-
fants born to Rh-immunized women it was found that the FA 
test could determine mildly and severely affected cases 
of haemolytic disease more accurately than the indirect 
antiglobulin titre. The correlation coefficient between 
the FA titre of the maternal serum at delivery and cord-
blood haemoglobin for liveborn Rh-positive infants was 
0.72. However, the FA titre was found to be unreliable 
for predicting intra-uterine death unless regular titrat-
ions were carried out from at least the twenty-fourth 
week of pregnancy. Follow-up studies showed tfiat this IS 
due to the rapid fall in FA titre observed in many cases 
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when the fetus has died in utero. 
In the final study a new procedure of Rh-antibody quan-
tification was introduced. Of importance here was the 
determination of the number of absorptions an Rh-antibody 
requires by Rh-positive red cells before it is completely 
removed from the serum. The Rh-antibody inhibition test 
was designed to consider both the time factor and the 
amount of antibody to which the infant is exposed during 
pregnancy. Extensive investigations confirmed that the 
application of this test, in conjunction with spectrophoto-
metric analysis of liquor amnii, can introduce a real meas-
ure of prognostic reliability in predicting the severity 
of Rh-haemolytic disease before the birth of the infant. 
The Rh-antibody inhibition test can in fact be considered 
as a testing procedure for revealing whether a clinically 
favourable forecast by liquor amnii studies between 26-30 
weeks gestation continues to be the same after 33 weeks 
gestation. This is particularly important when it is con-
sidered that (a) the spectrophotometric test can be com-
pletely misleading when performed after 33 weeks gestat-
ion and (b) that more frequent episodes of re-immunization 
can be expected from 30 weeks of pregnancy onwards. This 
was clearly established by finding a positive correlation 
between Rh-antibody inhibition index values and cord-blood 
bilirubin results. The absence of a similar positive co-
rrelation between amniotic fluid bilirubin values and 
cord-blood bilirubin indicates that liquor amnii studies 
cannot always predict whether increased fetal red cell 
destruction can be expected after the amniotic fluid 
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samples have been taken. 
The findings presented indicate that the effect of Rh-
antibodies on the fetus differs in almost every Rh-immun-
ized mother. In some immunized pregnancies the antibody 
value remains the same throughout pregnancy whilst sig-
nificant changes may increase fetal mortality in others . 
From the numerous tests performed it is also evident that 
the relationship between Rh-antibody titres and the sever-
ity of Rh-haemolytic disease is more complicated than has 
been thought up until now . In many laboratories antibod -
ies are titrated by the simple method of diluting the 
serum containing the antibody. In this way it is safe to 
predict that Rh-immunized mothers with antibody values 
below a certain critical dilution (titre of less than 
1:32) will generally give birth to Rh-positive infants 
who are only mildly affec t ed . Howev er , similar predict -
ions are not possible when the antibody values are above 
a certain cr i tical level. In an effort to find a much 
closer association between maternal Rh- antibodies and the 
severity of the diseas e the 'partial absorption test' was 
introduced. In terms of p r edi c ting the condition of the 
fetus in utero, the part i al absorption test is signific-
antly better than any other method of Rh-antibody deter-
mination based on serial dilutions of serum. 
A more refined innovation of the partial absorption 
test is the 'Rh antibody inhibi t ion test' . This test is 
based on the observation that some Rh- antibodies require 
many absorptions with Rh- positive red cells to remove the 
antibody, whilst others require only few absorptions. As 
a method for predicting the severity of Rh-haemolytic 
disease it is more sens itive than the partial absorption 
test . 
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These studies show that Rh-antibody quantification by 
serological procedures may be more accurately performed 
by measuring the amount of Rh-antigen utilized in absorpt-
ion studies than by expre s s i ng Rh- antibody reactivity in 
dilutions. 
SECTION TWO 
THE SPECIFICITY AND IMMUNOGLOBULIN 
CHARACTERISTICS OF AUTOANTIBODIES 
IN ACQUIRED HAEMOLYTIC ANAEMIA 




Early in this century Widal, Abrami and Brule (1908) 
and Chauffard and Troisie r (1908) described factors re-
sembling autoantibodies in the serum of patients with 
acquired haemolytic anaemia. They were the first invest-
igators to observe autoagglutination of patients' red 
cells in vitro and recognized it as a useful diagnostic 
indicator for this haematological disorder. Significant 
advances in the immunology of acquired haemolytic anaem-
ias were hindered for many years because of the lack of 
appropriate methods for detecting red cell antibodies, 
especially those that could not be detected by direct 
in vitro autoagglutination. It was not until Coombs, 
Mourant and Race (1945) introduced the anti-human glob-
ulin test (Chapter II) for detecting Rh-isoimmunization 
that Loutit and Mollison (1945) discovered the signific-
ance of this test to recognize the incomplete form of 
autoantibodies in acquired haemolytic anaemias. 
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The subsequent development of other serological meth-
ods, such as the procedure for recovering antibodies from 
sensitized red cells (Kidd, 1949; Vos and Kelsall, 1956; 
Weiner, 1957) enabled investigators to describe these 
autoantibodies in detail . The important demonstration 
followed that autoantibodies can be classified into two 
main groups: (1) the 'warm' type of autoantibodies and 
(2) the 'cold' type of autoantibodies. Patients in whom 
these two types of autoantibodies are found fall corres-
pondingly into two broadly distinguishable clinical types. 
The 'warm' type affects all ages and the patients may 
suffer from chronic mild anaemia to severe acute haemoly-
tic episodes. Jaundice due to excess unconjugated bili-
rubin in their blood and moderate enlargement of their 
spleen is common. The 'cold' type of autoantibody mainly 
affects elderly people and is generally a very chronic 
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disorder in which the anaemia is seldom severe. For much 
of the clinical information available concerning auto-
immune haemolytic anaemias we are indebted to Dacie's 
authoritative monograph published in 1962. 
In nearly one-third of the patients with autoimmune 
haemolytic anaemia of the 'warm' type the disease is des-
cribed as being 'secondary' because it is associated with 
other diseases, particularly chronic lymphocytic leukaemia, 
reticulosarcoma and also virus pneumonia and disseminated 
lupus erythematosus. Some of these 'secondary' conditions 
are considered to be autoimmune themselves. In the other 
two-thirds of patients there is no other disease specific-
ally associated with the haemolytic condition and these 
are described as being 'idiopathic', meaning a disease for 
which no cause is so far known. 
The 'warm' type of autoantibodies characteristically 
show maximal sensitizing activity for red cells at 37 0 C 
without lysing them, whereas the 'cold' types are only 
slightly or completely inactive at 37 0 C. They differ 
from the 'warm' type in their ability to lyse enzyme-
treated red cells. It is significant that both the 'warm' 
and 'cold' autoantibodies react not only with the patient's 
own red cells but also with almost all other human red 
cell s. For this reason it was originally thought that 
the autoantibodies were 'non-specific' in their combining 
activity for red cells. The term 'non-specific' used for 
these autoantibodies is however not immunologically corr-
t S ince all antibodies must have a specificity of re-ec , 
actions. 
It has since been shown that nearly all examples of 
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autoantibodies of the 'cold' type have anti-I specificity 
(Wiener, Unger, Cohen and Feldman, 1956). For the 'warm' 
type of autoantibodies to be discussed from now on the 
recognition of antibody specificity is not as simple. 
Using the antibodies recovered from the red cells of pat-
ients with autohaemolytic anaemia of the 'warm' type, 
Sturgeon (1947), Kidd (1949) and Wiener, Gordon and 
Gallop (1953) found that these autoantibodies reacted 
with the red cells of man, chimpanzees and Rhesus monkeys 
but not with red cells of the rabbit, fowl, sheep, guinea 
pig or horse. In this respect the reactions seemed to 
parallel the behaviour of Rhesus isoantibodies. However, 
these observations did not help to establish the specific-
ity of the autoantibodies. The first reported recognit-
ion of the role of Rh specificity in acquired haemolytic 
anaemia of the 'warm' type came from Weiner, Battey, Cleg-
horn, Marson and Meynell (1953) who demonstrated the pres-
ence of anti-e. Many investigators have since confirmed 
that other varieties of Rh-antibodies, e.g. anti-D, anti-
c, anti-c+e could also be recognized as autoantibodies. 
Using red cells possessing the normal complement of Rh-
antigen determinants, Mevli (1957) and Hollander and 
Batschelet (19~8) were able to show that the relative 
incidence of the specific Rh-antibodies found in auto-
immune haemolytic anaemia of the 'warm' type corresponds 
well with the incidence of the frequency of the D,C,E,e 
and e antigens in the population. 
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By combining the findings of other investigators Dacie 
(1962) established that only 34 per cent of the 152 pat-
ients examined actually had autoantibodies possessing 
true 'Rh specificity'. The nature of the autoantibodies 
which lacked Rh specificity could apparently not be re-
solved by testing the antibodies against red cells with 
a wide range of Rh-phenotypes. The first indication that 
the unidentified autoantibodies do possess detectable 'Rh-
related specificities' was established by Weiner (1961). 
He confirmed that the autoantibodies which always reacted 
with any combination of red cells possessing a normal 
complement of Rh antigens (DCe/DcE, DcE/ce, ce/ce, etc.), 
sometimes failed to sensitize red cells lacking the normal 
complement of Rh-antigens (Dc-/Dc- or D--/D--). This ob-
servation showed that specific autoantibodies directed 
against a high incidence antigen can appear to lack spec-
ificity unless tested against rare samples of blood from 
which some Rh-antigens have been lost by chromosomal de-
letion or suppression. With the aid of red cells lacking 
all recognizable Rh-antigens (Vos et al. 1961) and those 
lacking the Cc and Ee series of Rh-antigens (Race, Sanger 
and Selwyn, 1950), it was established that the so-called 
unidentified autoantibodies were in fact related to 
the Rh system (Weiner and Vos, 1963). 
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The discovery that a high percentage of autoantibodies 
do possess 'Rh-related specificities' has raised two quest -
ions: What is the significance of the source of the antig -
en involved in this autoimmune system, and to what extent 
can it provide additional information about the composit-
ion of the Rh genome? 
The investigations described from here on were designed 
to evaluate both the specificity and the nature of the 
immunoglobulin involved in acquired haemolytic anaemia of 
the 'warm' type. 
Another important fact to be considered in this disease 
is how the reactions of autoantibodies for Rh-antigens or 
Rh-related antigens could have developed. There is reason 
to suspect that under pathological conditions the red cell 
surface may be modified by some exogenous factor which in 
turn alters the physicochemical structure of the Rh-antigen 
to elicit the formation of autoantibodies. Proof of this 
concept has not yet been established because studies along 
these lines require a profound knowledge of the chemistry 
of Rh-antigens. Alternatively, one could explain the ab-
normality by postulating some defect of the patient's 
immunological apparatus and the emergence of 'forbidden' 
clones of lymphocytes which are unable to distinguish the 
body's own Rh-antigen from foreign Rh-antigen. This trend 
of thought would be in line with the immunological ideas 
of 'self and not self' of Burnet and Fenner (1949). 
Us ing a number of c las s ical serol ogica I ob serva t ions 
as a guide, Milgrom (1969) suggested that autoantibodies 
to Rhesus antigens may result from the inability of these 
antigens to elicit self-recognition when they are altered 
by certain viral or chemical agents. In this situation 
it was postulated that antibodies are not only produced 
against the affected Rh-antigen sites but also against 
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the autoantigens. The mechanism of autoantibody format-
ion to Rh-antigens is obviously of profound interest to 
the whole problem of autoimmune haemolytic anaemia. So 
far there is evidence available to indicate that auto-
antibodies with Rh-related specificities may be the result 
and not the cause of the disease. 
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Chapter XII 
THE RH SYSTEM OF BLOOD GROUPS 
1. INTRODUCTION 
Since the blood group specificities of autoantibodies 
found among patients suffering from acquired haemolytic 
anaemia of the 'warm' type have been identified as Rh or 
Rh-related antibodies it is important that a definition 
of the Rh system from 'normal' to the 'missing' Rh antigen 
types is included in this study. An appreciation of the 
complex factors surrounding the conventionaJ Rh system is 
of particular value in helping to classify the nature of 
Rh-related autoantibodies. These antibodies do not recog-
nize the well-defined DCEce antigens of the Rh system and 
are therefore difficult to incorporate into t~e accepted 
theories of today. Indeed , very little information about 
the relationship of these autoantibodies to the Rh system 
would have been available if rare bloods lacking some or 
all Rh antigens had not been discovered. Thus the inclus-
ion of the so-called 'unidentified' antibodies into the 
Rh system of antibodies begins with a basic perception of 
the present day structure of the Rh genome. 
2. THE NORMAL RH GENE COMPLEX 
Rh antigens are molecular configurations on the surface 
of red cells of which the chemical composition has not 
been clearly defined to date. Recent studies by Green 
(1968a, 1968b) do however suggest that Rh antigens are 
lipoproteins capable of being inactivated by certain sulf-
hydryl reagents by heating at 56 0 C and by enzymatic dig-
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est ion using proteases and urea. Their presence or absence 
on the red cells is determined by genes. 
Two theories have been proposed to explain the heredity 
of the Rh system (Figure 5). According to Wiener and Wex-
ler (1958) one gene at a single locus on a chromosome con-
trols the entire Rh system, whereas the Fisher-Race theory 
(1944) suggests that the Rh system is determined by three 
closely linked genes on each chromosome. A comparison of 
the Wiener and Fisher-Race notations for the eight major 
Rh alleles is shown in Table 38. Regardless of which con-
cept is considered to be correct, the pattern of inherit-
ance has been shown to fit both theories. The two con-
cepts have unfortunately led to the introduction of two 
nomenclatures of the Rh system. For the study presented 
here the Fisher Race notation has been used because most 
investigators regard it as a versatile representation of 
the genetical situation. 
The expression of Rh blood groups in man is demonstrated 
by specific antisera which determine the presence or absence 
of a particular Rh antigen on the red cells. The five 
main antisera concerned with this expression are anti-D, 
anti-e, anti-E, anti-c and anti-e and they define only the 
presence of the corresponding Rh antigen and not the geno-
type. As can be seen from Fig.5, the gene complex Dee 
determines the presence of antigens D,e and e on the red 
cells. The combinations of genes which the single chromo-
some carries are transmitted as a unit from mother to in-
fant. The Rh genotype of the infant is determined by pairs 
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Rho Rho, hr' , hr" 
OCe D,C,e Rl Rhl Rho, rh' , hr" 
DcE D,c,E R2 Rh2 Rho, hr' , rh" 
OCE D,C,E RZ Rh Z Rh rh' rh" 0' , 
dce c,e r rh hr' , hr" 
dCe C , e r' rh' rh' , hr" 
dcE c,E r" rh" hr' ,rh" 
dCE C,E rY rhy rh' ,rh" 
from the mother during fertilization. For example, all 
infants of a CDe/CDe x cde/cde parental combination will 
be of the genotype CDe/cde because one CDe chromosome 
would have been received from one parent and one cde 
chromosome from the other parent. Of the eight basic 
types of Rh chromosomes recognized through extensive 
family studies (Table 38) each individual is known to 
carry a pair of these chromosomes which represents his 
genotype. In numerous clinical and anthropological stud-
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ies carried out throughout the world the Rh gene complex 
has always been observed to follow a simple Mendelian pat-
tern of inheritance. Table 39 lists some of the Rh gene 
complexes known to exist today with the resulting Rh ant-
igens they possess. 
3. THE MISSING RH ANTIGEN TYPES 
In 1950 Race, Sanger and Selwyn described a blood which 
failed to react with any Rh antisera except those contain-
ing anti-D. The Rh genotype of the person concerned was 
described as D--/D-- and it was considered possible that 
the Ce and Ec portions of the Rh gene complex had been 
lost by deletion from the Rh chromosome. Since then sev-
eral other examples of D--/D-- have been described and 
people whose Rh genotype appears to be DCw_/DCw_ have been 
reported. In describing this particular Rh genotype Race 
and Sanger (1968), for the lack of absolute evidence , 
suggested that it could be the result of (1) a short de-
letion of a small piece of chromosome, or (2) a built in 
inhibitor which fails to express the missing antigens. 
During routine testing of blood collected for anthrop-
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TABLE 39 
Rh gene complexes with their corresponding antigens 
Gene complex Antigens 
cDe D G c ce e 
CDe D G C Ce e 
cDE D G c cE E 
CDE D G C CE E 
cde c ce e 
Cde G C Ce e 
cdE c cE E 
CdE G C CE E 
CWDe D G Cw ? e 
cDue (D) (G) c ce e 
cde s c ce s e S 
cDe s D G c ce s e S 
Cedes G C&c ce e S 
(C)d(e) G (C) (e) 
ological purposes from Australian aborigines from the 
Western Desert of Western Australia, a sample of blood 
was found (Vos, Vos, Kirk and Sanger, 1961) which failed 
to react with the following sera: 25 anti-D, 13 anti-C+D 
(+G), 13 anti-C (including some of the specificity anti-
Ce and anti-CE), 2 anti-Cw, 10 anti-E, 1 anti-Ew, 3 anti-
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c +E, 14 an t i - c , 14 an t i - e , 2 an t i - f (an t i - c e) 2 an t i-V 
(anti-ces), 2 anti-VS (anti-e s ), 5 sera from immunized D--/ 
D-- persons, 1 from an immunized DCw_/DCw_ person, 2 from 
immunized Dc-Dc- persons and with 7 sera from immunized 
Negroes who have made antibody not unlike anti-e (anti-
HrS) • 
The cells of individuals with such deletions have since 
been named 'Rhnull' by Ceppellini (1964) . The view that 
the Rhnull genotype is the result of suppression or delet-
ion of that part of the chromosome bearing the Rh locus 
has been considered (Vos, 1961). Another possibility may 
be that Rhnull (---/---) represents basic material remain-
ing after loss of products of the Rh genes by one or another 
genetic mechanism, but on the other hand, it could repres-
ent basic material on which the Rh genes deposit their 
produc t s. 
4. THE LW ANT I GEN AND THE RHn u 11 PHENOTYPE 
When Landsteiner and Wiener (1940) injected the red 
cells of Rhesus monkeys into rabbits they observed that 
the resulting antibody could, after partial absorption 
with human Rh negative cells, react strongly with Rh-
positive red cells and weakly with Rh-negative red cells. 
The strong positive reactions against Rh-positive red 
cells suggested that the specificity was the same as that 
of human anti -D. It is now accepted that the reaction of 
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the rabbit antibody to Rhesus monkey red cells is directed 
against a different specificity referred to as 'LW' in 
honour of Landsteiner and Wiener (Levine, Celano, Wallace 
and Sanger, 1963). Levine has also proposed that although 
the genes for Rh and LW are inherited independently they 
may act on the same basic Rh substance to produce their 
respective red cell antigens . 
With the discovery of the Rhnull (---/---) blood an 
excellent opportunity was provided to determine whether 
these red cells also carried the LWantigen. If not, the 
question arose of the relationship of the LW antigen to 
basic Rh substance. 
Parallel studies were undertaken, based on three crit-
erla: (a) absorption of guinea pig anti-LW with Rhnull 
cells, (b) elution of the antibody and (c) antigenicity 
of the Rhnull factor in guinea pigs. Immunization experi-
ments were carried out with Rh-negative and Rhnull red 
cells. At three-day intervals each of two series of 
guinea pigs received two injections of 2.0 ml of the 
bloods. When tested ten days later five guinea pigs in-
jected with Rhnull cells failed to produce anti-LW, two 
of these five produced an antibody identified as anti-No 
Since the Rhnull red cells used for this study were of the 
genotype NN the source of this antibody stimulation is ob-
vi ous. Of the four guinea pigs injected with Rh-negative 
red cells, three showed very weak anti-LW specificity 
when absorbed with Rh-negative red cells. After absorbing 
these sera with the Rhnull cells all four gave anti-LW 
specificity of stronger activity than that obtained on 
absorption with Rh- negative red cells . In contrast to Rh-
negative bloods, the Rhnull cells failed to yield eluates 
with anti-LW specificity, as shown in Table 40. 
The results of our study indicate that when a gene pro-
duces an Rh antigen determinant it almost always produces 
LW antigen and that the LW material constitutes unaltered 
basic Rh substance which, by a series of mutations in man , 
has evolved into the complex of Rh factors as it exists 
today. This theory was mentioned as early as 1952 by 
Murray and Clark. In any event it can be concluded that 
the LW antigen is associated with all human blood bearing 
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anyone or more of the antigenic determinant groups of the 
Rh system (see Chapter XVI) . 
5. THE ASSOCIATION OF MULTIPLE PHENOTYPIC ABNORMALITIES 
WITH RHnull. 
A most important observation with the discovery of the 
original Rhnull blood and some 15 or 20 other Rhnull pro-
positi which have now been found, is the failure of some 
Rhnull bloods to react with most anti-U or anti-s reagents. 
Although there is no evidence for linkage between the gene 
loci of Rh determinants and SsU blood group systems, there 
may, nevertheless, be a structural relationship between 
the antigenic determinants in these two systems . 
Examples of blood which fail to react with anti-U re-
agents have always been found in Negroes and have so far 
not been reported i n Caucas i ans , Mongeloids, Australoids 
TABLE 40 
Absorption and elution studies of anti-LW using Rh-negative and Rhnull 
red cells 
Tested wi th 
Pooled guinea pig 
anti-rhesus serum 1:5 R2R2 R1R1 R1 r Ror rr rr rr ---/---
Absorbed with rr + + + + + + + + + + 0 0 - -eluate from red blood 
cells: 
---/--- 0 0 0 0 0 0 0 0 
rr ++++ ++++ ++++ ++++ 0 0 0 0 
Readings were taken after incubation at room temperature for 1 hr., light 





or Asiatics. Only one example of a U-negative blood has 
so far been described in an Asiatic family (Moores, 1972), 
indicating that the U-negative characteristic is basically 
Negroid in origin. 
In the determination of the U blood group status of 
four .Rhnull individuals against a number of anti-U reag-
ents (Vos, Moores and Lowe, 1971) it was shown that only 
one (H. A.) possessed a normal U expression of the red 
cells (Table 41). This suggests that the absence of a 
normal U expression in samples H.H., L.M., and E.N., may 
be due to differences in the structural composition of 
the Rhnull factor. 
To provide further information on the genetic background 
of the Rhnull factor, extensive family studies have been 
carried out (Levine, et al. 1965; Ishimori and Hasekura, 
1967 ). A comparative analysis of these studies revealed 
some remarkable variations to explain why some but not all 
Rhnull bloods possess an aberrant U blood group. For fam-
i I y L. M. (Tab Ie 41) it was c onf i rmed that the Rhnull pro-
positus was able to transmit to her child the full express-
ion of the LW and CDE antigens, which she herself, being 
homozygous for the Rhnull factor, did not show. In the 
Japanese family the parents of the propositus (H.A. ,Table 
41) lacked the complete expression of one set of CDE anti-
gens on an allele, indicating that they were heterozygous 
for the RhnuII factor. 
These family studies clearly revealed the existence of 
two mechanisms that influence the LW and CDE expressions. 
Among the theories proposed to explain the absence of all 
TABLE 41 
Red cell agglutination test of known U-positive and U-negative bloods for various antisera 
SsU phenotYT.>e Reactivity of red cells for antisera 
Ant i-LW Ant i-S Anti-s An t i-U 
AHA G.Pig 1172 159 60 385 7 Dub 1. Perth 176 959 31 Mah 128 
Control S+s+U+ 4 4 4 4 4 4 4 4 2 2 4 4 3 4 
Con t rol S- s+U+ 4 4 0 0 0 4 4 4 2 2 4 4 4 4 
Control S+s-U+ 4 4 4 4 3 0 0 0 0 0 4 4 4 4 
2671 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
2538 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
1784 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
9484 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
5816 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
7799 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
4166 ~- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
3836 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
3357 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
4661 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
1458 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
2439 S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
Krum S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
Amich S- s- U- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
Kamla S- s- U- 4 4 0 · 0 0 0 0 0 0 0 0 0 0 0 
Sara S- s- u- 4 4 0 0 0 0 0 0 0 0 0 0 0 0 
H. A. S- s+ U+ 0 0 0 0 0 4 4 4 2 2 4 3 3 4 
H. H. S- s+U- 0 0 0 0 0 4 0 4 2 0 0 0 0 0 
L. M. S- s+U- 0 0 0 0 0 4 0 4 2 0 0 0 0 0 





Rh antigens on the red cells are (1) chromosomal deletions 
(Ishimori and Hasekura, 1967) and (2) the existence of an 
independent amorphic gene XOr which blocks the expression 
of the Rh genes (Levine et al., 1965). Fig.6 illustrates 
a tentative model for the two types of conditions that 
can lead to Rhnull expression. 
It is difficult to explain why some Rhnull red cells 
(samples H.H., L.M., and E.N.) do not react with anti-U 
reagents. The fact that the expression of the U antigen 
can be altered by the same mechanism that is involved in 
the blocking phenomenon of the Rh precursor substance 
suggests that the two independent systems Rh and Ssu are 
influenced by a single aberration. Schmidt et al., (1967) 
proposed that this aberration may be due to the sequential 
action of genes controlling shared terminal sugar(s) which 
in turn has the capacity to alter the various specificities 
depending on the basic precursor substance involved (Wat-
kins, 1966). 
Race and Sanger (1968) made the important observation 
that discrepant anti-S, anti-s and anti-U results against 
unrelated Rhnull bloods were not given when saline or al-
bumin tests could be used in place of the indirect anti-
globulin test. The question thus arises whether the ab-
sence of U reactivity in some Rhnull bloods may be assoc-
iated with a spatial membrane arrangement of the U antigen 
whereby the receptors are not fully exposed above the sur-
face. 
X'r 1- X'r /-
-/-
JAPANESE Rh null FAMILY 
X'r I X'r 
X'r / XOr 
UNITED STATES Rh null FAMILY 
D GENE DELETION _ BLOCKED GENE 
Figure 6: · An illustration of two types of 
condition that can lead to Rhnull expression. 
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Chapter XIII 
THE SPECIFICITY OF ACQUIRED HAEMOLYTIC 
ANAEMIA AUTOANTIBODIES 
1. INTRODUCTION 
If a serum contains a gammaglobulin which will react 
with (agglutinate, haemolyse or sensitize) certain genet-
ically well-defined red blood cells but not others, it is 
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said to possess an antibody, and the antibody is said to 
be specific for a certain property of the red cells. Thus 
the specificity of an antibody depends on this selective 
reactivity. This simple approach for determining anti-
body specificity is often difficult to demonstrate if the 
range of activity is widespread and if there are 9nly a 
few cells available which lack the property against which 
the antibody reacts. A good many blood grouping laborat-
ories have in their freezers sera containing antibodies 
against 'Public Antigens'. These sera have up to now re-
mained unclassified because they react with all available 
r ed cells except those of the patient or donor. Nobody 
will dispute the antibody nature of these reagents or call 
them 'non-specific'. If these 'non-specific' agents 
could be shown to be 'specific', that is not to react with 
c ertain genetically well-defined red cells, more workers 
migh t be persuaded to regard them as true antibodies. 
An important feature of the antibodies found in ac-
quired haemolytic anaemia of the 'warm' type is their 
ability to react with the patient's own red cells in 
vivo. Until 1953 when Weiner, Battey, Cleghorn, Marson 
and Meynell discovered that such autoantibodie~ possess 
definite 'specificity' it was generally thought that the 
antibodies reacted with an undetermined antigen. 
Using red cells with a wide variety of well~defined 
Rhesus phenotypes it was established that about 30 per 
cent of patients with acquired haemolytic anaemia of the 
'warm' type possess autoantibodies with specificities 
directed against several of the known Rhesus antigens on 
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the surface of the red cells. In the other 70 per cent of 
patients the specificity of the autoantibodies could not 
be identified because they did not share the true charact-
eristics of known Rhesus antibodies. 
With an added knqwledge of the genetics of the Rh 
system from the discovery of Rhnull cell~ (Vos et al . 1961) 
and red cells from which the Cc and Ee portions of the Rh 
gene complex had been lost (Race, Sanger and Selwyn, 1950) 
the nature of non-specific autoantibodies was re-examined. 
The autoantibodies from 60 patients suffering from ac-
quired haemolytic anaemia were tested against a variety of 
cells with common and very rare Rhesus genotypes. 
2. MATERIALS AND METHODS 
Eluates obtained from the red cells were used rather 
than sera because sera often do not contain all the anti-
bodies that can be detected in eluates. 
The eluates were prepared by the ether elution method 
of Vos and Kelsall (1956). They were tested against Cde/ 
Cde, cdE/cdE, CdE/cde, CDE/CDE, cde/cde KK cells, one 
D--/D-- blood, one Dc~/Dc- sample and the original Rhnull 
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blood. The cell panel included the following Rhesus 
antigens: 'normal' cells (not deleted: nI), 'partially' 
deleted cells (pdl) and 'fully' d~leted cells: (dI). The 
tests were performed with positive and negative controls. 
Indirect Coombs tests we~e done to confirm doubtful results 
but generally the enzyme method proved to be a valuable 
qualitative test. None of the eluates produced agglutin-
ation of saline-suspended cells. Most eluates agglutinated 
cells suspended in bovine aloumin but the reactions were 
much better with enzyme~treated cells and the latter method 
was generally used. 
Absorptions were done in the following way: 1 volume 
of packed red cells (usually unmodified) was incubated 
with 1 volume of eluate at 37 0 C for 2 hours. The super-
natant was removed and kept. rhe red cells were then 
(without washing) incubated for another 2 hours with 3- 4 
volumes of the same fresh eluate and were then eluted. 
Titrations were done using doubling dilutions of the 
eluates in saline and enzyme-treated cells. 66 eluates 
were available in q\lantities large enough for more de-
tailed investigation. Six showed 'blood group specificity' 
and were excluded. Of the remaining 60, 10 were from 
'normal' donors who were found to have 'coated' red cells. 
The remaining 50 eluates were from patients SUffering from 
typical autoimmune haemolytic anaemia (w<;l.rm type) of vary-
ing sever i ty. 
3. RESULTS 
Weiner (1961a) established that when 'partially' del-
eted cells (D--/D--) were used together with other 'nor-
mal' 
were 
red cells, the eluates fell into three groups which 
called Class 1, Class 2 and Class 3. This classi~ 
fication depended on whether they reacted as strongly 
wit h D- - / D- - cell s as with 'norma l' cell s (C 1 ass 1), more 
weakly with the former (Class 2) or not at all with them 
(Class 3). This classification was confirmed by us, but 
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a further subdivision was necessary to include the obser-
ved reactions obtained with completely deleted (---/--~) 
cells. Some Class 1 eluates reacted equally strongly with 
---/--- cells (la), others reacted more weakly (lb) and 
the rest showed no reactivity with them (lc). Class 2 
eluates could be subdivided in the same manner (2a, 2b,2c) 
but Class 3 eluates gave only one pattern of reactivity, 
i.e. they did not react with the deleted (---/---) cells 
at all. Table 42 shows the reactivity of the 60 eluates. 
There was no correlation between the class and subdiv-
ision of the eluates with the ABO groups or Rhesus geno-
types of the patients or donors. Both ABO groups and Rh 
genotypes showed the expected distribution. Amongst the 
patients there were 28 men and 24 women. Of the I normal' 
donors all 10 were men (amongst the donor population from 
which these donors were drawn, the ratio of men to women 
is almost exactly 1: I). 
It would appear that more women than men develop an 
antibody which will react with the ---/--- cell, but the 
differences shown in Table 43 are statistically not sig-
nificant. This table also shows that of the 60 eluates 
examined, 32 failed to react against the ---/--- cell and 
TABLE 42 
Classification of 60 acquired haemolytic anaemia 
red cell eluates 
Class 1 Class 2 Class 3 
a b c a b c 
Patients 13 3 10 2 6 8 8 
Donors 2 2 1 1 3 1 
Total 15 5 11 3 6 11 9 
Class 1: React equally strongly against D--/D-- cells as against 
" norma 1" cell s . 
Class 2: React less well against D--/D-- cells than against 
"normal" cells 
Class 3: React well against "normal" cells; do not react against 
D- - / D- - cell s . 
Sub - d i vis i on: 
a. Eluate reacts equally well with all three types of cells 
b. Eluate reacts less well with ---/--- cells than with "normal" 
or D--/D-- cells. 





Fa t i en t s 
Donors 
TABLE 43 
Distribution of the various classes of eluates 
between male and female, patients and donors 
Class 1 Class 2 Class 3 
a b c a b c 
(Male 6 3 7 2 1 10 7 
~Female 8 2 5 1 5 1 2 
(Male 4 1 6 1 1 7 6 
~Female 8 2 5 1 5 1 2 
2 2 1 1 0 3 1 
...... 
'" \..oJ 
11 eluates showed less activity against these cells than 
'normal' cells. Thus 43 (71 per cent) eluates did not 
react, or reacted weakly against ---1--- red cells when 
compared with the reactivity against 'normal' red cells. 
This pattern of reactivity suggested a mixture of anti-
bodies in the 'reacting' eluates which was confirmed by 
absorption and re-elution experiments. 
A few typical examples are given. Eluate B.A. B. (Table 
44) gave the following reactions: ++++ against normal 
cells, ++++ against the D--/D-- cell and +++ against the 
---1--- cell. When this eluate was absorbed with ---1---
cells the antibody against ---1--- was taken out but the 
reactivity against normal cells and D--/D-- was almost 
identical with the pre-absorption activity. A further 
absorption with D--/D-- left an antibody in the supernat-
ant which reacted only with 'normal' cells. Re-elution 
of the antibodies from the absorbing red cells produced 
reagents which had the expected reactivity. Table 45 
shows a similar absorption experiment on eluate L.A. 
Non- reactivity of certain eluates against D--/D-- and/ 
or ---/--- red cells might have been thought to be the 
result of quantitative rather than qualitative factors. 
However, the results demonstrate that the classes of the 
eluates obtained were independent of the titres of the 
eluates against 'normal' cells. Scores of different el-
uates against different red cells are shown in Table 46. 
It can be seen that the scores (or titres) against normal 
cells have no influence on the class or subdivision of 
the eluate. In Class 3, for instance, scores range from 
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TABLE 44 
Absorption experiments - Eluate B.A.B. 
cdE/cdE D--/D-- Cde/Cde cde/cde ---/--- CDe/cDE 
No. 1. Original eluate 3 4 4 4 3 4 
No. 2. Eluate absorbed ---/--- 3 3 3 3 3 
No. 3. Eluate absorbed D--/D-- 3 3 3 3 
No. 4. No. 2 absorb~d D--/D-- 2 2 2 2 
No. 5. Eluate re-eluted off 
---/--- 3 3 3 3 3 3 
No. 6. Eluate re-eluted off 
D--/D-- 3 3 3 3 3 3 





Absorption experiments - Eluate L.A. 
cdE/cdE D--/D-- Cde/Cde cde/cde ---/--- CDe/cDE 
No. 1. Original eluate 4 4 4 4 4 4 
No. 2. Eluate absorbed ---/--- 4 3 3 3 3 
No. 3. Eluate absorbed D--/D-- 4 3 3 3 
No. 4. No. 2 absorbed D--/D-- 4 3 3 3 
No. 5. Eluate re-eluted off 
---/--- 3 2 3 3 3 2 






Agglutination scores of eluates against enzymated cells 
"Normal" D- -/D-- ---/---cell 
Class Ia eluate 30 30 30 
Class Ib eluate 40 40 34 
Class 2c eluate 85 56 
Class 2c eluate 59 20 
Class 3 eluate 85 




45 to 85 and in other classes conditions were similar. 
4. DISCUSSION 
It was established that the eluates of cells from pat .. 
ients with AHA and from 'normal' donors contained three 
different types of antibodies. The red cell antigens re-
active with these antibodies are listed in Table 47. The 
results suggest that the eluates may contain anti-nl, 
anti-pdl, and anti-dl, singly or in combination. 
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It was found that one person may form one antibody 
whereas another may form two or three against related 
antigens. This is common in people developing antibodies 
within the Rhesus system (e.g. anti-D plus am i-C and anti-
G). It appears that all 'normal' cells contain the antigen 
designated as 'nl'. This may be produced by a gene on 
the Ee locus as it is · absent from the D--/D-- and the 
Dc-/Dc- cells. Or it may be a 'composite' antigen whose 
production depends on the presence of a full complement 
of 'normal' genes. Its absence from the partially del-
eted cells could be explained by either hypothesis. The 
anti-pdl antibody may react with an antigen produced by 
a gene near the D locus, nearer in fact than the C gene, 
as both D--/D-- and Dc-/Dc- carry it. It is not a part 
of th~ D antige~ as it can be found on D negative cells 
in the same strength as on D positive cells. As far as 
we know the 'dl' antigen has a universal distribution. 
The factors determining the type of antibody which is 
formed in different patients are not known. The severi ty 
of the illness has apparently no bearing on this question 
TABLE 47 
Suggested antigenic make-up of "normal", "partially" deleted and "fully" 
deleted cells 
"Norma I" cell s 
D--/D-- or Dc-/Dc- cells 
nl pdl dl 
Pdl dl 
---/--- cells dl 




as all types of eluates were found in all types of pat-
ients, even 'normal' donors. Similarly, the genotype of 
the patient or donor has no bearing on the development 
of a particular class of antibody. At present it is un-
170 
explained why some people form an antibody, eog. against 
c or e antigens and others against the antigens described 
in this study, though all patients or donors who were in-
vestigated carried the latter antigens on their cells. 
Investigation of antibodies contained in the eluates 
of patients and 'normal' donors has demonstrated three 
antigens within the Rh system, antigens which seem to be 
additional to those recognized by the commonly used Rh 
antisera. They have pemonstrated that the 'fully deleted 
cell' still carries an antigen. It is not known whether 
this antigen is the 'ground substance' of the Rh system 
or part of the complex Rh system necessary for the ex-
pression of other Rh antigens. 
Chapter XIV 
THE SEROLOGICAL CHARACTERISTICS OF ACQUIRED 
HAEMOLYTIC ANAEMIA AUTOANTIBODIES 
1. INTRODUCTION 
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The present study was designed to determine the serol-
ogical characteristics of the various autoantibodies 
found in patients with AHA. Using normal erythrocytes 
and Rhnull erythrocytes the autoantibody specificity was 
studied and the reactivity defined both with the antiglob-
ulin test and erythrocytes treated with a proteolytic 
enzyme (f ic in) . A further subject for study was the eval-
uation of complement components on the erythrocytes of 
patients with warm AHA autoantibodies. The presence of 
both IgG and complement components in erythrocyte eluates 
was defined with the antiglobulin test using monospecific 
antiglobulin sera (anti-IgG and anti-complement). From 
these results a hypothesis for the apparent discrepancy 
in the complement fixing properties of Rh isoantibodies 
and the autoantibodies found in AHA of the 'warm' type 
is presented. 
2. MATERIALS AND METHODS 
Selection of patients depended upon a positive direct 
antiglobulin test of the red cells and the haematological 
association of an autohaemolytic anaemia of the 'warm' 
type. Of the 24 patients on whom red cell eluate studies 
could be performed only 12 were available for a detailed 
investigation of the serum as well as the red cells. 
To avoid in vitro sensitization of the red cells due 
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to cold antibodies on storage at 50 C, separation of the 
red cells from the defibrinated blood was performed on 
the same day as collection. For the preparation of el-
uates red cells were washeo four times with 20-40-fold 
volumes of isotonic sodium chloride solution (0.85%) and 
stored at -20 0 C for varying periods as a 50% concentrat-
ion of packed red cells in saline. 
Antibody elution - To recover autoantibodies from the 
patient's in vivo sensitized red cells the ether elution 
procedure of Vos and Kelsall (1956) was used. The only 
modification to the published method was that ether was 
added directly to the 50% suspension of packed washed 
red cells. At no stage before or after the elution pro-
cedure was fresh human serum added to the suspension of 
haemolyzed red cells. 
Antiglobulin test ~ The antiglobulin test was performed 
on a translucent white rectangular tile as described by 
Dacie and Lewis (1963). A 'broad spectrum' commercial 
anti-human serum capable of detecting IgG and complement 
components was used. A specific anti-IgG was made by ab-
sorbing the broad spectrum anti-human globulin serum with 
cells sensitized with incomplete Lea (IgM) antibody and 
complement components. An 'anti-non-gamma' reagent was 
made by adding purified human IgG globulin to the broad 
spectrum serum as described by Dacie (1962). In the 
more recent experiments an antiserum to comp.lement com-
ponents C3 and C4 was used. Parallel experiments using 
the anti-complement and 'anti-non-gamma' serums showed 
similar reactivity to that reported previously by Harboe 
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et al. (1963) and Leddy and Bakemeier (1967). 
Ficin test - For the enzyme test a solution of 1% comm-
ercial ficin in isotonic sodium ch19ride solution and 
buffered to pH 7.2 with Sorensen buffer was prepared. To 
detect antibodies one drop of this enzyme solution was 
added to one drop of serum or red cell eluate, followed 
by one drop of a 5% suspension of known red cells. At 
no stage were the red cells pre-treated with this enzyme 
for the recognition of ficip-reactive antibodies. The 
enzyme agglutination tests were performed on translucent 
tiles and left in a damp chamber at room temperature 
(22 0 C) for one hour. Agglutinations were read macros-
copically with a 5 x magnification head fitting eyepiece. 
Red cells useq - To detect the presence of known anti-
bodies a commercial panel of red cells was used. Anti-
body absorption and elution studies were performed with 
DCe/DcE and Rhnull red cells, each obtained from a single 
donor. 
Definitions Rf antibody specificity - In acquired haem~ 
olytic anaemia it is not upusual to find more than one 
specific autoantibody. Antibodies characterized in this 
study were defined as detailed in Chapter XIII. 
(a) Antibodies for well~defined red cell antigens: ~ 
These antibodies show distinct specificity against 
any of the well-defined blaod graup antigens such as C,c, 
E,e,Kell, Fya, Lea etc. Since undiluted serum .or eluate 
same times reac ted wi th all narmal ce 11 s (i. e. thase wi th-
aut ~h gene deletians), absorptian studies were necessary 
ta demanstrate such specificity. 
(b) Antibodies reactive with 'normal' red cells (anti-
nl): Anti-nl antibodies are defined as those that 
react with normal human red cells possessing the common 
Rh phenotypes ce/ce-, OCe/ce, DcE/DcE etc. but fail to 
react with the fully deleted Rhnull red cells (---/---). 
Since partially deleted red cells of the phenotype D--/ 
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D-- were not available for this study, it is highly prob-
able that some antibodies for normal red cells could 
also contain anti-pdl (Weiner and Vos, 1963). 
(c) Antibodies reactive with Rhnull red cells (anti-dl): 
Anti-dl antibodies are defined as those reacting with 
Rhnull erythrocytes. The Rhnull bloods used were obtain-
ed from three sources: (1) Mrs.E.N. (the original Rhnull 
Australian Aborigine, Vos et al. 1961); (2) the Japanese 
Rhnull (Ishimori et al. 1966); (3) a white Californian 
Rhnull (P. Sturgeon, unpublished). Serum or red cell el-
uates reactive with normal cells and with Rhnull red cells 
were absorbed using equal volumes of serum or eluate 
against washed packed RhnuII red cells. If the ant ibody 
was completely removed by these red cells the specificity 
was considered to be anti-dl. If the RhnuII cells re-
moved the antibody against Rhnull cells but left an anti-
body against normal cells the antibody in the serum or 
red cell eluate was considered to be a combination of 
anti-nl and anti-pdl. 
Differentiation of ficin and antiglobulin-reactive auto~ 
antibodies - AHA autoantibodies can be detected by sero-
logical techniques such as the antiglobulin and ficin 
tests (Dacie, 1962). These techniques can also be used 
to further characterize AHA autoantibodies of multiple 
specificity. For example, should an AHA autoantibody 
sensitize normal red cells by the antiglobulin as well 
as the ficin test, and Rhnull red cells by the ficin 
test only, then the first procedure is to absorb this 
serum or eluate with ficin ... treated Rhnull red cells. 
Subsequent tests may then show that the absorbed serum 
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or eluate still contains the antiglobulin-reactive anti-
body for normal red cells but not the ficin-reactive anti-
body for Rhnull red cells. Using this mode of testing a 
clear differentiation of the type of serological reactiv-
ity involved can be established. 
3. RESULTS 
The specificity of antibodies found in the serum and 
red cell eluates of 12 patients with AHA is shown in 
Tab Ie 48. Antibodies reactive for well-defined red cell 
antigens (anti-e, anti-E etc.) are at times observed in 
the serum. In this series such antibodies were not found 
in the e I ua t e s • Since antibody activity in an erythro-
cyte eluate more strongly implicates it in the pathogen-
esis of the disease than antibody activity which is pres. 
ent only in the serum, emphasis was placed on those anti-
bodies present both in serum and eluates. 
Investigations were carried out to record how often 
anti-nl and anti-dl autoantibodies could he detected as 
ficin or antiglobulin-reactive varieties or a combination 
of both. 
Table 49 shows that autoantibodies detectable only by 
TABLE 48 
Observed frequency of "anti-nl" and "anti-dl" autoantibodies in the 
serum and the red cell eluates of 12 patients with acquired haemol yt ic 
anaemia. 
Patients Ant ibody ob served for " An t i - n I " "Anti-dl" 
investig- "known" red cell ant- ant ibody 
ant ibody 
ated igens 
Serum Eluate Serum Eluate Serum Eluate 
H. L. + anti-e + + + 
B. c. + + 
F. R. + E bH + + 
T. B. + Le + + 
H. N. + + + 
S. T. + + 
w. B. + Fyb + + 
c. R. + + + + 
L. T. + E + + 
c. F. + Jka + + 
K. p. + + + 
J. L. + + + 
Total 6 = 50% 0 9 = 75% 10 = 83% 4 = 33% 7 = 58% 
positive 







Frequency of "anti-nl" and "anti-dl" autoantibodies observed 
in 12 serums and red cell eluates by the ficin test and com-




Twelve red cell 
eluates 
Antibody detected No. of patients 
by: positive for: 
"anti-nl" "an t i-dl" 
Fic in test only 4 1 
An t i glob u lin test 
only 0 0 
Ficin as well as 
an t i glob u lin test 5 3 
Total ':' 9 4 
Ficin test only 4 0 
An t i glob u lin test 
only 3 5 
Ficin as well as 
ant i glob u lin test 3 2 
Total':' 10 7 




the antiglobulin te~t were not found in the serum but 
were frequeptly present in the red ~ell eluates. 
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Table 50 shows the frequency of anti-nl and anti-dl 
autoantibodies detected by the ficin and indirect anti-
globulin tests on the same 24 red cell eluates. The 
Rhnull red cells from three donors gave similar results 
and were mo~e often reactive by the antiglobulin test 
than by the ficin test. No marked differences were ob-
served between the ability of the ficin or the antiglob-
ulin test to recognize the autoimmune anti.nl antibodies. 
To determine whether this is because patients cannot pro-
duce at one time two different antibodies reactive by 
the same serological technique, the data were analyzed 
to determine how often ficin-reactive anti-nl could be 
found in the red cell eluates together with ficin-react-
ive anti-dl. Tables 51 and 52 detail this analysis for 
combinations possible considering the two different auto-
antibodies and the two testing procedures. Table 51 in-
dicate·s that the red cell eluates possessing strong ficin-
reactive anti-nl very seldom appeared to have strong 
ficin-reactive anti-dl. Table 52 shows that antiglobulin. 
reactive anti-nl, together with antiglobulin-reactive 
anti .. dl was also uncommon. In contrast, Tables 51 and 
52 show that strong £icin-reactive anti-nl and strong 
antiglobulin-reactive anti .. dl, or strong antiglobulin-
reactive anti-nl and strong ficin-reactive anti-nl were 
combinations of autoantibodies frequently recovered in 
eluates. The simultaneous recovery of anti-nl and anti-
dl antibodies which were stropgly reactive by the anti-
TABLE 50 
Number of ficin and antiglobulin-reactive autoantibodies observed 
by examining the red cell eluates against three "normal" and three 
Rhnull samples of blood 
24 red cell eluates examined by the: 
Test cells Ficin test Indirect antiglobulin test 
Pos it ive Negative Positive Negative 
"Normal" 
CDe/CDe (Rl Rl ) 18 6 21 3 
cDE/ cDE (R2 R2 ) 18 6 21 3 
cde/cde ( rr) 18 6 21 3 
Rhnull 
Australian (E. N. ) 3 21 11 13 
U. S. A. (H. H. ) 3 21 11 13 





An evaluation of the simultaneous occurrence of ficin-reactive "anti-nl" and ficin-reactive 
"anti-dl" or antiglobulin-reactive "anti-dl" 
No. of red cell eluates showing presence of: 
Ficin-reactive "anti-dl" An t i glob u 1 in reactive "anti-dl" 
No. of red cell eluates 
examined for: ++++ ++ ++++ ++ 
+++ + +++ + 
Ficin-reactive "anti-nl" ++++)11 0 1 10 3 2 6 
+++) 
++ ) 7 0 0 7 1 4 2 
+) 
6 2 0 4 0 1 5 






An evaluation of the simultaneous occurrence of antiglobulin-reactive "anti-nl" and antiglobulin-
No. of red cell eluates 
examined for: 
Antiglobulin reactive 








reactive 1'anti-dl" or ficin-reactive "anti-nl" 
No. of red cell eluates showing presence of: 
































globul in test was uncommon. Thus it was distinctly 
unusual to demonstrate both autoantibodies by a single 
serological technique. 
In an experiment designed to dete~mine the frequency 
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of complement activity in relation to a number of other 
parameters so far mentioned it could be shown that com-
plement components appeared only in those red cell eluates 
which also revealed strong ficin-reactive autoantibodies. 
In addition, strong ficin~reactive autoantibodies were 
often strongly reactive in the indirect antiglobulin 
test using anti-IgG and generally possessed a high incid-
ence of both anti-nl and anti-dl autoantibodies, the 
latter being uncommon among the weak ficin-reactive auto-
an t i b od i e s . It was also observed that the occurrence of 
complement components in the red cell eluates is not nec-
essarily associated with the presence of antibodies 
strongly reactive in the indirect antiglobulin test using 
ant i- IgG. Thus, using anti-complement sera nearly the 
same percentage of eluates reactive for the indirect 
antiglobulin test was found whether the eluates gave a 
strong or weak positive reaction with anti-IgG. 
A much better correlation was therefore evident be-
tween the occurrence of complement and a strongly posit-
ive ficin test. Table 53 demonstrates that six out of 
eight red cell eluates containing a combination of both 
anti-nl and anti-dl activity possessed complement compon-
ents. In contrast, none of the 16 eluates with either 
specific anti-nl or specific anti-dl activity (but not 
both) contained complement components. Thus all the red 
TABLE 53 
Relationship of indirect antiglobulin pattern to presence of "anti-nl" 





"Anti-nl" "Anti-dl" No. of red Percent-
cell elu- age 
Positive using anti- 18 
IgG only 75% 
Positive with anti-
IgG and anti-complement 6 
25% 
++++ denotes strong agglutination; 


































cell eluates containing complement components had both 
anti-nl and anti-dl activity. 
4. DISCUSSION 
This investigation was carried out to characterize 
autoantibodies found in the serum and on the red cells of 
patients with acquired haemolytic anaemia of the 'warm' 
type. Antibodies of varying specificity were found in-
cluding those specifically reactive against well-.defined 
red cell antigens (anti-e, anti-E), against all normal 
red cells (anti~nl) and against Rhnull red cells (anti-
dl). Antibodies against well-defined red cell antigens 
were found in the serum only and not in the red cell 
eluates, suggesting that in thls series such antibodies 
were isoantibodies resulting from blood transfusion. 
In contrast, anti-nl and anti-dl autoantibodies were 
often detected in the red cell eluates as well as in the 
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serum; they were observed either singly or in combination 
(anti-nl 54%, anti-nl plus anti-dl 33%, anti-dl 13%). Such 
antibody specificity was best delineated using both the 
an t i g I obul in t est and the f ic in t es t. Some autoantibodies 
were detected only by one or the other of these techniques. 
This is analogous to some Rh isoantibodies since on rare 
occasions Rh isoantibodies can be identified only by serol-
ogical techniques utilizing erythrocytes treated with pro-
teolytic . enzymes but not by the antiglobulin test (Vas et 
al. 1962; Kornstad et al. 1960) or conversely, only by 
the latter procedure but not the former (Lucia et al. 1960: 
Viessen et al. 1964). This confirms Race and Sanger's 
(1954) observation that Rh antibodies can exist which are 
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sharply separated from each other both by the nature of 
their antigenic specificity as well as by the technique 
needed for their demonstration. The latter distinctions 
are presumably explained by subtle differences in anti-
body molecular structure even within a given major immuno-
globul in class. Hence, antibody formation in AHA could 
be the result of sequential immunization which closely 
resembles the manner in which different combinations of 
specific Rh-isoantibodies are produced. For example, re-
peated episodes of immunization by DCe cells can result 
in the production of Rh-antibodies commencing from anti-D 
alone to anti-D and separable anti-C and then to a combin-
ation of anti-D and anti-CD (anti-G) (Vos, 1960). This 
might be analogous to the formation of anti-nl, anti-dl 
and then combined anti-nl and anti-dl. 
Another aspect of this study relates to the finding 
that AHA autoantibodies frequently fix complement to ery-
throcytes in vivo (Dacie, 1962). Red cell eluates may 
contain not only antibody but also components of comple-
ment which can be detected by the indirect antiglobulin 
test using an anticomplement reagent (Leddy, et al. 1965; 
Eyster et al. 1967; Petz, et al. 1968). It appears that 
such components of complement are fixed to the antibody 
and are carried with it in the eluate. Since in this 
study a source of fresh complement was not added during 
the incubation period of the indirect antiglobulin test, 
the antibody in the elua t e did not fix complement to the 
red cells at that time . 
Leddy and Bakemeier (1967) considered the possibility 
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that non-complement-fixing autoantibodies were 'Rh-related' 
and that complement-fixing autoantibodies were 'non-Rh-
related'. In support of this suggestion they found that 
the eluates from AHA red cells with a positive direct 
antiglobuljn reaction for both IgG and complement usually 
contained autoantibodies reactive with Rhnull cells whereas 
eluates from red cells that had a direct antiglobulin test 
positive for IgG only usually lacked reactivity with Rhnull 
cells. Results obtained with 24 eluates indicate, however, 
that anti-nl autoantibodies may be present with anti-dl 
, 
autoantibodies and that when both are present complement 
components will also be detectable in the eluate, whereas 
with anti-dl autoantibodies alone complement components 
need not necessarily be found. 
Since there is ample precedent for the fixation of 
complement components by multiple Rh isoantibodies (Harboe 
et al. 1963; Rosse, 1968) and since the absorption studies 
revealed multiple autoantibodies in those eluates contain-
ing complement components, there would seem to be no need 
to propose a 'non-Rh-related' autoantibody when complement 
fixation is present (Leddy et al. 1967). Hence it is pre-
ferred to hypothesize that the presence of complement com-
ponents in association with a combination of anti-nl and 
anti-dl autoantibodies is analogous to complement fixation 
produced by mUltiple Rh isoantibodies. In considering 
these autoantibodies of mUltiple specificity the more fre-
quent occurrence of anti-nl (Table 53) suggests that this 
autoantibody might indicate an early state of autoantibody 
production. The progressive formation of anti-nl with 
anti-dl which then tends to result i~ the fixation of 
complement on the eryth~ocytes may well be a natural pro-
gression to a more advanced ~tate of autoimmunization 
comparable with the development of Rh iso~ntibodies where 
as a rule anti-D is more often noted in the early stages 
of isoimmu~ization than ~nti-CD. 
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Chapter XV 
THE IMMUNOGLOBULIN CHARACTERISTICS OF 
ACQUIRED HAEMOLYTIC ANAEMIA AUTOANTIBODIES 
1. INTRODUCTION 
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The red cells of patients with acquired haemolytic 
anaemia of the 'warm' type are known to be coated with 
immunoglobulins which not only represent various specific-
ities of autoantibodies but also structural differences 
in the physicochemical composition of the autoantibody 
(Weiner and Vos, 1963; Vos, Petz and Fudenberg, 1970; 
Dacie and Worlledge, 1969; Leddy, Peterson, Yeaw and Bak-
emeier, 1970). Therefore the activity of the antibody can 
sometimes only be determined by using antisera specific 
against a variety of immunoglobulins. 
It has also been shown that some patients may form a 
mixture of specific autoantibodies, some components of 
which may react with all, or almost all, human red cells. 
Although such antibodies appear to lack specificity, in-
dividual specificities can often be demonstrated by sel-
ective absorptio~ and elution studies using rare red cell 
antigens. In this way it was shown that the autoantibod-
ies recovered from the red cells may possess different 
specificities against one or another well-defined red 
cell antigen closely associated with the Rh system (see 
Chap t er XI II). 
This study was designed to determine the incidence of 
IgG, IgM or IgA coating the red cells of 55 patients with 
acquired haemolytic anaemia of the 'warm' antibody type. 
It was important to establish whether one or more aut o-
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antibodies specific for each red cell antigen determinant 
found in erythrocyte eluates was correlated with the pres-
ence of more than one immunoglobulin class of antibody and 
wi th the presence of complement components. 
2. MATER IALS AND METHODS . 
Fifty-five consecutive patients with autoimmune haem-
olytic anaemia of the 'warm' type, as defined by haematol-
ogical and serological criteria (Dacie, 1962) and with 
strongly positive dire~t Coombs' tests, were studied. 
Red cells were s,eparated from defibrinated blood immed-
iately after collection. Tpe cells were then washed four 
times' with 40-fold volumes of isotonic sodium chloride 
solution (0.85%) and stored at _20 0 C for varying periods 
as a 50% concentration of packed red cells in saline. 
Reagents - Monospecific anti-IgG, ~nti-IgM and IgA were 
used. Specificity of these reagents was determined by 
haemagglutination techniques and not by immunoelectrophor-
esis. The reaction patterns of these antisera conformed 
with the findings of Engelfriet et aI, (1968). The anti-
complement serum used was prepared as described by Harboe 
et al. (1963). Previous experiments revealed that the 
antiserum was specific for complement components C3 and 
C4. 
Red cells used - To detect known antibody systems a sel-
ected panel of red cells was used. Antibody absorption 
and elut~on studies were performed with CDe/cDE red cells 
partially deleted red cells of the phenotype -D-/-D- and 
, 
fully deleted Rhnull ---/--- red cells. The Rhnull bloods 
used were obtained from the original Rhnull Australian 
Aborigine and the Japanese Rhnullo 
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Absorptions - Red cell eluates reactive with normal cells, 
partially deleted cells and fully deleted Rhnull red cells 
were absorbed using equal volumes of eluate against washed, 
packed Rhnull red cells. If all the antibody was completely 
removed by these red cells the specificity was considered 
to be 'anti-dl'. If the Rhnull cells removed the antibody 
against Rhnull cells but left an antibody that still re-
acted with normal and partially deleted red cells a second 
absorption was carried out using partially deleted cells. 
Removal of all antibody activity for partially deleted 
cells indicated that the eluate also contained 'anti-pdl'. 
If the eluate continued to show antibody activity for 
normal red cells the specificity was considered to be 
'anti-nl'. Using this method of abscrption a clear diff-
erentiation of the type of specific antibody or antibodies 
present could be established. 
3. RESULTS 
Three specific varieties of autoantibodies were recov-
ered from the red cells of patients with acquired haemoly-
tic anaemia. These antibodies were classified in accord-
ance with the antigenic make-up of a number of selected 
red cells as shown in Table 47. (page 169). 
55 red cell eluates were examined for the presence of 
one or more varieties of autoantibodies. As shown in 
Table 54, antibodies with a single specificity (anti-nI, 
or anti-pdl or anti-dl) were more often present (63%) in 
the eluates than antibodies with mUltiple specificities 
TABLE 54 
Distribution of "anti-nl", "anti-pdl ll and "anti-dIll 
in 55 red cell eluates 
Au toant ibody spec i f ic i ty No observed Percentage 
An t i-nl 24a 44) 
Ant i-pdl 5 9) 63% 
Anti-dl 6 11 ) 
Anti-nl plus pdl 4b 7) 
Anti-nl plus pdl plus dl 14 26) 37% 
Anti-pdl plus dl 2 3) 
Total: 55 
a Two red cell eluates in this group disclosed 
antibody activity for well defined Rh antigens, 
one anti-e and one anti-C. 
b One red cell eluate in this group possessed 
anti-e in addition to anti-nl and anti-pdl. 
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(37%). Table 5~ also shows that antibodies with 'nl' 
specificity were more frequent (77%) than antibodies with 
specificities 'anti-pdl' (46%) or'anti-dl' (40%). Three 
red cell eluates showed the presence of antibodies for 
192 
well-defined Rh antigen in addition to 'anti-nl' or 'anti-
pdt' . Tab Ie 55 descr ibes thi s ob serva t i on f or one examp Ie 
(eluate S.C.). This eluate failed to react with Rhnull 
cells but not with partially deleted (-0-/-0-) cells, 
indicating the absence of 'anti-dl' and the presence of 
'anti-pdl' (experiment 1). After absorption with -D-/-D-
red cells (experiment 2) the eluate retained antihody 
activity for six examples of normal red cells, suggesting 
the presence of 'anti-nl'. Subsequent absorption of this 
eluate by cDE/cDE red cells (experiment 3) disclosed the 
presence of anti-e. The 'anti-nl' activity was absorbed 
onto cDE/cDE cells and could be recovered by re~elution 
from the sensitized cells (experiment 4). 
Table 56 relates the autoantibody specificity to the 
results of indirect antiglobulin tests using antiglobulin 
reagents specific for IgG, IgM, IgA and complement. As 
shown, antibodies with single-blood-group specificity 
usually consist of a single class of immunoglobulin, but 
this is not true of red cell eluates containing two or 
three specific autoantibodies. Thus eluates of mUltiple 
specificities always contained more than one class of 
immunoglobulin. As further indicated in Table 56, comple-
ment compone;nts were detected in 18 of 55 red cell eluates 
examined (33%). All these pa t ients had positive direct 
an t i g 1 obul in tes t s with ant i-c omp 1 ement reagen t s. The 
TABLE 55 
Absorption experiments with red cell eluate S.C. 
Expt. Procedure Test Cells 
No. 1 2 3 4 5 6 7 8 
cDE/cDE CDe/CDe CDe/cDE cdE/cdE Cde/Cde cde/cde -D-/-D- ---/---
1 Original eluate 4 a 4 4 4 4 4 2 0 
2 Original eluate after ab-
s orp't i on wit h test cell 4 4 4 4 4 4 0 0 
No. 7 
3 Absorbed eluate from ex-
periment 2 reabsorbed 0 2 1 0 2 2 0 0 
wi th test cell No.1. 
4 Re-elution of test cell 
No.1. after sensitizat- 4 4 4 4 4 4 0 0 
ion with absorbed eluate 
from Experiment 2 
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demonstration of complement components was associated 
only with antibodies of multiple immunoglobulin clas ses 
or multiple antibody specificities. In contrast, c omple-
ment was not demonstrable in red cell eluates poss e ssing 
only one immunoglobulin type and a single specif i c auto~ 
ant ibody. Table 57 shows that autoantibodies of a single 
specificity were more often of the IgG than IgM o r I gA 
class. IgG autoantibody (and to a lesser extent IgM auto-
antibody) was most often observed when the autoantibody 
had specificity for a single red cell antigen. Multiple 
specificities were frequently associated with a wider 
range of immunoglobulin types, particularly IgM and IgA. 
The observed variation in the distribution of different 
types of immunoglobulin might perhaps be attributed to 
renewed episodes of antibody stimulation by reactive red 
cell antigens that are not coated by a specific antibody. 
4. DISCUSSION 
This investigation has shown that eluates of red ce lls 
f r om patients with acquired haemolytic anae~ia conta in 
autoantibodies of differing Rh specificities. 
specifically reactive against well-defined red cell a nt-
igens of the Rh system (anti~e, anti-C and the like) 
, 1 
others against all normal red cells (anti-nl), partiall y 
deleted Rh red cells (anti-pdl) and fully deleted Rh red 
cells (anti-dI). Autoantibodies directed against the 
patient's own well-defined CDEce antigens are seldom 
found in the red cell eluates. In contrast, anti-nl , 
anti-pdl and anti-dl were the predominating autoantibod-
ies, either singly or in combination. Such ant ibodie s 
TABLE 57 
Frequency of various immunoglobulin classes observed in 55 acquired 
haemolytic anaemia eluates 
Autoantibody combinations 
Single specificity, e. g., anti-"nl" 
anti-"pdl" or anti-"dl" 
Multiple specificities, e.g. anti-
"nl" + "pdl" + "dl", etc. 
Combined single and multiple spec-
ificities 
Immunoglobulin class of 
autoan t i body 
IgG IgM IgA 
27 11 0 
20 17 6 
47 28 6 
..... 
"" C1' 
could be formed by a sequential process of in vivo 
immunization. 
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Serum complement components on the red cells seem to 
be associated exclusively with autoantibodies of multiple 
immunoglobulin classes or mUltiple red cell specificities. 
The fixation of complement on the red cells of patients 
with acquired haemolytic anaemia together with the pro-
gressive formation of multiple red cell antibodies may 
represent the natural evolution of the disease. 
The variability in multiple antibodies may reflect 
continuous differences in the inciting stimulus resulting 
from altered configuration of red cell antigenic determin-
ants. Assuming ' that trapping and processing of antigen 
are prerequisites for the induction of antibody response 
it may be postulated that an adequate concentration of 
anti-nl on the red cell antigen site inhibits fu~ther 
synthesis of this antibody but not necessarily the enhance-
ment ' of antibody synthesis for other unbound antigens on 
the immunizing red cells (anti-pdl and anti-dl). The 
suggestion that multiple antibody and immunoglobulin form-
ation follows a predetermined course of development as a 
consequence of variability in antigen presentation is not 
in full agreement with the idea that the disease primar-
ily results from an aberration of the immune mechanism. 
The findings suggest that the initial site of action of 
autoantibody development to Rhesus-antibody-implicated 
haemolytic anaemia (anti-nl, anti-pdl and anti-dl) res-
ults from a defect of the structural composition of the 
Rhesus genome which is thereafter rejected by the normal 
immune mechanism. The subsequent development of addit-
ional specificities to other red blood cell antigens 
involving multiple immunoglobulin classes does not nec-
essarily indicate an aberrant immune apparatus. 
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The observed pattern of serological and immunological 
findings does not support the concept that red cell auto-
antibodies are a homogeneous population of immunoglobulins, 
at least not in the same sense that myeloma globulins are 
products of monoclonal proliferation. 
The concept that modification of an individual's red 
cell antigen can lead to the production of autoantibodies 
has been reported by others (Worlledge, Carstairs and 
Dacie, 1966; Mohn, Lambert, Bowman and Brason, 1965; van 
Loghem, 1965). It is postulated that the initial defect 
in most cases of autoimmune haemolytic anaemia does not 
involve an aberration of the antibody-forming mechanism 
but a modification of the Rh antigen determinant. 
Chapter XVI 
THE VARIOUS SPECIFICITIES OF AUTOANTIBODIES 
FOUND IN ACQUIRED HAEMOLYTIC ANAEMIA WITH 
SPECIAL REFERENCE TO THE LW FACTOR 
1. INTRODOCTION 
It has been established that patients with autoimmune 
haemolytic anaemia of the 'warm' type may form mixtures 
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of specific autoantibodies which react with all, or almost 
all, human red cells (Table 54). It has also been found 
that acquired haemolytic anaemia of the 'warm' type can 
be associated with autoantibodies to blood group factors 
LW and U (Celano and Levine, 1967, Nugent, Coledge and 
Marsh, 1971), suggesting that not all autoantibodies 
possess specificities against 'Rh-associated antigens' 
( an t i - n I, an t i - pd I, an t i - d 1) • 
The LW antigen is almost always found in human bloods 
bearing anyone or more of the known Rh antigen determin-
ants (DCEce), and is always lacking from the fully del-
eted RhnuII (---/---) red cells, indicating that the LW 
factor is closely linked to the Rh system (see Chapter 
XI1) • It was particularly important in the present in-
vestigation to establish whether autoantibodies to the LW 
factor may be regarded as a possible variant of one of the 
'Rh-associated antibodies' so far described. Confirmat-
ion of an association between LW and the various types of 
autoantibodies detailed in the previous chapters would 
not only further our knowledge of the LW system but would 
also help to place the 'nl', 'pdl' and 'dl' varieties of 
antigens (Table 47) more closely within the framework of 
the Rh system. 
Reports that autoantibodies are directed against other 
blood group antigens such as Kidd (van Loghem, J.J. and 
Hart, v.d.M., 1954), Kell (Da14sset and Colombani, 1959) 
and Xga are rare. 
2. MATERIALS AND METHODS 
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Selected AHA patients were studied because their red 
cell eluates had previously been shown to contain multiple 
antibodies. The panel of red cells used (Table 59) had 
been stored in a buffered glycerol citrate solution at 
-20 0 C. Frozen cells were recovered by Weiner's method 
(1961) using Visking dialysis tubing. In no instance did 
the frozen and thawed red cells react differently from 
fresh cells before storage. 
Antiglobulin tests were performed using standard tech-
niques and antiglobulin serum that had previously been 
evaluated in detail (Chapter XV). 
Absorption studies on AHA eluates were carried out 
using equal v~lumes of eluate and washed packed red cells. 
After incubation at 37 0 C for one hour the red cells were 
washed four times in saline. Antibody elution was then 
performed on a 50 per cent saline suspension of the red 
cells. The ether elution procedure of Vos and Kelsall 
(1956) was used, modified only in that ether was added 
directly to the 50 per cent suspension of packed washed 
red cells. The sequence of absorption and re-elution 
used for the differentiation of the type of specific anti -
body to be recovered is detailed in the Results. 
For the formation of anti-LW guinea pigs were given 
subcutaneous injections, at two-weekly intervals, of a 
5 per cent suspension of washed LW positive cells mixed 
in equal volumes of Freund's complete adjuvant. This 
produced intense antibody responses within 8 to 10 weeks. 
For absorption studies, the highest dilution of guinea 
pig serum giving the strongest reaction with the immuniz-
ing red cells was accepted as the optimal starting dilut-
ion. Using this procedure repeated absorption of the 
antibody with valuable LW negative red cells was avoided. 
The range of antibody titre values scored was between 
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1:512 and 1:4096. It was found that the method of Levine 
and Celano (1967) in which guinea pigs were given six 
intraperitoneal injections of a 25 per cent suspension 
of LW positive cells at intervals of three to four days 
resulted in considerably lower responses. 
3. RESULTS 
Table 58 records the indirect antiglobulin titre val-
ues of eight selected AHA eluates tested against a panel 
of red cells capable of differentiating a variety of spec-
ific antibodies. Six of the eight eluates revealed signif-
icant differences in reactivity when they were tested 
against red cells of varying genotypes, suggesting that 
mixtures of specific autoantibodies may be involved. 
Table 59 summarizes the results of antibody determinat-
ions performed on the same eluates using two different 
sets of panel cells. The findings show that cell panel 1 
was limited in its scope for detecting anti-U and anti-LW 
because it lacked the required cell types to differentiate 
TABLE 58 
Indirect antiglobulin reactions of various AHA red cell eluates for known red 
cell types 
Red Cell Eluates from Acquired Haemolytic Anaemia Patients 
Red Cell Type BN BL SF CT FR MT VP BS 
cDE/cDE, LW+, u+ 512 >:< 16 256 4 32 128 64 256 
cde/cde, LW+, u+ 256 16 256 4 32 128 64 256 
CDe/CDe, LW+, u- 512 16 256 4 32 128 64 256 
cDE/cde, LW+, u- 256 16 256 4 32 128 64 256 
CDe/ cde, LW-, u+ 256 16 256 4 8 128 64 256 
-D- / -D-, LW+, u+ 256 16 256 4 32 128 64 32 
---/---, LW- , u+ 8 4 256 4 0 0 64 0 
---/---, LW- , u- 0 4 256 0 0 0 64 0 














Specificities of autoantibodies recognized by selective absorption and 
elution studies using different panels of red cells. 
Antibodies in eluates from patients' red cells recognized by: 
Panel 1 
CDe/CDe, LW+, U+ 
crE/ cDE, LW+, U+ 
cde/cde, LW+, U+ 
-D- / -D-, LW+, U+ 







an t i-dl 
anti-nl, anti-e, anti-pdl 
13 specific autoantibodies 
Panel 2 
CDe/CDe, LW+, U-
cDE/ cDE, LW+, U+ 
cde/cde, LW+, U+ 
cDE/ cde, LW+, U-
CDe/cde, LW-, U+ 
anti-pdl, anti-U 
-D-/-D- LW+ U+ , , 
---/--- LW- U+ , , 
- - - / - - - , LW - , U-
anti-pdl, anti-dl, anti-LW 
anti-pdl, anti-dl, anti-LW 
an t i - LW , an t i - U 
anti-pdl, anti-LW 
anti-nl, anti-pdl, anti-LW 
an t i - d I, anti - U 
anti-nl, anti-e, anti-LW 




anti-U from anti-nl and anti-pdl, and also anti-LW from 
ant i-pdl. 
Restrictions on the availability of rare cell types, 
particularly the CDe/cde, LW-negative, U-positive cells 
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of Mrs Bigelow (De Veber, Clarke, Hunking and Stroup, 1971) 
and the Japanese Rhnull, LW-negative, U-positive blood 
(Ishimori and Hasekura, 1967) reduced the opportunity of 
isolating the full spectrum of autoantibodies. 
Table 60 shows the results of specificity testing using 
red cell eluate FR. This autoantibody had previously been 
classified as anti-pdl (Table 59) when a more limited 
panel of test cells was used. The demonstration of anti-
LW specificity and the close association of this antibody 
with anti-pdl was recognized when the rare CDe/cde, LW 
negative red cells of Mrs Bigelow were included. As shown 
in Table 60, step 1, the antibody in eluate FR reacted 
more strongly with LW positive cells than the LW negative 
cells of Mrs Bigelow. The eluate did not react with the 
two Rhnull LW negative red cells indicating the presence 
of anti-pdl, or anti-pdl + nl and possibly anti-LW as 
well. Step 2: Absorption of the antibody from the orig-
inal eluate with test cell number four (-D-, LW+,U+) which 
has pdl, LW and U antigens but not nl, completely removed 
all antibody activity indicating pdl, or pdl plus LW spec-
ificity. Step 3: The original eluate after one absorpt-
ion with test cell number 3 (CDe/cde, LW-, U+) retained 
antibody activity for LW positive test cells only. Step 4: 
Re-elution from test cells number 4 (-D~, LW+) following 
step 2, established the presence of an antibody that sen-
TABLE 60 
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* Titres are expressed as reciprocals of highest dilution giving definite positive 





sitized LW positive red cells more strongly than the LW 
negative red cells of Mrs Bigelow (test cell 3). This 
eluate was then tested against over 200 random samples of 
blood to determine whether other examples of weak positive 
reactions similar to the weak reactions observed with Mrs 
Bigelow's red cells could be recognized but none were 
found. 
Table 61 illustrates the results obtained when eluate 
PM, which reacted with all cells tested except Rhnull, 
was absorbed with various cells including animal cells. 
One absorption of the eluate with Mrs. Bigelow's CDe/cde 
LW negative cells removed activity for her cells completely 
and reduced the reaction against cde/cde LW positive and 
CDe/cde LW positive cells. Absorption with cde/cde LW 
positive cells removed the activity against Mrs Bigelow's 
cells and CDe/cde LW positive cells and reduced the activ-
ity against CDe/cDE LW positive cells. Ab sorpt i on wi th 
CDe/cDE LW positive cells removed all antibody activity. 
Baboon and monkey cells also removed all antibody activ-
ity but absorption with sheep, rabbit or horse did not. 
These results expand the observations made in Table 60. 
The data may be interpreted as follows: If Mrs Bigel-
ow's cells represent a weak variant of LW the antibody 
recovered from the -D-/-D-, LW positive sensitized red 
cells (Table 60), step 4) can be designated as anti-LW 
ra ther than an t i-pdl. This implies that Rhnull red cells 
would remain as the true LW negative bloods, as originally 
described by Levine, Celano, Vas and Morrison (1962), The 
ability of anti-pdl to react more strongly with LW posit-
TABLE 61 
Absorption experiments with red cell eluate PM 
Reactions with test 
CDe/cDE CDe/cde cde/cde 
LW+ LW+ LW+ 
Before absorpt ion ++++ ++++ ++++ 
Rhnull, LW- +++ +++ +++ 
CDe/cde,LW- +++ ++ + 
cde/cde,LW+ + 0 0 
Ab sorbing CDe/cDE,LW+ 0 0 0 
cells Baboon 0 0 0 
Monkey 0 0 0 
Sheep ++++ ++++ ++++ 
Rabbi t ++++ ++++ ++++ 





























ive test cells (Table 60, step 4) and very weakly with 
the LW negative test cells of Mrs Bigelow, may be inter-
preted to imply that anti-pdl is anti-LW plus anti-LW1 
which may be compared with a group B serum with anti-A 
plus anti-A1. If such an analogy exists then it might 
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be expected that absorption of anti-LW plus LW1 (anti-pdl) 
by a subgroup of LW (e.g. Mrs Bigelow) should leave un-
absorbed anti-LW1 activity and that the eluate from the 
absorbing red cells would contain anti-LW and react with 
LW positive cells. This hypothesis was confirmed by ab-
sorbing the original eluate with Mrs Bigelow's red cells 
(Table 60, step 3). These cells not only removed the LW 
activity from anti-LW plus LW1 but also considerably re-
duced the strength of anti-LW1, a feature which parallels 
the preparation of anti-A1 serum which has been absorbed 
with group A2 cells. The results in Table 61 confirm and 
expand these findings as monkey and baboon cells are known 
to be rich in LW antigen (Levine and Celano, 1962). The 
results further suggest that homozygous D positive cells 
have more LW antigen than heterozygous D positive cells, 
which have more LW antigen than D negative cells . 
To confirm that Mrs Bigelow does possess a weak LW 
antigen her cells were injected into guinea pigs. The 
results are shown in Table 62. The antibody formed by 
Mrs Bigelow's cells was exactly the same as that observed 
after injection of LW positive cells. In all the immuniz-
ation experiments, whether Rh positive, LW negative, or 
Rh positive LW positive cells were used, the guinea pigs 
always produced two types of antibody; one that reacted 
TABLE 62 
Absorption experiments using guinea pig antisera to Rh positive LW-(Mrs Bigelow) cells 
Reactions with test cells 
CDe/cDE CDe/cde cde/cde CDe/cde Rhnull 
LW+ LW+ LW+ LW- LW-
Before absorption ++++ ++++ ++++ ++++ ++++ 
RhnuII, LW- ++++ +:+- ++ +++ ++ 0 
CDe/cde, LW- ++++ +++ + 0 0 
cde/cde, LW+ ++ (+) 0 0 0 
Ab sorbing CDe/cDE, LW+ 0 0 0 0 0 
cells Baboon 0 0 0 0 0 
Monkey 0 0 0 0 0 
Sheep ++++ ++++ ++++ ++++ ++++ 
Rabb it ++++ ++++ ++++ ++++ ++++ 





with all human cells and could be removed with one absorpt-
ion with Rhnull cells {probably anti-dl)j and an antibody 
that reacted exactly the same as the eluate shown in Table 
61. The reactions of this antibody were apparent only 
after the guinea pig serum had been absorbed with Rhnull 
cells. The guinea pig antibody for Rh positive, LW posit-
ive red cells could always be completely removed by one 
absorption with Rh positive, LW positive cells and red 
cells from baboons and monkeys, suggesting that these 
red cells possess an abundance of LW sites. 
Autoantibodies reactive for Rhnull cells were observed 
in nearly 40 per cent of 51 red cell eluates from AHA 
patients (Chapter XIII). They were found either singly 
or in combination with other Rh-related autoantibodies. 
The activity of autoantibodies for Rhnull red cells can 
be removed by absorption with any human or non-human 
primate red cells but not sheep, rabbit or horse red cells. 
This is illustrated in the results obtained with eluate 
KP. (Table 63) where it was found that the specificity 
of the antibody may be directed against the 'nucleus of 
the Rh substance', as postulated by Wiener, Gordon and 
Gallop (1953). The ability of Rhnull cells to separate 
this autoantibody from other varieties of Rh-related anti-
bodies influenced us to classify this autoantibody as 
an t i - d I (i. e. ' del e t i on' ) • 
Guinea pigs injected with the original RhnuII red cells 
produced antibodies which were identical to those recovered 
in the eluates from the red cells of some patients with 












Absorption experiments with red cell eluate KP 
Reac t ions wi th test cells 
CDe/cDE CDe/cde cde/cde CDe/cde 
LW+ LW+ LW+ Uf-
++++ ++++ ++++ ++++ 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
++++ ++++ ++++ ++++ 
++++ ++++ ++++ ++++ 













tv ..... ..... 
known varieties of Rh-related antibodies observed, e.g. 
anti-LW in guinea pigs injected with Rhnull red cells. 
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Table 64 shows the results obtained with a third var-
iety of Rh-related autoantibody often recovered from the 
red cells of AHA patients. These antibodies do not agglut-
inate partially deleted -D-/-D-, LW positive red cells 
and Rhnull cells but react with all other red cells (i.e. 
anti-nIL Their specific activity seems to be directed 
towards a region of the Rh antigen representing the CcEe 
sequences. The antibody can be completely absorbed by Rh 
positive, LW negative, and Rh positive, LW positive cells 
but not with red cells from baboons and monkeys. In our 
immunization studies we were never successful in produc-
ing this type of antibody in guinea pigs. Experiments 
are now in progress to establish whether antibodies to 
the CcE:e reg i on may be more read i I y produced in non-human 
primates. Like the donor of the partially deleted -D-/-D-
red cells they are known to lack these particular determin-
ant s. 
4. DISCUSSION 
Nugent, Coledge and Marsh (1971) and Marsh, Reid and 
Scott (1972) recently reported anti-U as a specific auto-
an t ibody in AHA. They also postulated that the 'Rh related' 
autoantibodies which often fail to be identified as spec-
ific Rh antibodies may in fact be anti-U. In our study 
the reactions of red cell eluates from eight AHA patients 
were examined against a selected combination of extremely 
rare types of red cells. Absorption and elution experi-
ments showed autoantibodies with U specificity to be found 
TABLE 64 
Absorption experiments using a selected red cell eluate which did not react 
with Rhnull or partially deleted red cells 
Reac t ions wit h test cells 
CDe/cDE CDe/cde cde/cde CDe/ cde -D- / -D- Rhnull 
LW+ LW+ LW+ LW- LW- LW-
Before absorption ++++ ++++ ++++ ++++ 0 0 
CDe/ cde, LW- 0 0 0 0 0 0 
cde/ cde, LW+ 0 0 0 0 0 0 
Absorbing CDe/cDE, LW+ 0 0 0 0 0 0 
cells -D-/ -D-, LW+ ++++ ++++ ++++ ++++ 0 0 
Baboon ++++ ++++ ++++ ++++ 0 0 
Monkey ++++ ++++ ++++ ++++ 0 0 
N .... 
W 
in some, but not all, preparations of red cell eluates. 
Thus, no association between anti-U activity and other 
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'Rh related' autoantibodies was found and the suggestion 
by Nugent et al. (1971) that the reported 'Rh related' 
antibodies may be anti-U in specificity was not confirmed. 
In eight selected AHA eluates two examples of anti-nl, 
five anti-pdl, three anti-dl, six anti-LW, one anti-e and 
three anti-U autoantibodies were observed. This repres-
ents an 85 per cent incidence of antibodies with specific-
ities related to the Rh system and a 15 per cent incidence 
of anti-U. Considering that almost all autoantibodies so 
far described are related to the Rh system, the finding 
of a 15 per cent incidence of anti-U lends support to the 
suggestion that some association may exist between Rh and 
U antigens (Schmidt, Lostumbo, English and Hunter, 1967). 
The 'pdl' autoantibody is often found in AHA eluates 
and is known to react with all human red cells except 
Rhnull. Previously this antibody could not be classified 
as anti-LW because it sensitized Mrs Bigelow's 'LW negat-
ive' red cells. In the present study it was particularly 
interesting to find that Mrs Bigelow's LW negative red 
cells could separate anti-pdl into anti-pdl plus anti-LW 
(Table 60), It therefore appears that although Mrs Big-
elow has been accepted to be LW negative there is a weak 
form of LW antigen present. The presence of LW antigen 
on Mrs Bigelow's red cells was also established by inject-
ing her red cells into guinea pigs (Table 62), 
It is tempting to suggest an analogy to the ABO system 
and postulate that Rh positive cells represent LWl; Rh 
negative cells, LW2 (as suggested by Levine and Celano, 
1967) and Mrs Bigelow, LW3. Rhnull appears to be the 
true LW negative (? lw). It will be interesting to see 
whether known Rh negative, LW negative samples represent 
215 
a weaker form of LW than Mrs Bigelow, who is Rh positive. 
A contradiction of this analogy would be that if Mrs. Big-
elow represents LW3, comparable to A3 in the ABO system, 
then the anti-LW in her serum should react with only LWl 
(i.e. Rh positive) red cells, comparable to the anti-Al 
found in the serum of an A3 individual. However, the 
anti-LW reacts strongly with Rh positive (LW1) cells and 
weakly with LW2 (Rh negative) cells. It is possible that 
the results are simply reflecting a quantitative rather 
than qualitative difference. Even though anti-Al usually 
does not agglutinafe A2 cells, some workers have reported 
that anti-Al found in Ax individuals reacts with both Al 
and A2 cell s (I s sit t, 1 970 ) • 
We know there is a quantitative effect, as anti-Al can 
be removed by several absorptions with A2 cells. This dem-
onstrates that anti-Al does react with A2 cells. By anal-
ogy ant i-LWl reacts wi th LWl strongly and LW2 weakly. The 
only difference between the reactions of LWl and those of 
anti-Al with Al and A2 cells is that the LW reactions are 
demonstrated by strong agglutination versus weak agglutin-
ation, whereas the Al, A2 reactions are demonstrated by 
agglutination versus absorption. The results of these 
studies indicate that LW represents a spectrum of variat-
ions from LW1, LW2, LW3 and maybe LW4. LW vari es even be .. 
tween homozygous D positive and heterozygous D positive 
individuals which adds to the evidence of the very close 
assoc ia t i on between D and LW. 
SUMMARY 
The discovery of red cells lacking some (D--/D--) or 
all (---/---) Rh antigen determinants made it possible 
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to identify not only the so-called 'non specific' auto-
antibodies in patients with acquired haemolytic anaemia 
but also to demonstrate more clearly the possible com-
position of the basic structure of the Rh genome. Figure 
7 represents a schematic construction of the Rh chromosome 
developed in the light of our observations. In this model 
it is suggested that the 'deletion' factor (recognized 
by the ability of certain AHA autoantibodies to sensitize 
Rhnull cells) represents a fundamental precursor of the 
Rh gene complex capable of directing the formation of 
specific enzymes for the subsequent development of the 
'pdl' (LW, LW1, LW2), D, 'nl' C,c,E and e determinants. 
The 'dl' factor can always be found on the red cells of 
anthropoid apes, the 'nl' factor never, indicating the 
possible sequence of these factors in the evolution of 
modern man. 
The 'pdl' factor is assumed to have been formed as a 
r,esult of gene duplication, 'pdl' being a precursor of 
the adjacent 'dl' factor in the synthetic pathway b~t 
differing from it in possessing enzymes that will add 
additional specificities to it not possessed by the 'dl' 
fac tor. The subsequent appearance of the 'nl' factor 
adjacent to the 'pdl' factor can be accepted as a later 
expansion of the Rh genome which has occurred only in man. 
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Figure 7 : A model of the Rh chromosomes based on the evaluation 




the D,C,E,c and e determinants is not clear. The i dl' 
factor, being present on Rhnull red cells (---/---) as 
well as on those possessing the D,C,E,c,e determinants 
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(Figure 8) is the least complicated part of the Rh syst~m 
since it has no substance of the LW, D,C,E,c,e variety 
in its structure. It could therefore be considered 
as the primary precursor with enzymatic potential to de-
velop secondary precursors on which the genes giving rise 
to the development of antigens LW, D,C,E,c and e can ex-
ert their effects. 
Evidence that 'non specific' autoantibodies possess 
distinct blood group specificities within the Rh system 
also contributed to a better understanding of the serol-
ogical and immunological characteristics of these auto-
an t i bod i e s. 
In a study of many red cell eluates from patients with 
acquired haemolytic anaemia of the 'warm' type it was 
established that antibodies of varying Rh specificities 
can be involved in the disease. Some are specifically 
reactive against well-defined red cell antigens of the 
Rh system (anti-e, anti-C and the like), some against 
all normal Rh red cells (anti-nl), some against partially 
deleted Rh red cells (anti-pdl) and some against fully 
deleted Rh red cells (anti-dl). Antibodies against well-
defined Rh antigens (CDEce) were not often detected in 
the red cell eluates. In contrast, anti-nl, anti-pdl and 
anti-dl autoantibodies were frequently found. 
The demonstration of serum complement on patients' 
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Figure 8: Rh chromosomes of man and apes and their relationship to 





of multiple immunoglobulin classes or multiple red cell 
specificities. The structural heterogeneity of immuno-
globulin types (IgG, IgM and IgA) for the various variet-
ies of autoantibodies (anti-nl, anti-pdl and anti-dl) can 
be pictured as arising from multiple antibody-forming 
cell lines. 
The findings suggest that the initial site of auto-
antibody development in AHA results from a defect in the 
structural composition of the Rhesus genome, which is 
thereafter rejected by a normal immune mechanism. The 
subsequent development of a more generalized auto-immune 
abnormality involving the formation of multiple autoanti-
body-forming cell lines does not necessarily indicate 
that an aberrant immune apparatus has been established. 
Additional studies using red cell eluates revealed that 
no direct correlation could be established between the 
presence of complement components and the intensity of 
the indirect antiglobulin test using anti-IgG serum. How-
ever, the simultaneous presence of 'anti-nl' and 'anti-dl' 
autoantibodies was often associated with the presence of 
complement components in the red cell eluates. Fixation 
of complement by Rh isoantibodies of mUltiple specificity 
has been reported and thus the presence of complement 
components in association with anti-nl and anti-dl may be 
analogous to complement fixation by mUltiple Rh isoanti-
bodies. The formation of anti-nl with anti-dl which , 
tends to result in complement components being fixed by 
the antibody, may be considered as a natural progression 
of antibody synthesis associated with an advanced state 
of autoimmunization. 
Absorption and elution studies using rare Rh positive 
LW negative cells (Mrs Bigelow) showed that anti-pdl may 
in fact represent anti-LW plus LW1 and that Mrs Bigelow's 
cells may possess a weak variant of LW. Injection of her 
red cells into guinea pigs produced an anti-LW that re-
acted similarly to the antibody produced by injecting Rh 
positive LW positive cells . It is suggested that normal 
Rh positive LW positive cells represent LW1; Rh negative 
LW positive cells represent LW2, Mrs Bigelow's cells LW3 
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